Photocontrolling the Diels-Alder reaction by Göstl, Robert
  
Photocontrolling the Diels-Alder Reaction 
DISSERTATION 
zur Erlangung des akademischen Grades 
d o c t o r  r e r u m  n a t u r a l i u m  
(Dr. rer. nat.) 
im Fach Chemie 
eingereicht an der 
Mathematisch-Naturwissenschaftlichen Fakultät 
der Humboldt-Universität zu Berlin 
von 
Dipl.-Chem. Robert Göstl 
 
Präsident der Humboldt-Universität zu Berlin 
Prof. Dr. Jan-Hendrik Olbertz 
Dekan der Mathematisch-Naturwissenschaftlichen Fakultät 
Prof. Dr. Elmar Kulke 
 
 
 
Gutachter:     1. Prof. Stefan Hecht, Ph.D. 
     2. Prof. Dr. Hans-Werner Abraham 
     3. Prof. Neil R. Branda, Ph.D. 
Tag der mündlichen Prüfung: 10. November 2014 
  
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Die vorliegende Arbeit wurde in der Zeit von Juni 2011 bis August 2014 am Institut für 
Chemie der Humboldt-Universität zu Berlin unter der Anleitung von Prof. Stefan Hecht, 
Ph.D. angefertigt.  
iii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Teile dieser Arbeit wurden bereits veröffentlicht in: / Parts of this work have already been 
published in: 
 
[1] R. Göstl, S. Hecht, Angew. Chem. Int. Ed. 2014, 53, 8784–8787. 
[2] R. Göstl, A. Senf, S. Hecht, Chem. Soc. Rev. 2014, 43, 1982–1996.  
iv 
Danksagung 
Ich möchte mich bei Prof. Stefan Hecht, Ph.D. für das Ermöglichen dieser Dissertation 
bedanken. Unter seiner Anleitung habe ich mich nicht nur fachlich ausgezeichnet 
weiterentwickeln können und stets hervorragende Arbeitsbedingungen vorgefunden, sondern 
habe von ihm im Besonderen auch die Dinge über das wissenschaftliche Arbeiten gelernt, die 
in Lehrbüchern nicht abgedruckt werden. 
Mein weiterer Dank geht an Martin Herder, Dr. Jan J. Klein, Dr. Maria-Melanie 
Russew, Dr. Sonia Castellanos Ortega, Dr. Bernd M. Schmidt, Dr. Philipp Viehmann, Derk 
Jan van Dijken und Dr. Alexis Goulet-Hanssens ohne deren fachliche Kompetenz und 
Freundschaft meine Dissertation in dieser Form nicht zustande gekommen wäre. Damit einher 
geht mein Dank an den gesamten AK Hecht, der sich in seinem stetigen Wandel immer wieder 
von einer neuen Seite präsentiert hat. Herauszuheben ist mein Dank an die Frühstücksrunde 
bestehend aus Dr. Michael Pätzel, Dr. Lutz Grubert und Dr. Joachim Leistner, die mich stets 
motiviert in den Tag entlassen haben. 
Für zahlreiche Lösungen meiner NMR-Probleme danke ich Prof. Dr. Clemens Mügge, 
Angela Thiesies und Katharina Pfaff. Prof. Dr. Rainer Mahrwald danke ich für stets 
abwechslungsreiche Gespräche im Fahrstuhl. Felix Hanßke möchte ich für das Durchführen 
von DLS-Messungen danken. 
Bei der Deutschen Forschungsgemeinschaft möchte ich mich für die finanzielle und 
fachliche Unterstützung durch den SFB 658 bedanken, ohne die diese Dissertation nicht 
möglich gewesen wäre. 
An meine Lebensgefährtin Linda Hübner geht mein besonderer Dank dafür, dass sie es 
schafft in meiner Gegenwart nicht wahnsinnig zu werden und für die beste Mischung aus 
intellektueller und kulinarischer Unterstützung. Schließlich geht großer Dank an meine 
Mutter Anne Göstl und meine Großmutter Charlotte Göstl, die mich nicht nur moralisch 
sondern auch finanziell sehr ausführlich gestützt haben. 
  
v 
Abstract 
The synthetic chemist’s profession is devoted to the formation of chemical bonds to create 
new molecules, building blocks, or drugs from basic starting materials. However, the growing 
complexity of these synthetic products necessitates that the development of the tools to fulfill 
this task must also keep pace. Light as a stimulus with its superior spatial, temporal, as well as 
energetic resolution in combination with its non-invasive character outperforms the traditional 
means to control a chemical reaction, such as heat, pressure, or pH, clearly. In this work, the 
unprecedented reversible photocontrol over a dynamic covalent reaction was established by 
the combination of a molecular photoswitch and the well-known Diels-Alder reaction. The 
outcome of the reaction of a furyl-substituted diarylethene and maleimide could be 
determined exclusively by illumination with differently colored light. This prototypical 
system was then advanced for the application under physiological conditions while retaining 
its superior photochemical properties. The release of therapeutically effective concentrations 
of different antitumor agents could be photoreversibly triggered in buffered, aqueous solution 
at body temperature employing bioorthogonal visible light. It is shown how the release 
properties of these photoswitchable prodrugs can be fine-tuned and a thorough investigation 
of the release dynamics is presented promoting this system to a level where in vivo 
application can be considered. Furthermore, the foundations for the implementation of the 
photocontrollable Diels-Alder reaction in the reversible covalent functionalization of carbon 
nanotubes have been laid. Despite the fact that a successful functionalization has not yet been 
achieved, the basic principles were investigated and have paved the way for the application of 
more advanced techniques to effectively modulate the physicochemical properties of sp2-
carbon allotropes. 
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Zusammenfassung 
Die Aufgabe des synthetischen Chemikers besteht darin neue Moleküle, Bauelemente oder 
Medikamente aus einfachen Edukten herzustellen. Die wachsende Komplexität dieser 
synthetischen Produkte bedingt jedoch, dass die Entwicklung der dazu benötigten Werkzeuge 
ebenso schritthalten muss. Licht ist mit seiner herausragenden räumlichen, zeitlichen und 
energetischen Auflösung sowie seinem nicht-invasiven Charakter den traditionell 
verwendeten Stimuli überlegen. In dieser Arbeit wurde durch die Kombination eines 
molekularen Photoschalters mit der Diels-Alder-Reaktion die Photokontrolle über eine 
dynamisch-kovalente Reaktion erlangt. Das Ergebnis der Reaktion eines furyl-substituierten 
Diarylethens mit Maleinimid konnte ausschließlich durch die Bestrahlung mit Licht 
unterschiedlicher Farbe bestimmt werden. Dieses prototypische System wurde dann unter 
Erhalt seiner photochemischen Eigenschaften für die Anwendung unter physiologischen 
Bedingungen weiterentwickelt. Es konnte die photoreversible Freisetzung therapeutisch 
wirksamer Konzentrationen verschiedener Anti-Tumor-Medikamente in gepufferter, wässriger 
Lösung bei Körpertemperatur durch bioorthogonales sichtbares Licht ausgelöst werden. 
Weiterhin wurden die Feinabstimmung der Freisetzung dieser photoschaltbaren Diels-Alder-
Addukte und eine ausführliche Untersuchung der Freisetzungs-Dynamiken gezeigt. Hierdurch 
wurde das System auf eine Stufe gehoben, an der in vivo Anwendungen erwägt werden 
können. Des Weiteren wurden die Grundlagen zur Implementierung der photokontrollierbaren 
Diels-Alder-Reaktion in der reversiblen kovalenten Funktionalisierung von 
Kohlenstoffnanoröhren gelegt. Trotzdem noch keine erfolgreiche Funktionalisierung 
nachgewiesen werden konnte, wurde durch die Untersuchung der zugrundeliegenden 
Prinzipien der Weg für die Anwendung fortgeschrittener Techniken zur Modulation 
physikochemischer Eigenschaften von sp2-Kohlenstoff Allotropen geebnet. 
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1. Introduction  
1.1 Preliminary Remarks 
Besides its analytical and theoretical element, chemistry has always been a creative and 
constructive science. The synthetic chemist utilizes compounds that are readily available and 
converts them to a desired product through a chemical reaction constructing new materials, 
drugs, and technologically basic modules. As the demand for complexity and finesse of these 
products increases with the proceeding industrial advancement of our society, it becomes 
imperative that the methods to control a chemical reaction must also keep pace. Whereas so 
far it was enough to exert control over a chemical transformation by varying reaction 
temperature and time, the tailor-made molecules of the future clearly demand for stimuli 
featuring higher precision and orthogonality. Many physical and chemical stimuli, such as 
pressure and pH, exist that could possibly be employed to incorporate a higher dimension of 
control into a reaction system. Light, however, with its superior spatial, temporal, and 
energetic resolution in combination with its non-invasive character offers the possibility to 
remote control different processes simultaneously with molecular scale resolution. It is thus 
only consequential to design molecules that respond to light as a stimulus and that can transfer 
the acquired information to manipulate the outcome of a chemical reaction.  
In this work the reader is guided through a process starting with the design of a 
photoresponsive molecule that is then applied to influence the outcome of the well-known and 
heavily used Diels-Alder reaction. This system is then advanced towards an application where 
the additional stimulus enables the unprecedented control over the release of antitumor agents 
in physiological systems – an application that would not be possible without the extra 
dimension in control. Additionally, the foundations for the implementation of the 
photocontrollable Diels-Alder reaction in the reversible covalent functionalization of carbon 
nanotubes are laid. The results and accompanying experimental details follow a short 
introduction to the basic principles used which are necessary to fully recognize the extent of 
this work.  
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1.2 Photochromism 
Simply put, photochromism is defined as a light-induced reversible change of color. A more 
precise formulation would be helpful and translated into the realm of the sciences 
photochromism indicates a reversible transformation of a chemical species induced in one or 
both directions by absorption of electromagnetic radiation between two forms, A and B, 
having different absorption spectra (Scheme 1-1).[1,2] 
 
Scheme 1-1: General expression of a photochromic transformation. 
However, over the last decade research on photochromes has reached a new quality as 
we consistently progress from seeing photochromism as simple switching between two 
colored states towards employing it as a tool to control chemical, physical, and biological 
processes through the application of external light stimuli.[3–7] The outcome of this is an ever-
growing academic interest in photochromic molecules[8–10] that directly reflects the chemist’s 
desire to control diverse chemical transformations on the molecular level resolved in time as 
well as in space.  
There exists a considerable amount of classes of photochromic molecules, the most 
popular derivatives of which are depicted in Scheme 1-2. The azobenzene class has been 
known for decades but still enjoys an unimpaired popularity amongst its users (Scheme 1-2a). 
The huge geometrical change upon UV-light induced isomerization from the 
thermodynamically more stable E-form to the Z-azobenzene is accompanied by a large 
variation in the dipole moment rendering it especially useful for the alteration of molecular 
geometries,[11] directed modification of shapes in preorganized ensembles on materials and 
surfaces,[12,13] or conformational changes in biomacromolecules.[14] The Z- to E-isomerization 
is possible via the photochemical as well as the thermal pathway since azobenzene is a T-type 
photochrome, meaning that it reconverts to its thermodynamically more stable E-isomer 
thermally over time. The spiropyran class complements the azobenzene class as the UV-light 
induced formation of the merocyanine form is reversible by both visible light as well as 
thermally (Scheme 1-2b). Besides the advantageously large spectral separation of the two 
isomers, the switching to the merocyanine form entails a charge separation, which renders the 
3 
alteration of the dipole moment much more pronounced as compared to the azobenzene 
class.[15] Unfortunately, spiropyran is prone to a number of irreversible side-reactions (fatigue) 
in solution. As a direct result, the most impressive research results incorporating spiropyrans 
as switches rely on the molecule being attached to a bulk surface or nanoparticles limiting its 
translational freedom and thus inhibiting unwanted intermolecular fatigue-reactions.[16] This 
immobilization can also be realized through the incorporation of the switch into polymer 
blends and accordingly to this day the only industrial application of organic photochromes is 
that of spiropyran or spirooxazine derivatives in photochromic lenses.[17] 
 
Scheme 1-2: Classes of popular photochromic molecules depicted in their respective switching states. a) 
Azobenzene, b) spiropyran, c) triphenylimidazole dimer, d) dihydropyrene, and e) diarylethene. 
A relatively new kind of T-type photochromic compounds is the triphenylimidazole 
dimer class (Scheme 1-2c). By irradiation with UV-light a triphenylimidazole dimer breaks 
into two aromatically stabilized, colored triphenylimidazolyl radicals.[18,19] The significance of 
this system lies in its tremendously fast thermal back reaction (tens of milliseconds) rendering 
it potentially interesting for time-dependent applications that are only executed under 
irradiation and cease to function as soon as the light source is removed.[20]  
The aforementioned T-type photochromes all have in common that the uncolored 
isomer is the thermodynamically more stable form and thus the default position of the 
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switching system. Contrarily, dihydropyrenes are colored in their thermodynamically more 
stable ring-closed form classifying these compounds as negative photochromes (Scheme 
1-2d).[21,22] This characteristic switching behavior appears to be especially advantageous for 
possible in vivo applications as the default state can be addressed with vis-light lying in the 
therapeutic optical window of biological tissue.[23] 
By far one of the most popular photochromes is the diarylethene (DAE) class of 
molecules (Scheme 1-2e).[24,25] These differ considerably from the switches mentioned earlier 
in a number of characteristics. DAEs can be rendered P-type photochromes and thus both the 
ring-open as well as the ring-closed isomers can be thermally stable constituting a system that 
is addressable with light exclusively. Besides featuring high photocyclization quantum yields 
with low fatigue – offering reversible switching over hundreds to thousands of cycles – the 
isomerization process is accompanied by a rather small change in the molecular geometry and 
can thus be induced in very confined spaces, such as densely packed single crystals.[26] 
Conversely, the electronic modulation during the isomerization process is quite remarkable: 
When the reactive sp2-carbon centers are connected, a conjugation pathway is opened 
throughout the molecule in a way that the two aryl moieties can ‘communicate’ electronically 
with each other. This permits reactivity modulation for functional sites located on the switch 
by connecting electronically modifying groups into the conjugated π-system.[3,27–29] Hence, 
the synthetically convenient modifiability, high switching efficiency, and superior fatigue 
resistance accompanied by pronounced changes between the ring-open and ring-closed forms 
render DAEs the molecule of choice for applications where reliable photoswitching is 
demanded.  
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1.3 The Diarylethene Class Photochromes 
1.3.1 Molecular Construction 
Historically, all DAEs are related to their parent compound stilbene. Besides the E-Z-
isomerization, stilbene can undergo a 6π-electrocyclization yielding dihydrophenanthrene 
upon irradiation with UV-light (Scheme 1-3). This photoreaction is, however, only poorly 
reversible as the ring-closed dihydrophenanthrene oxidizes easily to phenanthrene under 
aerated conditions. As useful as the photocyclization with following oxidative 
dehydrogenation is for the synthesis of condensed ring systems, it is just as counterproductive 
for providing reversible photochromism. Hence, replacing the oxidatively labile protons in the 
dihydrophenanthrene with more inert, yet sterically low-demanding, substituents, such as 
methyl residues, has proven to successfully inhibit the oxidation to the aromatically stabilized 
phenanthrene.  
 
Scheme 1-3: E-Z-isomerization, electrocyclization, and oxidation of stilbene. 
Despite the considerable improvement, methylated stilbene still makes for a poor 
bistable photoswitch, the main reason being the phenyl residues. When the aromatic 
stabilization energy of the ring-open form is large as compared to the ring-closed 
dihydrophenanthrene derivative, the latter is destabilized considerably and the system 
becomes thermally reversible. It was, however, found that the incorporation of aromatically 
less stabilized moieties, such as thienyl-residues, reduces the effective energy difference 
between the ring-open and the ring-closed forms enough to prolong the thermal half-life of 
the ring-closed forms almost indefinitely (Scheme 1-4).[30] Furthermore, elongation of the 
conjugated π-system induces a bathochromic shift of the S1-transition in the ring-closed form. 
This spectral separation considerably accounts for the independent addressability of ring-open 
and ring-closed forms. As research on DAEs has intensified over the past few decades, a vast 
amount of different aryl substituents has been successfully incorporated. Amongst them are 
benzothiophene,[31–34] furan,[30,35–39] benzofuran,[40–44] indole,[45,46] isoxazole,[47] thiazole,[48–54], 
pyrrole,[55] pyrimidine,[56] pyridine,[43,57–60] tetrathiafulvalene,[61] and various polycyclic 
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aromatic hydrocarbons.[52,62–64] Furthermore, the attachment of the heterocycle can be varied 
leading to inverse type DAEs that exhibit distinctively different spectral characteristics and 
increased cycloreversion quantum yields. For details on this type of switch the reader is 
referred to Chapter 1.3.3. 
 
Scheme 1-4: Thermal half-life values (τ½) of the ring-closed forms of different diarylethenes. 
Having suppressed the oxidation to the phenanthrene derivative and improved the 
thermal half-life considerably, another design flaw becomes obvious: The E-Z-isomerization 
can compete with the 6π-electrocyclization, severely diminishing the quantum yields of the 
desired ring-closing and ring-opening reactions. This issue is addressed by the mechanical 
fixation of the central C–C double bond in its Z-geometry via the introduction of a bridging 
moiety linking its 1- and 2-positions. Although four- and six-membered rings have already 
been incorporated into DAEs, five-membered rings, especially cyclopentene and 
hexafluorocyclopentene, are generally employed for this purpose.[65,66] The latter two motifs, 
are seen as the ideal compromise between the distinct planarity of the four-membered ring 
bridges and the overemphasized aryl-bridge torsion angle of the six-membered bridges.[67,68] 
Moreover, the bridge moiety partially governs the optical and electronic properties of the 
DAE. While cyclopentene can be seen as electron-rich and thus donating residue, 
hexafluorocyclopentene withdraws electron density from the photoswitch (Scheme 1-5a).  
 
Scheme 1-5: Popular bridge motifs for the design of DAEs. a) Hexafluorocyclopentene and cyclopentene, b) 
maleimide and maleic anhydride. 
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Concomitantly, maleimide or maleic anhydride bridged DAEs exhibit a considerable 
bathochromic shift in their ring-open form allowing for vis-light induced photocyclization 
(Scheme 1-5b).[51,53] 
Naturally, countless other bridge substituents have been successfully incorporated into 
DAEs so far, amongst them furan,[69–71] imidazole and imidazoline,[49,72] dihydrophosphole 
and dihydrosilole,[73] thiazole,[34,74–76] thiophene and dihydrothiophene,[34,77–79] substituted and 
unsubstituted polycyclic aromatic hydrocarbons,[80–86] and various substituted 
cyclopentenes.[87–91] Particularly the latter can be employed to enhance photocyclization 
quantum yields, as described later in Chapter 1.3.3. 
Many successful routes for the synthesis of differently substituted DAEs have been 
published in the literature, the most important and general of which are depicted in Scheme 
1-6.[92] Amongst the first popular DAE derivatives stand the hexafluorocyclopentenes that 
were – and still are – mostly synthesized by an organolithium reagent induced halogen-metal 
exchange on an aryl moiety followed by a nucleophilic addition/elimination sequence 
employing octafluorocyclopentene (Scheme 1-6a).[65] This route has proven reliable and 
typically provides good yields. However, the volatility of octafluorocyclopentene under 
ambient conditions as well as its high cost have inspired researchers to find an alternate route 
to the desired hexafluorocyclopentene switches. Hence, the palladium-catalyzed cross 
coupling of aryl boronic acids to dichlorohexafluorocyclopentene, being less volatile and 
costly, was reported (Scheme 1-6b).[93] As the Suzuki-Miyaura type coupling usually results in 
poor yields or does not work at all when oxidative insertion has to take place into a C–Cl 
bond, specific organophosphorous ligands, such as XPhos (2-dicyclohexylphosphino-2‘,4‘,6‘-
triisopropylbiphenyl), have to be employed to ensure sufficient reactivity. 
Conversely, cyclopentene bridged DAEs are generally synthesized by Friedel-Crafts 
acylation of the aryl moiety to a glutaric acid derivative and subsequent reductive McMurry 
coupling of the resulting diketone (Scheme 1-6c).[66] This route is also a reasonable alternative 
towards hexafluorocyclopentene bridged DAEs even though the perfluorinated glutaric acid 
esters are quite costly. As supposed, the synthesis of non-symmetric cyclopentene DAEs is 
synthetically more challenging and was approached by a consecutive Friedel-Crafts ring-
opening reaction of an aryl moiety to glutaric acid anhydride followed by generation of the 
acid chloride and a Friedel-Crafts acylation with the second aryl moiety (Scheme 1-6d).[94] 
Simultaneously, we developed a route towards substituted cyclopentene bridged DAEs by 
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relying on a base catalyzed Michael addition of an acetylated aryl moiety to an α-β-
unsaturated heteroaryl compound of a different origin.[88] We further improved and modified 
this reaction during the course of this work[95] (Scheme 1-6e) and the reader is referred to 
Chapter 2.1.2 for a detailed description of this novel approach. Only recently discovered was 
a novel route towards a series of terarylenes that have been synthesized by Pd-catalyzed C–H 
activation.[96] 
 
Scheme 1-6: Different synthetic approaches towards DAEs. 
Once the aryl moieties are connected to the central double bond, subsequent post-
functionalization offers the possibility to introduce a vast amount of different substituents 
(Scheme 1-6f).[92] This is generally carried out by halogen-metal exchange of the remaining 
aryl halide with an organolithium reagent. Subsequently, the resulting metalated aryl moieties 
are either quenched with an electrophile producing the final switch or are boronated for 
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further conversion via a palladium-catalyzed cross-coupling reaction. Equally, the 
functionalization employing Suzuki-Miyaura type conditions can be performed directly on the 
aryl halide using a boronate as the coupling partner. 
1.3.2 Fatigue Behavior 
Most research articles on DAEs (as does this work in Chapter 1.2) boldly claim that DAEs 
can undergo hundreds if not thousands of switching cycles without any notable fatigue. Yet, 
thorough investigation of a DAE over several switching cycles usually reveals that this 
statement is rather euphemistic. Besides the unspecific, triplet self-sensitized degradation 
involving singlet-oxygen and other reactive oxygen species,[97,98] DAEs’ fatigue mechanism 
generally lies in the formation of an irreversible by-product upon prolonged irradiation of the 
ring-closed isomer with UV-light (Scheme 1-7). This acenaphthene type by-product was first 
observed and isolated by Irie and coworkers, who then also managed to grow single-crystals 
of the compound and perform a respective X-ray crystallographic analysis for its structure 
determination.[99]  
While a particular derivative (Scheme 1-7, X = Me) was reported not to undergo by-
product formation upon thousands of switching cycles, this is a fortunate design resulting in 
an exceptional shape of the excited state potential energy surface and of no universal validity. 
Calculations suggest that this distinct derivative’s slightly higher activation energy 
(5 kcal/mol) from the intermediate to the by-product arising from steric hindrance is the 
reason for the effective suppression of its formation.[100] However, as the by-product’s 
mechanism of formation is still only scarcely investigated,[101] no universal guidelines for the 
molecular design of fatigue resistant DAEs are currently available. 
 
Scheme 1-7: Photochemical by-product formation of DAEs upon prolonged irradiation of the ring-closed form 
with UV-light. 
As long as researchers avoid facing the optimization towards truly fatigue resistant 
modifiable DAEs, these switches will not find uses in long term application as they will 
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always be limited in recyclability and lifetime, thus making them inferior to their more fatigue 
resistant non-organic counterparts. 
1.3.3 Photochemical Efficiency 
The photochemical efficiency of an organic photochromic system is generally expressed by 
two parameters: i) the reaction quantum yield for the desired photoprocess and ii) the 
composition of the two isomers at the photostationary state. For a uniform photoreaction of a 
distinct chemical entity A to entity Β (compare Scheme 1-1), an integral photochemical 
reaction quantum yield ABγ  can be intuitively defined and is expressed through 
 reacAB
absA
N
N
γ =   (1.1) 
where absAN  are the number of photons absorbed by species A and reacN  the number of 
photons that have induced the photoreaction of A to B.[102] For ease of use, however, the 
differential quantum yield ABφ  defined by  
 AAB A
absA absA
d 1 1
d
c c
t I I
φ = − ⋅ = − ⋅  (1.2) 
is usually favored as it assumes an infinitesimally small change in concentration over a given 
time interval.[8] Here, Ac  is the differential change of the concentration of species A over time 
and absAI  the amount of light absorbed by species A as a function of Ac . According to 
Lambert-Beer’s law absAI  can be defined as  
 
'
absA 0 A A
1 101000
'
A
I I c
A
ε
−−
= ⋅ ⋅ ⋅ ⋅  (1.3) 
with a correction factor of 1000 cm3L-1, the incident photon irradiance 0I  
2 1E cm s− − ⋅ ⋅  ,
[103] 
the molar absorptivity of species A Aε , and the overall absorbance at the irradiation 
wavelength 'A .[8,104–106] Equations (1.2) and (1.3) combine to give the differential expression 
of a uniform photochemical reaction where the product B is photoinactive 
 
'
A
0 A AB A
d 1 101000
d '
Ac I c
t A
ε φ
−−
= − ⋅ ⋅ ⋅ ⋅ ⋅ . (1.4) 
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However, if both species A as well as B absorb at the irradiation wavelength, i.e. their 
molar absorptivities ε  are different from 0, and the reaction is photoreversible, forward and 
backward reactions have to be taken into account with 
 ( )
'
A
0 A AB A B BA B
d 1 101000
d '
Ac I c c
t A
ε φ ε φ
−−
= − ⋅ ⋅ ⋅ ⋅ − ⋅ ⋅ ⋅ . (1.5) 
This equation cannot be solved to give a closed-form expression and consequently it is 
practical to make an approximation. The initial slope method (or ‘method of initial rates’) is 
an approach to measure ABφ  in a regime where the contribution of species B to the overall 
absorbance is assumed to be negligible ( )0B A0.05 0c c< ⋅ ≈  and thus the rate of the back 
reaction can be neglected. Additionally, within the 5% conversion limit the photokinetic factor 
'1 10
'
A
A
−−  is assumed to remain constant. Applying these restraints to Equation (1.5) while 
considering that A Bc c= −   gives the term 
 
'
B
0 A AB A
d 1 101000
d '
Ac I c
t A
ε φ
−−
= ⋅ ⋅ ⋅ ⋅ ⋅ . (1.6) 
'A  can be expressed as the sum of the overall absorbances of the species existing in solution  
 A A B B'A c cε ε= ⋅ + ⋅  (1.7) 
and as B 0c ≈ , Equation (1.6) can be altered accordingly to 
 ( )'B 0 ABd 1000 1 10d
Ac I
t
φ −= ⋅ ⋅ ⋅ − . (1.8) 
If the reaction is monitored by absorption spectroscopy at a wavelength where A 0ε = , the 
concentration of species B can be directly expressed through its absorbance BA  at that 
wavelength and subsequently results in the equation  
 ( )'B AB 0 Bd 1000 1 10d
AA I
t
φ ε −= ⋅ ⋅ ⋅ −  (1.9) 
where the quantum yield ABφ  can be extracted as the slope of a pseudo-linear relation. 
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A direct consequence of the overlapping absorption bands of species A and B in the 
UV-range is that the conversion to the photoproduct usually converges non-quantitatively 
during the photocyclization reaction and a photostationary state (PSS) is reached. This can be 
explained by consulting Equation (1.5) and the fact that A 0c =  at t = ∞  and results in the 
expression 
 A BA B
B AB A
c
c
φ ε
φ ε
∞
∞
⋅
=
⋅
 (1.10) 
that directly determines the composition at the PSS through the ratio of BA Bφ ε⋅  and AB Aφ ε⋅ . 
As can be expected, ample research has been devoted to unveil the structure-property 
relationships governing the photochemical efficiency in DAEs and some general design 
guidelines have been established. A universal approach to increase the ring-opening quantum 
yield is, for instance, the inverse attachment of the aryl moiety to the bridging unit (Scheme 
1-8).[107–109]  
 
Scheme 1-8: Comparison of the photocyclization and cycloreversion quantum yields of normal, inverse, and 
oxidized type DAEs. 
The enhancement of the cycloreversion quantum yield coφ  is quite remarkable as it comprises 
typically more than a whole order of magnitude. However, for this advantage these inverse 
type DAEs sacrifice the beneficial spectral separation of ring-open and -closed isomers and a 
high photocyclization quantum yield ocφ , and are thus considered not the best choice for 
photoreversible DAEs.[110] Contrarily to the inverse type architecture, coφ  can be diminished 
by two orders of magnitude via oxidation of one thienyl residue while retaining the spectral 
separation of ring-open and -closed form (Scheme 1-8).[111] This can be attributed to the 
oxidized type DAEs’ strong fluorescent decay pathway from the excited state in the ring-
closed form inhibiting effective cycloreversion. In addition, it was only recently shown that 
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the cycloreversion quantum yield can be significantly enhanced by photoinduced oxidation of 
the ring-closed isomer in an electrocatalytic process.[34,112] 
Despite the fact that the cycloreversion quantum yield can be tuned by adhering to 
some general molecular design principles, the role of the photocyclization quantum yield is 
usually regarded as more important since the default state of DAEs is the ring-open form. The 
most common approach to improve ocφ  is to bias the ground state dynamic conformational 
equilibrium of the ring-open DAE between the parallel (p) and anti-parallel (a-p) form. 
According to the Woodward-Hoffman rules the electrocyclization of a 6π-electron system can 
only take place in a conrotatory manner from the excited state (Scheme 1-9).[113] As the 
photoactive a-p form and the photoinactive p form are constantly equilibrating at ambient 
conditions because the rotational barrier is small, the a-p conformer is generally populated to 
about 50%. Consequently, the highest possible photocyclization quantum yield that can be 
achieved with an unbiased system is 0.50. 
 
Scheme 1-9: Dynamic equilibrium between the p and a-p form with subsequent photocyclization from the a-p 
conformer only. 
Efforts have been undertaken to bias this conformational equilibrium towards the side 
of the a-p conformer ranging from the incorporation of a DAE in a polymer backbone,[114] 
sterically crowding the aryl substituents,[115–119] locking the a-p form by attaching covalent 
bridges,[120–122] physical separation of the a-p conformer,[123] over incorporation into films or 
single crystals,[10,124,125] to intramolecular non-covalent interactions.[59,83] Amongst these 
efforts, two examples are especially remarkable: Firstly, Kawai and coworkers synthesized a 
dithiazolylarylene that locks the ring-open DAE in the a-p form through intramolecular 
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hydrogen bond as well as attractive S–N interactions (Scheme 1-10a).[84] By thorough 
photokinetic measurements it was confirmed that the photocyclization amounts to a quantum 
yield of 0.98 for this derivative, essentially enabling a photon-quantitative reaction. However, 
the intramolecular interactions are weakened in polar and in protic solvents rendering the 
system not universally applicable. In 2012 we reported on a system that addresses this 
disadvantage by employing steric repulsion of substituents incorporated in the bridge moiety 
as a design principle to improve the quantum yield of dithienylethenes from the unbiased 0.50 
up to 0.83 (Scheme 1-10b).[88] As the modification of the bridge moiety is the only 
prerequisite for the improvement and the synthetic route remains straightforward and 
modifiable, this approach remains as one of the few general molecular design guidelines 
towards enhanced photo-performance of DAEs. 
 
Scheme 1-10: Attempts to bias the conformational equilibrium of DAEs in the ring-open form. a) 
Dithiazolylarylene investigated by Kawai and coworkers, b) Tetramethylcyclopentene derivative designed by 
Hecht and coworkers. 
Regardless of the success that has been accomplished improving DAE switching 
efficiency, there is still huge demand for more generally applicable design principles. It has 
become clear over iterations of DAE improvements that the increased population of the a-p 
conformer is not the sole solution towards a higher photocyclization quantum yield and that 
other factors, such as C–C bond distance of the reacting carbon atoms or electronic effects 
contribute significantly. These latter two factors, however, cannot be rationalized as easily as 
the equilibration of the conformers.  
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1.4 Photoswitchable Stoichiometric Reactions 
1.4.1 General Aspects 
In order to design photoswitchable systems that are capable of controlling ground-state, i.e. 
thermal chemical reactions, photochromic ‘gates’ (introduced in Chapter 1.2) have to be 
incorporated into the system in a manner that the structural differences between their two 
switching states are translated into different chemical reactivity. Therefore, one has to 
optimize the intrinsic switching properties of the photochrome itself as well as the way it is 
intersecting with the chemical reaction to be gated. To translate molecular changes during the 
course of photoswitching into differences in reactivity, the photochrome should undergo 
significant geometrical or electronic changes. Large geometrical changes are typically 
achieved via E-Z-photoisomerization reactions of azobenzene (or stilbenes), leading to largely 
reduced distances between the phenyl termini in the bent, non-planar Z-configuration when 
compared to the extended, planar E-configuration. Complementary to the systems with large 
geometrical changes, the electrocyclic ring-closing/ring-opening reactions of 1,3,5-hexatriene 
systems, for example in DAEs, result in substantially different electronic properties of the 
ring-closed isomer as compared to the ring-open form. Most notably the double bonds 
relocate during the switching process – a characteristic that has been exploited in the 
literature[71,126–129] and will be used as well in Chapter 2.1. It is important to maintain the 
switching behavior throughout the reaction and therefore the excitation of the photochromic 
moiety should be selective and local, without interfering quenching processes by energy or 
electron transfer. 
The photochromic gate can be incorporated either directly by covalent connection to 
one of the components participating in the reaction, or indirectly by non-covalent interaction 
with the same. This chapter will focus on the former as covalent constructs offer the 
advantage that they operate more independently of concentration as opposed to 
supramolecular approaches. For an overview regarding the non-covalent interactions of 
switches on reactivity-controlling entities the reader is referred to the existing literature.[130] In 
general, the coupling of a photochromic system to gate another thermal reaction can be 
realized using various concepts depending on the particular geometrical or electronic 
alteration of the switch and the point of interference. Such interference can occur either at the 
level of the substrate, product, or template, leading to stoichiometric processes with maximum 
overall quantum yields of unity ( 1φ ≤ ). When these changes occur at the level of the catalyst 
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or effector, a rise in amplification of the light stimulus and overall reaction quantum yields 
exceeding unity ( 1φ > ) can be seen. This chapter focusses on the former, as light controlled 
catalysts have been reviewed in the literature extensively.[3,5,130]  
The introduction of light as a gating stimulus means enabling manipulation of one 
reaction component in a way that it can be switched from an unreactive state to a reactive 
state or vice versa. This can be achieved through three different approaches. (i) Switching one 
of the starting materials from an inactive to an active form allows the respective compound to 
participate in the reaction and to form the desired product on demand (starting material 
control). (ii) Switching the reaction product from an active form to an inactive form removes 
the compound from the initial equilibrium between the reactants and thus locks the product in 
an unreactive state (product control). (iii) Switching neither substrate(s) nor product but a 
‘reaction mediator’, namely a template, from an inactive to an active form and thereby 
controlling conversion by supramolecular complexation (template control). 
1.4.2 Starting Material Control 
The photoreversible activation of a starting material allowing it to participate in a chemical 
reaction is conceptually depicted in Figure 1-1. As opposed to photocaging, true reversibility 
can only be achieved if the photodynamic reaction is coupled to a dynamic thermal 
equilibrium, i.e. the starting material can be reformed thermally and subsequently deactivated 
by light. 
 
Figure 1-1: Concept of starting material control: Photoswitching a substrate between inactive and active forms 
allows for controlled feeding or removal of a starting material to or from a dynamic covalent equilibrium. 
Kawashima and coworkers reported silicon fluoride derivatives bearing a covalently 
attached azobenzene ligand as early as 2001 where the photochemical Z- to E-isomerization 
of the azobenzene could reversibly change the complex from the pentacoordinate to the 
hexacoordinate geometry.[131] The group then transferred this reversible geometry change to 
an azobenzene-substituted allyldifluorosilane.[132] Photoisomerization of the Z- to the E-
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isomer followed by subsequent treatment with 18-crown-6 and potassium fluoride induces an 
allyl-shift to the azobenzene reducing it to the diphenylhydrazine (Scheme 1-11). However, 
the original Z-isomer is unreactive under those reaction conditions. Further work on this 
system enabled photocontrol not only over the allyl-shift but also over disiloxane 
formation[133] and intermolecular hydrosilylation and desilylation reactions.[134] The latter is 
an exceptional example, as it not only allows the ‘on’/’off’-switching of a reaction but offers 
the choice between two different reaction types. 
 
Scheme 1-11: Photocontrolled allyl transfer reaction of silyl azobenzenes with fluoride yielding hydrazine 
rearrangement products. 
Another elaborate example of starting material control is the incorporation of an 
aromatic imidazolium moiety into the bridge position of a diarylethene reported by Kawai and 
coworkers (Scheme 1-12).[49] Due to its aromatic stabilization, the imidazolium ion is not 
prone to the nucleophilic addition of methoxide. However, upon photocyclization to the ring-
closed form the bridge moiety is transformed into an imidazolinium ion removing the crucial 
double bond as well as the aromatic stabilization. The closed form switch can then react 
reversibly to yield the methanol adduct. 
 
Scheme 1-12: Photocontrolled addition of methanol to imidazol(in)ium ions embedded in a diarylethene 
framework. 
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Kawai and coworkers further exploited the combination of photoswitching and 
aromatic stabilization in benzothienyl-substituted terarylenes.[33] The crucial methyl 
substituent in the 2-position of the aryl moieties was omitted on one benzothiophene and 
replaced by a methoxy group on the other. UV-induced photocyclization of this switch to the 
dihydrophenanthrene derivative enables the elimination of methanol under acidic conditions 
while generating the aromatically stabilized phenanthrene derivative. This system could be 
tuned to the point where the authors were also able to achieve photocontrol over the 
elimination of ethanol and reversible nucleophilic addition-elimination cascades.[76] 
Photomodulation of nucleophilicity could be achieved by Branda and coworkers, who 
reported a diarylethene incorporating a pyridyl substituent into one aryl moiety and an 
electron-withdrawing pyridinium group into the other (Scheme 1-13).[28,29] In the ring-open 
form the two aryl moieties are not in conjugation and thus the nucleophilicity of the pyridyl-
lone pair is unbiased in a reaction with p-bromobenzyl bromide. However, upon UV-induced 
photocyclization a conjugation pathway between the two aryl moieties is opened up and 
electron density is removed from the pyridyl-lone pair lowering its nucleophilic character and 
hampering the reaction with p-bromobenzyl bromide severely. 
 
Scheme 1-13: Photomodulation of nucleophilicity by switchable coupling to an acceptor moiety through a 
diarylethene bridge. 
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In the same manner, a further example of switching on the starting materials of a 
chemical reaction was reported by Morimoto, Murata, and Michinobu in 2011. They 
synthesized a phenylacetylene-substituted dithienylethene that upon photocyclization to the 
ring-closed form coupled an electron-donating dimethylaminophenyl residue into the 
conjugated π-system of the molecule rendering the alkyne moiety reactive towards the 
addition of tetracyanoethylene.[135] 
1.4.3 Product Control 
Analogously to switching on the starting materials in a covalent chemical reaction, switching 
of a reaction product crucially demands for the thermal reaction to be in a dynamic 
equilibrium. Only in this way can the reaction products be removed from the initial reaction 
mixture and locked in an unreactive state (Figure 1-2). 
 
Figure 1-2: Concept of product control: Photoswitching a product to an inactive ‘locked’ form removes it from a 
dynamic covalent equilibrium, while switching it back into its active ‘unleashed’ form re-introduces it to the 
system. 
Branda and coworkers synthesized a number of pro-diarylethenes incorporating a 
cisoid diene moiety that can undergo a Diels-Alder reaction with the corresponding 
dienophile. Upon adduct formation, a diarylethene 6π-electron system is generated and 
photocyclization can be induced by UV-light removing the diarylethene adduct from the 
chemical equilibrium and locking it in an unreactive state. 
The first work employing this concept relied on a hexadiene motif in the bridge 
position of a pro-diarylethene that could undergo the Diels-Alder reaction with maleic 
anhydride to yield the target photochrome.[126] Since the equilibrium was shifted to the 
product side, this system proved to be especially useful for gating photochromism through 
chemical reactivity. However, the potential of the overall concept was quickly recognized and 
a publication followed that advanced the bridge motif of a pro-diarylethene to the 
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photochromically more advantageous fulvenyl moiety.[127] Reaction of this pro-photochrome 
with dicyanofumarate yielded the respective diarylethene that could undergo photocyclization 
locking it in its unreactive state (Scheme 1-14). 
 
Scheme 1-14: Photoswitching locks the Diels-Alder adduct and removes it from the dynamic equilibrium.  
However, the equilibrium between diene and dienophile was lying strongly on the 
starting materials side at room temperature. This allows exploitation of the design for photo-
release of the dicyanofumarate from the pure locked Diels-Alder adduct, which was isolated 
beforehand. Only recently the scope was expanded by incorporating a furyl moiety in the 
bridge position as the diene in another pro-dithienylethene enabling the use of maleimide 
derivatives as dienophiles (Scheme 1-15).[71] Since the furan-maleimide couple exists in a 
highly reversible regime under ambient conditions, the system could be exploited far beyond 
the simple photorelease adding new potential applications for the light controlled adduct-
locking in materials sciences and biological environments. Consequentially, the motif was 
exploited to design an elaborate photoswitchable adhesive relying on the switching ‘on’ of the 
retro Diels-Alder reaction.[129]  
 
Scheme 1-15: Photoswitching locks the Diels-Alder adduct and removes it from the dynamic equilibrium.  
Note that the concept to control the Diels-Alder reaction via the adduct exclusively 
significantly differs from our efforts to introduce photocontrol over starting materials as well 
as products of the Diels-Alder reaction outlined in Chapter 2.1. 
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1.4.4 Template Control 
Substrate switching offers convenient possibilities of enabling or disabling a chemical 
reaction. However, since the photoswitchable unit has to be incorporated into one of the 
reaction partners, its inherent disadvantage lies in the lack of flexibility in choosing the 
substrates. Template switching addresses this issue by outsourcing the photocontrollable unit 
from the substrate to an external molecule that pre-arranges the reactive centers of the starting 
materials so that a previously inhibited reaction can take place (Figure 1-3). 
 
Figure 1-3: Concept of template control: Photoswitching a template between inactive and active forms allows 
for conversion control of starting materials to products. 
 
Scheme 1-16: Photoswitchable template, which in its Z-form enables the coupling of an amine and an activated 
acid to the corresponding amide. 
The first photoswitchable template was synthesized as early as 1995 by Würthner and 
Rebek.[136] They designed a complex biscarbazolylimide terminated azobenzene (Scheme 
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1-16). In the E-form this template is inactive and shows no conversion in the coupling 
reaction between aminoadenosine and a p-nitrophenyl ester to the corresponding amide, 
whereas upon UV-induced isomerization to the Z-form the formed cavity acts as an ideal host 
to promote the coupling reaction. However, the coupling product remains bound to the host 
upon bond formation, thereby not completely fulfilling the ambitious task of designing a 
photoswitchable catalyst. The authors later showed that product inhibition as well as 
inhibition by competitive binders are observed during the reaction and neither photochemical 
nor thermal Z- to E-isomerization could be induced into the host while being bound to the 
coupled product.[137]  
 
Scheme 1-17: In a molecular walker-track conjugate, a photoswitchable stilbene moiety in the track guides the 
walker along the track by biasing the individual dynamic covalent equilibria for disulfide and hydrazone 
formation. 
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Switching of the template can, in a broader sense, also be achieved by manipulating 
the track of a molecular walker by light.[138] Leigh and coworkers synthesized a walker-track 
conjugate offering different possibilities for hydrazone and disulfide binding (Scheme 1-17). 
The key step in the movement of the walker is the isomerization of the stilbene moiety 
incorporated into the center of the track. Upon UV-induced isomerization from E-1,2 to Z-1,2 
the equilibrium between disulfide formation on the first position and the third position is 
highly biased toward the latter position and the walker moves along the track to form Z-2,3. 
Subsequent vis-light induced back isomerization from Z-2,3 to E-2,3 shifts the equilibrium 
between the hydrazone formation on the second and fourth position towards the fourth 
position to form E-3,4. Overall, the walker was moved successfully along the track by 
dynamically breaking and forming covalent bonds and biasing the associated equilibria by 
photoisomerization. 
Besides directly switching the template ‘on’ or ‘off’, the assembly of the template 
itself can be dynamic and controlled by light (Figure 1-4). As opposed to the switching of a 
stable and inert template molecule, the formation of the template itself can be rendered 
photoswitchable by coupling the template-assembly to dynamic covalent chemistry. Typically, 
a dynamic combinatorial library consists of a large number of equilibrated host structures, 
derived from a quantity of building blocks connected via reversible covalent bonds, and the 
equilibria present in the library can be biased towards one or a few particular structures by 
stabilizing non-covalent interactions with a certain guest molecule, thereby leading to a 
selection and amplification of the best binder. If one of the building blocks of the library 
consists of a photochrome, one should be able to modulate the initial composition of the 
unbiased library and therefore also the selection and amplification process by light. 
 
Figure 1-4: Concept of dynamic template control: Photoswitching a building block of a dynamic constitutional 
library between reactive and non-reactive forms allows for the assembly of an active template, which facilitates 
the conversion of starting materials to products. 
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Such a system has been described by Waters and Ingerman, who employed a dynamic 
constitutional library consisting of one azobenzene and two proline building blocks (Scheme 
1-18).[139] The library was equilibrated in the presence of an oligoproline guest and yielded a 
distinct distribution of host molecules. However, upon UV-induced isomerization of the 
building blocks from the E-form to the Z-form the distribution amongst the possible 
macrocycles changed significantly, therefore amplifying one macrocycle by more than 60%. 
This shows that in addition to switching the template ‘on’ or ‘off’, it is also possible to switch 
between different receptor states. 
 
Scheme 1-18: Photoswitching the composition of a dynamic constitutional library by incorporating a 
photochromic building block leads to a change of the host distribution in the presence of an oligoproline guest. 
The photoswitching of stoichiometric reactions remains a comparably young and 
unexplored field. As it becomes necessary to control increasingly complex reactions on a 
continuously shrinking scale, advancements in this field are of high importance and relevance 
for the proceeding of nanosciences and -technology.[3,140] However, a few intrinsic difficulties 
still have to be overcome by future reaction systems to raise it beyond the level of pure 
academic interest.  
Most studies, for example, are performed with isolated (i.e. ex situ switched) 
molecules and thus produce effects of magnitudes, perhaps unachievable while switching the 
molecules in situ. This problem originates mainly from the large discrepancy of 
concentrations at which chemical reactions take place, namely in the molar to millimolar 
range, and the concentrations at which the overall optical density of the system is low enough 
to perform clean and fast photochemistry, i.e. the micromolar range. Marrying these two 
worlds has been a challenge since the beginning of photochemistry and requires careful 
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engineering of the employed reactants’ absorption characteristics to avoid low conversions at 
the PSS or total absorption preventing light to reach and therefore ‘switch’ all molecules 
inside the solution. Furthermore, organic photochromes are prone to degradation and might 
perhaps always fall behind their inorganic counterparts with regards to photostability. Here, 
the inherent advantage of organic chemistry, the modularity in synthesis regarding structure-
property relationship, will have to be exploited to design and engineer organic molecules that 
circumvent or compensate their intrinsic weaknesses in novel and unexpected ways. 
It thus becomes clear that there lies a tremendous amount of work ahead until the 
control over chemical reactivity will leave the safe confines of academic research. Although 
only a glimpse of the possibilities of what these techniques could yield has been seen, the 
potential of amalgamating reversible photochemistry and traditional chemical reactivity 
promise very interesting research for decades to come.  
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1.5 The Diels-Alder Reaction with Furan 
1.5.1 General Aspects 
The mechanism and enormous potential of the reversible [4+2] cycloaddition of an electron-
rich diene and an electron-poor dienophile was first realized at the beginning of the 20th 
century by Otto Diels and Kurt Alder and is since then widely known as the Diels-Alder (DA) 
reaction (Scheme 1-19).[141] 
 
Scheme 1-19: Diels-Alder reaction between furan and maleimide. 
Since its discovery, the DA reaction has evolved into one of the most powerful 
synthetic protocols in the organic chemist’s toolbox for the assembly of complex six-
membered ring-systems.[142,143] The reaction of an annulated diene usually yields a mixture of 
the endo and exo addition products with the exo product being the sterically less strained and 
thus thermodynamically more stable isomer. However, in many cases the endo isomer is 
preferably formed due to kinetic control – a phenomenon widely known as the ‘endo-rule’. 
Furthermore, Lewis acid- and salt-catalyzed and homo-DA reactions (in which the diene is 
not conjugated) are literature-known today and applied widely.[144,145] The back reaction is 
called the retro DA reaction and can be induced by applying high temperatures, though this 
pathway is usually unwanted in the course of a reaction leading to C–C bond formation. 
 
Figure 1-5: Qualitative frontier orbital energy diagram of the DA reaction. a) Normal case, b) inverse case. 
A prerequisite for the DA reaction is a sufficient overlap of orbitals between the reacting diene 
and the dienophile that can be explained by consulting the frontier molecular orbital theory 
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(Figure 1-5). To permit a high orbital overlap and thus a high DA reactivity, diene and 
dienophile must exhibit orthogonal electronic character, i.e. the diene’s HOMO has to be 
electron-rich and the dienophile’s LUMO electron-poor (normal case) or vice versa (inverse 
case).  
Furan is one of the most popular diene building blocks employed in synthetic DA 
reactions[146] as its aromatic character is pronounced enough to be stable at ambient conditions 
allowing for the introduction of substituents but low enough that its double bonds exhibit a 
high degree of localization necessary for the orbital overlap with the dienophile (Scheme 
1-20). Moreover, the resulting oxanorbonene adducts can be aromatized easily by acid 
induced ring-opening enabling for the easy construction of aromatic systems subsequent to 
the DA reaction (Scheme 1-21).[146] 
 
Scheme 1-20: Aromatic character of five-membered (hetero-)cycles. 
 
Scheme 1-21: Synthetic application of furan to build six-membered, aromatic carbocycles. 
Beyond its mere use as a synthetic auxiliary, furan proves to be a versatile and 
powerful diene for diverse applications of the DA reaction, particularly in the field of 
reversibly crosslinkable polymers with maleimide[147–150] and the reversible covalent 
functionalization of sp2-carbon,[151] both of which are elucidated in later sections. 
1.5.2 The Furan-Maleimide Couple 
As the DA reaction is a bimolecular reaction, a dienophile with a compatible reactivity 
towards furan is desirable. Maleimide has been established as a very popular partner to furan 
already decades ago[152] as their characteristic reaction temperatures lie between 25 °C and 
50 °C for the forward reaction and above 70 °C to 100 °C for the retro DA reaction to occur. 
28 
This renders the furan-maleimide couple one of the few self-containing (i.e. by-product free) 
systems that exhibit fully dynamic covalent properties at relatively mild conditions. In 
addition to the complete reversibility, maleimide and furan can be easily functionalized and 
thus their incorporation as practical linker units into larger chemical entities is effortlessly 
achieved. While maleimides are generally substituted at the N-terminus by condensation of 
maleic anhydride with functionalized amines, furan can be modified simply by employing one 
of its low cost commercial precursors, such as furfural, furfuryl alcohol, or 2,5-dimethylfuran. 
As a direct consequence the furan-maleimide couple is employed in a vast amount of 
reversible crosslinkable polymeric materials to impart self-healing properties.[147–150] It is used 
in reversible interpenetrating hybrid networks[153] and thermally responsive dendrons and 
dendrimers,[154,155] as well as for reversible, modular printing and lithography.[156,157]  
Despite this ostensibly simple reactant system, a closer look at the DA reaction 
between furan and maleimide reveals important details. To begin with and as already touched 
on in Scheme 1-19, this reaction yields two different stereoisomers, endo and exo. Scheme 
1-22 briefly summarizes the underlying equilibria with the corresponding reaction rate 
constants for forward kf and backward reaction kb to the respective stereoisomers. 
 
Scheme 1-22: Itemized equilibria leading to the endo or exo adduct in the course of a DA reaction between furan 
and maleimide. 
Kinetic 1H-NMR experiments have been carried out on this system to gain an insight into the 
driving force governing the outcome of this particular DA equilibrium. This offers the 
possibility to derive a potential energy diagram out of the data reported in the literature.[158] At 
room temperature it was shown that with  
 f fexo endo2k k=  (1.11) 
the rate constant for the formation of the endo stereoisomer is about twice the magnitude of 
the rate constant for the formation of the exo stereoisomer. Taking into account the dimension 
of the back reactions of both isomers it became clear that with 
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>  (1.12) 
at room temperature the formation of the exo isomer is slightly thermodynamically favored 
but that the formation of the endo isomer is considerably faster. When this experiment is 
repeated at 65 °C it becomes clear that with 
 f fexo endok k=  (1.13) 
the rate constants for the formation of both isomers are of comparable magnitude. However, 
as bendok  grows extraordinarily as compared to bexok , the formation of the exo isomer becomes 
thermodynamically extremely predominant since 
 
f f
exo endo
b b
exo endo
k k
k k
>>   (1.14) 
Out of these data a qualitative potential energy diagram for the DA reaction between 
furan and maleimide can be derived (Figure 1-6). 
 
Figure 1-6: Qualitative potential energy diagram of the DA reaction of furan with maleimide. 
It is obvious that when the reaction temperature is low, the difference in both transition states’ 
Gibbs free energies ‡G∆∆  is the governing quantity, the reaction is under kinetic control, and 
the endo stereoisomer is the preferred product. Contrarily, if the reaction temperature is high, 
both transition states are accessible and hence the difference in ground state Gibbs free 
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energies G∆∆  is the prevalent factor, the reaction is under thermodynamic control, and the 
exo stereoisomer is the main product.  
Moreover, the ratio between exo and endo adducts can be biased by attaching 
Substituents with different electronic properties (Scheme 1-23).[159] While the N-terminal 
functionalization of maleimide seems to have little to no effect on the stereoselectivity, the 
introduction of electron-withdrawing substituents in the 2- or 3-positions of the furan lowers 
the Gibbs free energy of the exo transition state ‡exoG∆  more significantly than ‡endoG∆ . 
Whereas electron-donating substituents appear to favor the endo adduct as the main product 
with a low ‡endoG∆  (at low temperatures), residues exhibiting large electron-withdrawing 
properties tend to prefer the exo stereoisomer even under kinetically controlled conditions. 
 
Scheme 1-23: Influence of the substituent’s electron-withdrawing effect on the stereodiscrimination in the DA 
reaction between furan and maleimide. 
It should be noted, however, that these data are specifically valid only for furan and 
maleimide and that from these, no general trend for other DA reactant systems can be 
deduced. Nevertheless, the thorough kinetic analysis of the particular furan-maleimide couple 
shows that the frequently stressed endo-rule[160–162] assuming transition state discrimination as 
cause for the effective stereoselectivity should be taken with a pinch of salt when predicting 
endo-exo-selectivity on paper.  
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1.6 Maleimide Derivatives and Their Potential use in Photopharmacology 
1.6.1 Principles of Photopharmacology 
Photopharmacology describes the incorporation of photoswitches into drugs used in 
pharmacotherapy to gain control over their therapeutic properties through the application of 
light.[23] With this goal, photopharmacology emerged from the efforts to achieve photocontrol 
over structure and function of biological systems.[163,164] Today’s drug administration 
oftentimes faces challenges associated with poor selectivity resulting in high toxicity and drug 
resistance, both of which have their origin in the limited spatiotemporal control offered by 
conventional drugs. That means that there is generally no possibility to control where and 
when, in- or outside the organism the drug is active. For example, most antitumor agents 
unselectively impair mitosis, which particularly affects the fast-dividing cells in tumors, but 
also causes many unwanted side effects. Also, poor drug selectivity severely narrows the 
therapeutic window as oftentimes the toxic side effects predominate over the drug’s 
therapeutic value. Moreover, gratuitous drug administration based on poor selectivity 
contributes to the development of drug resistant strains of pathogenic agents. 
As highlighted before in Chapters 1.2 and 1.4, light as a non-invasive stimulus with 
superior spatial, temporal, and energetic resolution in combination with its high orthogonality 
to biological processes would make for an excellent gate to control drug activity with higher 
precision. Photocontrol over drug activity can be achieved in two ways: i) irreversibly 
releasing or activating the drug from a prodrug by the photochemical reaction of a one-cycle 
photoswitch or a photoprotecting group or ii) employing a multi-cycle photoswitch that 
allows not only for activating the drug inside of the organism but also for its deactivation after 
leaving the organism and the desired therapeutic effect has been achieved. Photodynamic 
therapy (PTD) takes a special place in the context of photopharmacology as it relies on the 
triplet sensitized generation of singlet oxygen 1O2 by photoexcitation.[165–170] Since the 
physiologically active component 1O2 invokes unspecific cell death, PTD has rather low 
selectivity and is mainly useful where the locally resolved destruction of tissue is necessary, 
e.g. for the treatment of tumors. Also, the employed sensitizers remain active within the body 
for weeks complicating the patients’ post-treatment phases. 
The photoswitch governing the drug’s activity or selectivity must certainly fulfill 
multiple criteria for the successful application in the organism. One key criterion is that the 
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drug needs to retain its biological activity and also should not be active towards secondary 
targets upon incorporation of the photoswitch. As modern drugs are usually highly optimized 
molecules, this is a major challenge for the design of novel photoswitch-drug conjugates. 
Since bioavailability is of importance, sufficient solubility in physiological media of the 
photoswitch-drug conjugate has to be guaranteed. A direct follow-up requirement is that the 
photochrome still maintains its switchability in the aqueous environment as well while being 
attached to the drug. Ideally, the compositions at the respective photostationary states in the 
active and inactive form should be high to achieve the best possible modulation in the drug’s 
bioavailable concentration. Furthermore, there exists a so-called ‘phototherapeutic window’ in 
which electromagnetic radiation can penetrate tissue most efficiently, lying in the visible 
range of the spectrum. Due to its cytotoxic side effects as well as its low penetration depth, 
UV-light is generally not regarded as the best option in view of highly selective drug design 
incorporating photoswitches. Hence, special design considerations have to be made when 
choosing an appropriate photoswitch for the task. 
The pioneering examples in the field of photopharmacology have been reported by the 
groups of Erlanger and Nachmansohn that reported on a variety of differently substituted 
azobenzene photoswitches that could modulate the activity of acetylcholine receptors by light-
induced isomerization from the inactive E-form to the active Z-form.[171–173] However, most of 
the outstanding advances regarding the photoreversible switching of drugs’ activities have 
been made only recently.  
Besides Trauner and coworkers’ exceptional overall work on photochromic ion 
channel blockers,[174–177] the reversible control over the induction of pain in organisms is a 
particularly outstanding example.[178] For that purpose, they designed an azobenzene bearing a 
moiety that resembles the scaffold of capsaicin, the active compound in chili peppers, that 
was able to bind to the heat and pain receptor TRPV1. While binding to TRPV1 in its Z-form, 
the photoswitch is able to antagonize the effect of simultaneously administered capsaicin. 
However, it can be switched to its inactive E-form by visible light allowing capsaicin to bind 
to TRPV1 again inducing a painful sensation upon irradiation (Scheme 1-24).  
Trauner and coworkers furthermore synthesized a photoswitchable azopropofol that 
could be shown to reversibly switch GABA-induced Cl- currents to control neural systems 
(Scheme 1-25).[179] While the E-form of the azopropofol is active just as its parent compound 
propofol, the Z-form produced by irradiation with violet light is inactive and exhibits lower 
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anesthetic behavior. This development is particularly important with regard to improved 
temporal control over anesthetically active drugs. 
 
Scheme 1-24: Photoswitchable TRPV1 channel inhibitor that can be switched from its active Z-form to the 
inactive E-form by irradiation with blue light. 
 
Scheme 1-25: Photoswitchable azopropofol that can be switched from its active E-form to the inactive Z-form 
by irradiation with violet light. 
Another exceptional work incorporating an azobenzene attached to a drug motif was 
published only lately by Feringa and coworkers and involves the possibility to photoswitch 
the activity of a quinolone antibiotic.[180] By attaching an azobenzene moiety it was possible 
to modulate the quinolone antibiotic’s antibacterial activity from high in the E-form to low in 
the Z-form and thus to gain spatial control over the growth of bacteria (Scheme 1-26). 
 
Scheme 1-26: Photoswitchable quinolone that can be switched from its active E-form to the inactive Z-form by 
irradiation with UV-light. 
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Abell and coworkers synthesized a potent photoswitchable m-calpain inhibitor, the 
molecular design of which is based on common peptide m-calpain and µ-calpain 
inhibitors.[181] The protease calpain is made responsible for multiple diseases, specifically 
cataract, and its activity could be successfully inhibited by the azobenzene-drug conjugate in 
its active E-form (Scheme 1-27). Isomerizing the molecule to the Z-form by irradiation with 
UV-light deactivates the m-calpain inhibiting effect thus offering some potential as a means to 
control cataract. 
 
Scheme 1-27: Photoswitchable m-calpain inhibitor that can be switched from its active E-form to the inactive Z-
form by irradiation with UV-light. 
Though diarylethenes are less frequently used in the context of photopharmacology, as 
researchers prefer azobenzene’s pronounced geometrical change upon photoisomerization, 
some notable examples have been reported that incorporate DAEs as the photoswitch. A 
notable case is the design of a photoswitchable human carbonic anhydrase I (hCAI) inhibitor 
by the groups of Branda and König.[182] This enzyme is of particular interest as it is central to 
cellular transport as well as metabolic processes in the organism. A histidine binding Cu 
iminodiacetate group was incorporated in one aryl moiety of the DAE and a hCAI inhibiting 
sulfonamide motif on the remaining aryl substituent (Scheme 1-28). In the ring-closed form 
the DAE backbone is rigid and thus retains the sulfonamide group from binding to hCAI. 
Upon visible light induced cycloreversion, however, the backbone becomes flexible thus 
enabling the inhibiting group to bind to its target.  
 
Scheme 1-28: Photoswitchable hCAI inhibitor that can be reversibly switched from its inactive ring-closed form 
to the active ring-open form by irradiation with blue light. 
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Only recently the groups of Komarov and Ulrich designed a peptidomimetic 
macrocycle incorporating a DAE in its backbone.[183] The Gramicidin S analogue exhibits 
antimicrobial activity in the ring-closed form while irradiation to the ring-open form with 
visible light disabled this effect. Analogously to the hCAI inhibitor reported by the groups of 
Branda and König, the decisive difference between the two isomers is the DAE backbone’s 
alteration in flexibility. While the flexible backbone in the ring-open form grants more 
degrees of freedom allowing for spatial arrangement of the functional groups, the rigid 
backbone in the ring-closed form forces the molecule into a predetermined conformation. 
While the molecules investigated so far generally rely on the change of geometry or 
modulation of conformational flexibility to achieve the desired pharmacotherapeutic effects, 
other variable properties, such as the change in the dipole moment or the HOMO-LUMO gap, 
appear harder to implement. However, this leaves lots of room for creative design that can be 
realized in future generations of photoresponsive drugs. Eventually, it can be seen that during 
the last decade the research area of photopharmacology took big steps towards in vivo 
application in humans. Though the main efforts undertaken in this field are currently 
accomplished by only a handful of research groups, the impact on the academic landscape is 
considerable. Its interdisciplinary character will provide unprecedented options for 
collaborations and hopefully establish photopharmacology as a force to be reckoned with in 
the daily clinical routine. 
1.6.2 Maleimide Derivatives as Catalytic DNA Topoisomerase II Inhibitors 
DNA topoisomerase II (TOP2) is an enzyme that catalyzes the interconversion of different 
DNA toposiomers (e.g. supercoiled or catenated DNA) by religation of the DNA strands thus 
promoting chromosome disentanglement (Figure 1-7).[184] The catalytic cycle of TOP2 action 
is depicted in Figure 1-8.[185] First, a gate segment of DNA (‘G segment’) is bound to TOP2. A 
second strand, the transport segment or ‘T segment’, is then captured by TOP2. Binding and 
hydrolysis of ATP then lead to the cleavage of the G segment and subsequently the T segment 
is transported through the G segment as the two strands separate. Finally, the G segment is 
sealed and release of ADP leads to the reset of the system. 
Xenobiotics can act via different pathways upon this function leading to lethal DNA 
strand breaks when TOP2 action is affected.[186–188] Supposedly, many antitumor drugs and 
antibiotics act upon the scission and ligation reactions of TOP2 by stabilizing the so-called 
‘cleaved complex’ of TOP2 and DNA (Figure 1-8). 
36 
 
Figure 1-7: Decatenation and relaxation of DNA strands performed by TOP2. 
 
Figure 1-8: Mechanism of TOP2 action upon religation of a DNA strand (G segment) through binding and 
transport of a T segment. 
At that stage the T segment has already passed and cleaved the G segment. However, the T 
segment cannot leave the complex and TOP2 is halted inhibiting enzyme turnover. This 
produces enzyme mediated DNA damage that interferes with many DNA metabolic events 
such as transcription and replication. Drugs that act upon TOP2 in this way, such as 
doxorubicin, daunorubicin, etoposide, mitoxantrone, and m-AMSA, are classified as TOP2 
poisons (compare Scheme 1-29). As TOP2 poisons can provoke unwanted secondary 
malignancies or topical cell necrosis, it can be necessary to inhibit the formation of stable 
cleaved complexes between TOP2 and DNA alongside pharmacotherapy.[189] Compared to 
TOP2 poisons, catalytic TOP2 inhibitors prevent ATP hydrolysis and maintain the TOP2 
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structure as a closed clamp.[190–192] In this way they do not prevent religation of the G segment 
thus avoiding the production of loose DNA strands. Hence, this mode of inhibition 
supposedly leads to less toxic or lethal side effects. 
 
Scheme 1-29: Molecular structures of the common TOP2 poisons doxorubicin, daunorubicin, etoposide, 
mitoxantrone, and m-AMSA. 
Recently it was proposed that maleimide, N-methylmaleimide, and N-ethylmaleimide 
belong to the class of catalytic TOP2 inhibitors.[193,194] When assessed as drug for TOP2 
depletion, these maleimide derivatives exhibited strong TOP2 inhibiting properties with 
effective concentrations already showing activity in the micromolar range.[194,195] More 
importantly, in the same study maleimide derivatives have been shown to antagonize the 
toxicity caused by TOP2 poisons, such as etoposide. While individual administration of 
etoposide led to TOP2 depletion as expected, the simultaneous application of different 
maleimide derivatives antagonized the TOP2 poison’s effect. Interestingly, during this 
simultaneous administration low concentrations of the maleimide drug did not lead to TOP2 
inhibition. These results point towards an alternative inhibition mechanism different from the 
ones known for existing catalytic TOP2 inhibitors. As succinimide did not have an effect on 
the TOP2 catalytic cycle, it was reasoned that the inhibition is caused by thiol-ene-ligation (a 
variant of the Michael addition) of exposed thiols belonging to cysteine residues exposed by 
TOP2.[193,194] Chemical modification would take place before the G segment is initially 
captured and decrease the overall available concentration of catalytically active TOP2. In that 
way maleimide derivatives could antagonize the TOP2 related side effects of drugs used for 
the treatment of cancer in vitro as well as in vivo preventing uncontrolled DNA cleavage. This 
is a significant finding as the toxicity of most TOP2 poisons employed in antitumor 
applications is the factor that restricts their extensive clinical application.  
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As Michael acceptor systems are generally thought to belong to the class of reactive 
inhibitors because of their high alkylation potential,[196] it would be advantageous to introduce 
a new level of control over the activity of maleimide’s ability to undergo thiol alkylation 
reactions. The Diels-Alder reaction with furan seems predestined for this task as it is, to the 
best of our knowledge, the only effective way of protecting maleimide functionalities. The 
DA reaction with furan masks the reactive C–C double bond and can be tuned easily to be 
reversible at physiological temperatures. Gaining additional control over this protecting group 
via an external stimulus, such as light, allowing for the reversible control over the drugs 
activity would hence be very desirable and will be discussed in detail in Chapter 2.2.  
39 
1.7 Furan for the Reversible Covalent Functionalization of Carbon Nanotubes 
For a long time graphite, amorphous carbon, and diamond have been the only known major 
carbon allotropes and their chemistry was regarded as rather dull since elementary carbon 
exists in a thermodynamic valley rendering it quite unreactive. This changed extraordinarily 
with the discovery of fullerene, carbon nanotubes (CNTs), and graphene, all of which are 
modifications of sp2-hybridized carbon atoms connected to each other, as they possess 
outstanding physicochemical properties and unique reactivity. Graphene can be seen as a two-
dimensional sheet of sp2-carbon atoms attached to each other in a honeycomb lattice while 
CNTs are best imagined as a rolled-up graphene sheet to yield a cylindrical nanostructure and 
fullerenes as a ball resulting from a wrapped-up graphene sheet (Scheme 1-30).[197–199] 
 
Scheme 1-30: Exemplified depictions of a fullerene (C60), as well as pieces of a carbon nanotube and a graphene 
sheet. 
CNTs demonstrate remarkable properties, such as very high tensile strength while 
retaining elasticity that outshines conventional materials, metallic or semiconducting 
electrical properties, excellent thermal conductivity, and particular photoluminescence that 
renders CNTs promising candidates as nanotechnology materials.[200,201] Besides the 
difficulties associated with the bulk synthesis of defined species, the lack of easy 
processability is a major factor hampering the breakthrough of CNTs for most applications on 
a large industrial scale. Intrinsically, CNTs are hardly soluble in common solvents and thus 
have to be functionalized with solubilizing groups in order to achieve a minimum degree of 
processability. This functionalization can also be carried out to adapt and fine-tune CNTs’ 
optoelectronic properties or to add new functional moieties. 
Functionalization of CNTs can be achieved either by the non-covalent approach, the 
covalent approach, or by mechanical interlocking (MINT).[202–205] Non-covalent 
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functionalization relies on the exploitation of weak interactions between CNT and a 
functional unit, such as van der Waals and π-π interactions, wrapping around, or filling of the 
tube. This method has the advantage that the tube’s conjugated π-system remains more or less 
unaffected and the CNTs are easily defunctionalized as the non-covalent interactions can be 
generally regarded as weak. However, as non-covalent interactions tend to exhibit dynamic 
character at ambient conditions rendering a fixed, durable, and localized functionalization 
difficult, this is also the major disadvantage of this approach. Conversely, covalent 
functionalization relies on the formation of stable covalent bonds through esterification or 
amidation reactions with oxidized CNTs, radical additions, or various cycloadditions usually 
irreversibly disrupting the tube’s skeleton. Only very recently the MINT approach was 
established by the group of Martín and coworkers based on the formation of rotaxane-
resembling structures that interlock the tube mechanically but do not react with the sp2-
lattice.[205] 
It becomes clear that a protocol is desirable that merges the advantages of covalent as 
well as non-covalent functionalization, i.e. which forms stable covalent bonds which can be 
cleaved on demand to regenerate the tubes’ π-systems. The DA reaction fulfills these demands 
and besides its use for the bottom-up synthesis of defined sp2-carbon structures, it has been 
successfully employed for the reversible covalent functionalization of multiwall carbon 
nanotubes (MWCNTs) as well as single wall carbon nanotubes (SWCNTs).[151] Sp2-carbon 
allotropes can react either as diene or dienophile in a DA reaction visualized through the 
different mesomeric structures that can be drawn for their electronic configuration (Scheme 
1-31).[206,207] For CNTs reacting as diene, solely modifications using maleimide or maleic 
anhydride as dienophile are known.[208–210] Conversely, when the CNTs react as dienophile 
they can be functionalized by employing anthracene,[211,212] dimethoxybutadiene,[213] 
arynes,[214] o-quinodimethane,[215–218] as well as cyclopentadiene.[219–222] Subsequent to all the 
advantages mentioned in Chapter 1.5.1, one of the most extensively used dienes in this 
application remains furan.[209,210] París and coworkers could modulate CNTs fluorescence 
properties via the attachment of a copolymer consisting of polystyrene, BODIPY 
fluorophores, and furan as a linker diene.[223] Furthermore, Chang and Liu could significantly 
enhance the bulk electrical conductivity of MWCNTs by reacting a difuryl crosslinker with 
pristine MWCNTs creating densely connected MWCNT networks that retained their superior 
mechanical properties.[224] Quijada-Garrido and coworkers synthesized bionanocomposites by 
reacting furyl-substituted poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) with MWCNTs as 
potential scaffold for neural growth application.[225] 
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Scheme 1-31: Exemplified depictions of different mesomeric structures that can be drawn for sp2-carbon 
allotropes to illustrate their reactivity in DA reactions. 
While the DA reaction is usually performed at temperatures slightly above ambient 
conditions over the course of multiple days with high concentrations of the diene in solution 
or even in the bulk, the retro DA reaction is generally carried out in several hours at 
temperatures above 150 °C. The successful functionalization and/or defunctionalization is 
then verified via thermogravimetric analysis (TGA), Fourier transform infrared (FTIR), or 
Raman spectroscopy. The CNTs’ pronounced reactivity towards cycloadditions is caused by 
the curvature directivity of the π-bonds[226] and diminishes with increasing radius of the 
tube.[227,228] 
Though the reversible covalent functionalization of sp2-carbon allotropes clearly has 
advantages when compared to the simple covalent or non-covalent approaches, a control over 
where and when these processes happen would be highly desirable. Carbonaceous sp2-
materials in particular unfold most of their strengths not in the bulk solid or in solution but in 
surface or interface applications where a local addressability is outstandingly useful. Thus, 
Chapter 2.3 will be devoted to the development of a photocontrolled reversible covalent 
functionalization approach prospectively leading to resolution of these processes in time and 
space. 
  
42 
2. Results and Discussion 
2.1 Controlling Covalent Connection and Disconnection by Light 
2.1.1 Conceptual Outline 
Feature miniaturization and the growing complexity of structures used in nanomaterials and 
nanotechnology demand the precise and controlled formation of covalent bonds on the 
molecular scale.[140,229,230] In a conventional dynamic reaction,[231–233] the distribution of 
products can be controlled by applying different chemical and physical triggers, such as 
temperature, pressure, or light.[139,234,235] As light delivers superior spatial, temporal, as well as 
energetic resolution, photoaddressable molecular switches are ideal candidates to exploit the 
typical dynamic covalent reactions available to the organic chemist. These include the 
reversible formation of imines, hydrazones, oximes, thiols, aldols, boronates, or olefins by 
metathesis,[233,236–239] and are already employed to control stoichiometric chemical reactions 
as shown in Chapter 1.4. In addition to the listed reactions, the DA reaction – particularly with 
furan as diene and maleimide as dienophile – unifies a number of advantageous features that 
were already explained in detail in Chapter 1.5. The high reversibility of the furan-maleimide 
couple causes the temperature-dependent conversion to the adduct to be generally not 
quantitative. Conversely, this dynamic character is the prerequisite for the integration of light 
as an additional stimulus that offers the possibility to reach a new level of control over this 
type of reaction. DAEs are the photochromes of choice for this purpose due to their thermal 
stability and high fatigue resistance in combination with large optical changes between their 
ring-open and -closed forms (Chapter 1.3). 
Branda and coworkers have already reported a series of photoswitchable DAEs with a 
diene motif incorporated in their bridge moieties that can undergo DA reactions with various 
dienophiles and inhibit the retro DA reaction through photochemical cyclization of the adduct 
(Chapter 1.4.3) The intrinsic design margins, however, do not allow for locking the DA 
reaction to either the side of the starting materials or the products by application of light. This 
is only possible through choice of different diene-dienophile combinations, as the unreacted 
diene is photochemically inactive. Thus, these truly innovative molecules unfold their 
capabilities rather as devices for the photocontrolled release of small molecules.[127]  
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Conversely, having the possibility of using light as a stimulus to switch both starting 
materials (diene) and reaction product (DA adduct) would offer true photocontrol over the 
dynamic covalent reaction system and enable the precise access to the underlying equilibrium 
(Figure 2-1a). The desired ability to photoswitch the unreacted DAE as well as the DA adduct 
sets certain demands on the molecular design of the respective target compound. The need to 
have a photoswitchable system that removes the reactive double bonds in the diene as well as 
in the adduct upon irradiation with light, thereby preventing either the DA reaction or the retro 
DA reaction, is addressed conveniently by replacing one of the thienyl moieties of a 
dithienylethene by incorporation of a furyl residue as the reactive diene (Figure 2-1b). 
     
Figure 2-1: Photocontrol over the formation and scission of a dynamic bond using photoswitches as locks. a) 
Concept. b) A furyl-substituted diarylethene to achieve a photocontrolled DA reaction with maleimide. 
2.1.2 Synthesis and Characterization of the Target Molecules 
DAE 1o was the first furylthienylethene synthesized to fulfil the specific demands outlined in 
Chapter 2.1.1 with the critical intermediate towards it being diketone 11 (Scheme 2-1). The 
synthesis en route to 11 can be approached by two major pathways: i) a subsequent cascade of 
Friedel-Crafts type reactions or ii) a Michael type enolate addition.  
The first path starts with the smooth reaction of thiophene 5 and glutaric acid 
monoethyl ester chloride to give the acylated ethyl ester 6 with 64% yield. Saponification 
with excess NaOH in EtOH easily yielded the corresponding carboxylic acid 7 in basically 
quantitative yields. Note that the supposedly more facile[94] synthesis of acid 7 starting 
directly with thiophene 5 and glutaric anhydride was also attempted but purification of the 
received crude carboxylic acid proved to be laborious and inefficient. Subsequently, 
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chlorination of acid 7 with oxalyl chloride in CH2Cl2 efficiently produced the acid chloride 8 
which was employed for the subsequent reaction without any further workup. 
 
Scheme 2-1: Synthesis of furyl-substituted DAEs 1o and 2o. 
However, the following Friedel-Crafts acylation of commercially available 2,5-
dimethylfuran to the obtained acid chloride 8 was found to be an inefficient process as the 
yields did not surpass 20% in any attempt. The degradation behavior of furans when exposed 
to Lewis acids is sufficiently documented[240] and thus only few Lewis acids could be 
considered in the first place. SnCl4 is known to exhibit the right balance regarding activity and 
degradative behavior towards furan[146] but even this Lewis acid led to ample destruction of 
the starting material 8. Hence, the second route relying on a Michael type addition was 
selected. Starting with thiophene 5, the first step gives the acylated compound 9 by Friedel-
Crafts acylation with chloropropanoyl chloride in 97% yield as mixture of the 3- and 4-
regioisomers. Basic elimination of HCl employing DBU results in the corresponding α,β-
unsaturated ketone 10 that can undergo a Michael type addition with the lithium enolate of 
commercially available 3-acetyl-2,5-dimethylfuran to give diketone 11 with a yield of 31%. 
Though this reaction pathway apparently produces yields that are only slightly higher 
compared to pathway 1, the overall effort is lower as there are fewer steps involved and the 
elimination-addition-cascade can be carried out in situ. Then, standard McMurry type 
conditions produce the reductively coupled precursor 12 in 59% yield which, in turn, can be 
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functionalized conveniently by an in situ boronation with subsequent Suzuki-Miyaura 
palladium catalyzed cross-coupling yielding the respective diarylethene 1o with a yield of 
61%. DAE 1o can successfully undergo the DA reaction with N-phenylmaleimide to its 
corresponding DA adduct 3o – consisting of the stereoisomers exo-3o and endo-3o – and 
exhibits full reversibility to the starting materials at elevated temperatures (Scheme 2-2). 
Though both stereoisomers were isolated and appear to exhibit the same spectral 
characteristics, only the thermodynamically more stable exo-3o, synthesized with a yield of 
37%, was employed for thorough analytical characterization and photochemistry. 
 
Scheme 2-2: Diels-Alder reaction between DAEs 1o and 2o with maleimides towards respective adducts 3o and 
4o. 
Unreacted switch 1o as well as adduct exo-3o show fully reversible photochromism 
and exhibit the appearance of the typical band in the visible part of the spectrum upon 
photocyclization (Figure 2-2). The photocyclization and cycloreversion quantum yields along 
with molar absorptivities and compositions and the PSS of switches 1 and exo-3 are combined 
in Table 2-1 and Table 2-2. 
   
Figure 2-2: UV/vis absorption spectra during the course of ring-closure of a) DAE 1o and b) respective Diels-
Alder adduct exo-3o in MeCN (c ~ 10-5 M), induced by irradiation with UV-light (λirr = 313 nm) at 25 °C. 
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Table 2-1: Molar absorptivities, absorption maxima, composition at the PSS, as well as cyclization and 
cycloreversion quantum yields of DAE 1 in MeCN. 
 
ε / L mol-1cm-1 λmax / nm 
 
λirr / nm 
1o 1c 1o 1c 
313  
o→c 
436  
c→o 
MeCN 20000 14600 280 468 
ϕ 0.63 0.06 
PSS / % 73 100 
 
Table 2-2: Molar absorptivities, absorption maxima, composition at the PSS, as well as cyclization and 
cycloreversion quantum yields of DAE exo-3 in MeCN. 
 
ε / L mol-1cm-1 λmax / nm 
 
λirr / nm 
exo-3o exo-3c exo-3o exo-3c 
313  
o→c 
436  
c→o 
MeCN 22000 13500 278 400 
ϕ 0.25 0.08 
PSS / % 70 100 
 
Despite the fact that the system constituting of diarylethene 1o and N-
phenylmaleimide showed full function in reactivity as well as photochemistry, it was not 
employed for further studies as 1o is prone to fast oxidation under aerated conditions, the 
photocyclization and cycloreversion quantum yields of 1 and exo-3 are low, and the amounts 
of 1c and exo-3c at their respective PSSs are dissatisfying. Thus the practicality of this system 
is widely restricted and instead, the 3,5-bis(trifluoromethyl)phenyl terminated DAE 2o was 
synthesized with a yield of 82% analogously to 1o by varying only the aryl bromide as the 
coupling partner in the last step of the synthesis (Scheme 2-1). The 3,5-
bis(trifluoromethyl)phenyl substituent was chosen as it is known from work in our research 
group to substantially enhance fatigue resistance and its electron-withdrawing character 
increases the bathochromic shift of the ring-closed form’s absorption band. Similar to 1o, 
DAE 2o can successfully undergo the DA reaction with maleimide to yield the corresponding 
adduct 4o as a mixture of exo and endo stereoisomers, the formation of which are reversible at 
100 °C (Scheme 2-2). Again both stereoisomers were isolated, however, for thorough 
analytical characterization and photochemistry only the thermodynamically more stable exo-
4o, received with a yield of 59%, was employed. Both switches 2o and exo-4o show fully 
reversible photochromism and their photocyclization reactions are each characterized by the 
typical appearance of a band in the visible part of the spectrum (Figure 2-3). Notably, the 
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adduct 4c’s absorption maximum exhibits a strong hypsochromic shift when compared to the 
unreacted species 2c of max 86 nmλ∆ = , which can be attributed to the additional double bond 
of the furyl moiety and thus larger π-electron system in 2c.  
  
Figure 2-3: UV/vis absorption spectra during the course of ring-closure of a) DAE 2o and b) respective Diels-
Alder adduct exo-4o in MeCN (c ~ 10-5 M), induced by irradiation with UV-light (λirr = 313 nm) at 25 °C. 
The photocyclization quantum yield of 2o was determined to be as high as 0.80 in 
acetonitrile at the irradiation wavelength irr 313 nmλ =  (Table 2-3). However, the reason for 
this extraordinarily high photochemical efficiency is until now still unclear, particularly as 
ocφ  drops to 0.40 when the solvent is changed to the less polar toluene. Conversion to 2c at 
the PSS is also acceptable in acetonitrile as well as in toluene and suffers only from a small 
drop to around 84–86% at the irradiation wavelength irr 375 nmλ = . This can be attributed to 
the smaller molar absorptivity ε2o  and gain in ε2c  in this spectral region leading to increased 
competition of the cycloreversion reaction (Figure 2-3a). 
Table 2-3: Molar absorptivities, absorption maxima, composition at the PSS, as well as cyclization and 
cycloreversion quantum yields in different solvents at different wavelengths of DAE 2. 
 
ε / L mol-1cm-1 λmax / nm 
 
λirr / nm 
2o 2c 2o 2c 
313 
o→c 
334 
o→c 
375 
o→c 
395 
o→c 
546 
c→o 
MeCN 17000 11900 290 505 
ϕ 0.80 0.77 - - 0.04 
PSS / % 97 98 86 9 - 
toluene 17000 11900 292 512 
ϕ 0.40 0.49 - - 0.04 
PSS / % 91 94 84 - - 
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Though solvent independent, the photocyclization quantum yield of adduct 4 with a 
value of 0.30 is much lower than the unreacted DAE 2 (Table 2-4). However, the 
cycloreversion quantum yields are drastically increased to about 0.10 rendering 4 an ideal 
candidate for dynamic switching that requires acceptable photochemical efficiencies in both 
directions. The conversion to 4c at the photostationary state is with values >90% also more 
than satisfactory. 
Table 2-4: Molar absorptivities, absorption maxima, composition at the PSS, as well as cyclization and 
cycloreversion quantum yields in different solvents at different wavelengths of adduct DAE exo-4. 
 
ε / L mol-1cm-1 λmax / nm 
 
λirr / nm 
exo-4o exo-4c exo-4o exo-4c 
313 
o→c 
334 
o→c 
436 
c→o 
MeCN 15000 10800 283 419 
ϕ 0.31 - 0.10 
PSS / % 90 - - 
Toluene 15000 10800 289 425 
ϕ 0.30 0.33 0.11 
PSS / % 90 99 - 
 
2.1.3 Amplification or Inhibition of the Diels-Alder Reaction 
Two main aspects can be extracted from the findings that have been elucidated in 
Chapter 2.1.2 so far and are summarized in Scheme 2-3: i) Photocyclization of 2o to 2c 
removes the reactive cisoid diene functionality of the furyl moiety and thus detains the 
molecule from participation in the DA reaction; and ii) ring-closure of 4o to 4c removes the 
reactive double bond from the oxanorbornene skeleton, thereby thermally locking the adduct 
and preventing the retro DA reaction. As can be seen in Figure 2-4a, reaction of 2o with 
maleimide results in conversion to the adducts exo-4o and endo-4o even at very low 
concentrations. To prove that the forward DA reaction can be inhibited by photocyclization, 
2o was irradiated to the PSS consisting almost only of 2c and then submitted to the same 
reaction conditions with no apparent conversion to the DA adduct (Figure 2-4b). In an 
analogous manner Figure 2-4c shows the smooth retro DA reaction from exo-4o to 2o upon 
heating. However, heating a mixture of exo-4c and residual exo-4o at the PSS clearly reveals 
that the ring-closed adduct exo-4c is unreactive and stable under these conditions and only the 
residual amount of the ring-open isomer exo-4o can undergo the retro DA reaction (Figure 
2-4d). 
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Scheme 2-3: Reaction scheme depicting the different components 2o, 2c, 4o, 4c, and maleimide in the course of 
a photocontrolled Diels-Alder reaction with respective photocyclization and cycloreversion quantum yields 
measured in toluene and irradiation wavelengths employed for the in situ reaction. 
 
Figure 2-4: Locking the DA as well as the retro DA reaction by light: UPLC diode array detector (DAD) traces 
at λ = 270 nm of a) formation of exo-4o and endo-4o after heating 2o and maleimide (MI) at 50 °C for 1 d, b) no 
formation of adduct is visible after heating 2c and maleimide at 50 °C for 1 d, c) 2o after heating exo-4o at 
100 °C for 15 min (exo-4o before heating shown in grey with offset for comparison), d) No retro DA for exo-4c 
is visible after heating a mixture of exo-4o and exo-4c at the PSS for 1 h at 100 °C (PSS of exo-4o and exo-4c 
before heating shown in grey with offset for comparison). Concentrations of switches 2o, 4o, 2c, and 4c 
employed were 10-5 M, that of maleimide was 10-2 M. 
The ability to lock 2o as well as 4o by converting them to 2c and 4c, respectively, with 
UV-irradiation is remarkable and offers various possibilities to employ these switch 
prototypes as photocontrollable locks. However, the true value of the system arises from the 
feature that the reverse photoprocesses to unleash the reactive diene or DA adduct can be 
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induced each selectively by choosing the proper irradiation wavelength. Comparing the 
absorption spectra of both ring-closed forms reveals a considerable spectral separation 
( max 86 nmλ∆ = ) between the absorption maxima of 2c absorbing in the green and exo-4c 
absorbing in the blue region (Figure 2-5a). Thus, and despite the fact that 2c absorbs slightly 
in the region where exo-4c is addressed, this allows for almost independent initiation of 
cycloreversion reactions while irradiating a mixture of both ring-closed derivatives – the key 
to achieve control over a dynamic system with light. 
  
Figure 2-5: a) Comparison of the absorption spectra of 2o, 2c, exo-4o, and exo-4c in acetonitrile at 25 °C. 
Residual absorbance of exo-4c above 500 nm is attributed to minor retro DA reaction taking place during the 
irradiation process. b) Relative amplification or inhibition of DA adduct formation depending on illumination 
wavelength. Changes in conversion to 4 (4o, 4c both exo and endo combined) reacting DAE 2o (~10-5 M) with 
maleimide (~10-2 M) employing irradiation either at 335 nm and 535 nm for 6 h (amplification) or at 375 nm for 
24 h (inhibition) as compared to the corresponding dark reaction as a function of temperature. See Table 2-5 for 
absolute values. 
Indeed, simultaneous irradiation of a mixture of 2o and maleimide with light enables 
in situ control over the outcome of the DA reaction. While thermal reactions of 2o with 
maleimide exhibit conversions of 18–35% to 2o after 24 h depending on the applied 
temperature (Figure 2-6a and Table 2-5), the formation of the DA adduct can be amplified or 
inhibited by irradiation with light of the appropriate wavelength and subsequent formation of 
the respective ring-closed isomers (Figure 2-5b). Irradiating a mixture of 2o and maleimide 
with 335 nm and 535 nm light induces cyclization of both ring-open isomers 2o and 4o but 
cycloreversion only in 2c (Figure 2-5a), therefore effectively leading to an enrichment of 4c in 
the reaction mixture. This method leads to an amplification of DA adduct formation already 
after 6 h as compared to the dark DA reaction (striped bars in Figure 2-5b). The respective 
liquid chromatography traces for the amplification reaction at 25–60 °C can be found in 
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Figure 2-6b with the corresponding relative peak areas in Table 2-5. At the temperature of 
40 °C the amplification was monitored exemplarily by UV/vis absorption spectroscopy 
confirming the initial formation of 2c followed by its depletion over time to form 4c (Figure 
2-7a). Note that the heating time was reduced as prolonged irradiation and heating result in 
degradation. The same method but using different wavelengths can also be applied to bias the 
DA reaction in favor of adduct inhibition. Using light of 375 nm cyclizes 2o to 2c as well as 
4o to 4c but simultaneously addresses the vis-band of the ring-closed adduct 4c, thereby also 
inducing cycloreversion towards 4o (Figure 2-5a). According to Le Châtelier’s principle, 
diene 2o is removed from the dynamic DA equilibrium by conversion to 2c and thus the 
reaction is inhibited effectively as compared to the dark, i.e. solely thermal, DA reaction 
(checkered bars in Figure 2-5b). The respective liquid chromatography traces for the 
inhibition reaction at 25–60 °C can be found in Figure 2-6c with the corresponding relative 
peak areas in Table 2-5. Again, at the temperature of 40 °C the inhibition was monitored 
exemplarily by UV/vis absorption spectroscopy revealing the formation of 2c as the major 
component absorbing in the visible region in the reaction mixture (Figure 2-7b). 
 
Figure 2-6: UPLC-MS DAD traces at 270 nm after the in situ DA reaction of DAE 2o with maleimide at 
different temperatures after a) 1 d without irradiation (dark reaction), b) 6 h and irradiation with 335 & 535 nm 
light (amplification), and c) irradiation with 375 nm light (inhibition). The observed oxidation product OP at 
t ~ 2.5 min is not a result of the reaction and was formed over several weeks in the stock solution of 2o. 
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Table 2-5: Summarized integrated peak areas during the in situ DA reaction of 2o and maleimide of exo-4 and 
endo-4 (both ring-open and -closed) at different temperatures employing different irradiation conditions. 
T / °C 
Peak area / % 
dark 375 nm 335 & 535 nm 
25 18 15 33 
30 24 16 36 
40 30 18 40 
50 35 23 42 
60 28 27 40 
 
  
Figure 2-7: Exemplary UV/vis absorption spectra during the course of either in situ a) amplification carried out 
for 6 h at 40 °C irradiating with light of the wavelengths 335 & 535 nm or b) inhibition of the DA reaction 
between 2o and maleimide for 1 d at 40 °C irradiating with light of the wavelength 335 nm. Concentration of 
switch 2o was 10-5 M, that of maleimide was 10-2 M. 
In addition to the applied irradiation wavelength, the quantity of amplification or 
inhibition is strongly dependent on the applied temperature (Figure 2-5b). However, 
rationalization of the process is difficult since the overall outcome is a result of a 
superposition of thermal and photochemical equilibria in the ground as well as in the excited 
states. Elevated temperatures, for example, not only promote the retro DA reaction but also 
increase the ring-opening quantum yields, hence affecting the composition at the PSS 
noticeably.[241,242] Furthermore, amplification works best at temperatures typically unfavorable 
for the DA reaction (i.e. in the highly reversible regime) while inhibition works best at 
temperatures yielding already high conversion in the dark. This indicates that amplification 
and inhibition unfold their potential primarily when the reaction rate constant for the thermal 
DA reaction at a given temperature favors the opposite direction. 
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In summary, we have been able to selectively either amplify or inhibit a DA reaction 
by illumination with light of different wavelengths, thus broadening the repertoire of DCC. 
Not only could the DA reaction be shifted to either the side of the starting materials or the side 
of the products in situ and on demand, in addition our prototypic DAE has tremendous 
potential for a variety of possible applications, such as the release of maleimide derivatives in 
physiological systems or the reversible covalent functionalization of carbon nanotubes, both 
of which will be discussed in detail in Chapters 2.2 and 2.3.  
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2.2 Photoinduced Release of Maleimide Derivatives in Physiological Systems 
2.2.1 Conceptual Outline 
In Chapter 1.6.2, it was highlighted that maleimide derivatives show great potential as DNA 
Topoisomerase II (TOP2) inhibitors as well as TOP2 poison antagonists. It was emphasized 
that maleimide derivatives do not stabilize the cleaving complexes of DNA G segment, 
T segment, and TOP2, but in contrast decrease the bioavailable TOP2 concentration through 
its respective alkylation. This circumvents side-effects of common antitumor or antibiotic 
drugs.[193–195] 
As pointed out in Chapter 1.6.1 that exerting control over ‘where’ and ‘when’ a drug is 
administered in the organism is regarded as highly beneficial to bypass poor selectivity and 
toxicity, a release of maleimide derivatives activated by an external stimulus would be highly 
sought after.[23] It was clarified in the earlier sections that light as a stimulus has many 
advantages, including its high bioorthogonality, and thus a photoactivatable release system 
can be seen as promising with view on actual in vivo application. Additionally, conventional 
drug administration usually suffers from an initially high but comparatively short 
bioavailability of the drug as reactive sites are generally metabolized quickly. Hence, the 
means to achieve long-term release of the active drug, i.e. a ‘depot effect’, is very desirable. 
Conceptually, these demands to a photocontrolled release system have been composed in 
Figure 2-8. 
 
Figure 2-8: Conceptual depiction of the photoreversible activation of a release system relying on a subsequent 
thermal equilibrium. 
The photocontrollable DA reaction highlighted in Chapter 2.1 fulfills all of the criteria 
defined for this task as it i) protects the maleimide derivative’s reactive double bond by 
formation of the DA adduct thus inhibiting its biological activity,[194] ii) can lock and unlock 
the DA adduct photoreversibly granting external control over the release system,[95] and iii) 
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features a subsequent thermal equilibrium acting as a depot for long-term release of the 
maleimide based drug.  
To the best of our knowledge, photoswitching of a DAE derivative that is soluble in 
physiological media has only been reported in two cases[182,183] and also literature documented 
examples of water-soluble DAEs are pretty rare.[243–249] As the route towards the photocontrol 
over the DA reaction was already covered in Chapter 2.1, the main effort for the realization of 
this application thus lies in the design of a photoswitchable DA system that is soluble in 
physiological (i.e. buffered aqueous) media while retaining its high photochemical efficiency 
therein. 
2.2.2 Synthesis and Characterization of the Target Molecules 
Since the methylated pyridine moiety is a reoccurring motif to solubilize DAEs in aqueous 
environments,[243,245] the first furyl switch that was designed to fulfill the criteria outlined in 
Chapter 2.2.1 was the methylpyridinium salt 14 (Scheme 2-4). Starting from the already 
established chloro precursor 12 the p-pyridyl-substituted furyl switch 13 was obtained with a 
yield of 76% by one-pot halogen-metal exchange and Suzuki-Miyaura type cross-coupling 
conditions employing the commercial hydrochloride of p-bromo pyridine. Subsequent 
methylation using methyl iodide in acetonitrile and washing with brine yielded the desired 
methylpyridinium chloride 14 with a good yield of 89%. 
 
Scheme 2-4. Syntheses of water-soluble furyl-substituted DAEs 14 and 15. 
DAE 14 possesses outstanding water-solubility up to hundreds of milligrams per 
milliliter. Yet, no reversible photochromic behavior could be detected as upon irradiation with 
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UV-light only unspecific degradation could be observed. Figure 2-9a noticeably shows the 
development of a new absorption band around 640 nm upon irradiation of 14o with light of 
the wavelength λirr = 313 nm. This absorption band, however, is depleted after a short time 
and a new band around 500 nm is formed. Subsequent irradiation of the resulting mixture 
with visible light of the wavelength λirr = 546 nm did not reproduce the ring-open form 14o 
(Figure 2-9b). It was reasoned that the halogen anion could interfere with the photochemistry, 
e.g. by forming radical species, and could lead to the production of unwanted side-products 
during the irradiation process. Hence, the hexafluorophosphate 15 was synthesized by stirring 
14 and NaPF6 in acetonitrile. The repeated washing steps necessary to remove residual NaPF6 
are accounted for the fact that only 44% yield were received after this simple ion exchange. 
However, similar degradation behavior to 14o was observed and no reversible photochromic 
processes could be detected while irradiating a solution of 15o in acetonitrile with UV-light of 
the wavelength λirr = 313 nm. A possible reason for that irreversible photoreaction could be an 
initially occurring charge transfer or photoinduced electron transfer between the electron-
donating furyl and the electron-withdrawing methylpyridinium moieties in the DAE’s ring-
open form, as indicated by the bathochromically shifted S1-transitions of 14 and 15 (Figure 
2-9).[53,250] A resulting pyridine-based radical could then engage in some irreversible 
subsequent reaction leading to fatigue. 
  
Figure 2-9: UV/vis absorption spectra during the course of a) ring-closure of DAE 14o induced by irradiation 
with UV-light (λirr = 313 nm) and b) ring-opening of DAE 14c induced by irradiation with vis-light 
(λirr = 546 nm) in H2O (c ~ 10-5 M) at 25 °C. 
Consequently, the charged, electron-withdrawing species was excluded from the π-
electron system that participates in the photochromic reaction leading to the design of 
bis(dimethylamino) ester 16 (Scheme 2-5). Starting from the chloro precursor 12, one-pot 
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halogen-metal exchange, Suzuki-Miyaura type cross-coupling conditions, and subsequent 
precipitation with anhydrous HCl from an Et2O solution led to bis(dimethylamino) ester 
hydrochloride 16 in 62% yield. Diaminoester bromide 17 employed in this reaction was 
synthesized in a straightforward manner by the drop-wise addition of p-bromobenzoyl 
chloride to a solution of the commercial 1,3-bis(dimethylamino)propan-2-ol in methylene 
chloride. Normally, this reaction should be quantitative and the comparably poor yield of 67% 
is caused by the contamination of the starting material with p-bromobenzoic acid. 
 
Scheme 2-5: Syntheses of water-soluble furyl-substituted ester 16 and its free base precursor building block 17. 
DAE 16o is readily dispersed in water and exhibits reversible switching behavior, as 
indicated by the appearance of a band at around 540 nm upon irradiation with UV-light and 
its vanishing upon irradiation with vis-light (Figure 2-10a and Figure 2-10b). However, only a 
low fraction of ring-closed isomer 16c could be produced at the photostationary state, strongly 
suggesting that effective photoisomerization is somehow hindered. Furthermore, hydrolysis of 
16o to the free acid and 1,3-bis(dimethylamino)propan-2-ol was observed over the timescale 
of days rendering this derivative not useful in long-term applications. The formation of 
aggregates becomes apparent through the increased baseline absorption attributed to 
unspecific scattering in solution and is most likely responsible for the unsatisfying 
photochromic properties as the switching process could be hampered in densely packed 
aggregates.  
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Figure 2-10: UV/vis absorption spectra during the course of a) ring-closure of DAE 16o induced by irradiation 
with UV-light (λirr = 313 nm) and b) ring-opening of DAE 16c induced by irradiation with vis-light 
(λirr = 546 nm) in H2O (c ~ 10-5 M) at 25 °C. 
Subsequently, we decided to dismiss the design of DAE 16 and to synthesize the 
sodium salt of a carboxylic acid, as sodium carboxylates are well-known to permit solubility 
in aqueous media. Therefore, precursor 12 was employed in the familiar cross-coupling 
sequence with ethyl p-bromobenzoate to yield ester 18 with a yield of 67%. The latter was 
subsequently saponified quantitatively with NaOH in ethanol to yield desired sodium 
carboxylate 19 (Scheme 2-6). With a yield of 75% this otherwise quantitative reaction was 
again hampered by multiple washing steps. DAE 19o exhibits excellent solubility in water 
and also suitable photochromic behavior, as indicated by the reversible formation of a band 
around 500 nm upon irradiation of 19o to 19c employing UV-light (Figure 2-11a). However, 
over time in H2O and immediately upon dissolution in phosphate buffered saline (PBS), 
aggregation of 19o was observed (compare scattering in Figure 2-11b). Efforts to elucidate 
this aggregation behavior will be described in Chapter 2.2.4.  
 
Scheme 2-6: Synthesis of water-soluble furyl-substituted sodium carboxylate 19. 
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Figure 2-11: UV/vis absorption spectra during the course of ring-closure of DAE 19o induced by irradiation to 
the PSS with UV-light (λirr = 313 nm, c ~ 10-5 M) at 25 °C in a) H2O and b) PBS. 
Against our expectations, the ring-closed form 19c was found not to be stable. As can be seen 
in Figure 2-12, upon stirring the mixture of 19c and 19o at the PSS at 25 °C, the absorption in 
the visible part of the spectrum fades over the period of multiple hours. This could point 
towards a thermal instability of the ring-closed switch, a property not usually observed in 
DAEs substituted with 3-thienyl or 3-furyl residues.[30,35,36] A UPLC analysis of the solution’s 
composition after the thermal bleaching, however, reveals that the ring-open form 19o is not 
regenerated (Figure 2-13). Instead, a different compound RPo with a molecular weight of 
16 Da higher than 19o was detected. These results, alongside with the observed sensitivity of 
furyl-substituted DAEs towards molecular oxygen (compare furyl DAE 1o in Chapter 2.2.2), 
strongly suggest that an oxidation reaction occurs. Furthermore, the reaction product RPo 
exhibits photochromic behavior but thermally reverts to its ring-open form after a short time 
again. We thus reason that the chemical reaction that only takes place from the ring-closed 
form 19c but not from the ring-open form 19o leads to a novel, perhaps oxidized, ring-closed 
species RPc, which exhibits thermal reversibility and consequentially reverts back to its ring-
open form RPo. Two major reasons for the thermal back reaction of DAEs are discussed in 
the literature. i) Oxidation of the closed-form leads to a DAE cation which subsequently 
reverts to its ring-open form[53] or ii) the aromatic stabilization energy of the aryl moieties is 
increased to a point where the difference in ground state energies of ring-open and ring-closed 
forms becomes too high and the thermal bistability is lost.[24] Up to now it is unclear which 
one of the suggested effects the supposed oxidation reaction is inducing. Despite its unusual 
photochromic and aggregation behavior, 19 will be explored as suitable molecule to form 
water-soluble DA adducts with maleimide derivatives, as their photochromic behavior should 
differ to a certain extent from 19o due to the altered furyl moiety. 
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Figure 2-12: Reaction induced cycloreversion of 19c after irradiation to the PSS with UV-light (λirr = 313 nm, 
c ~ 10-5 M) at 25 °C in H2O. a) Stacked UV/vis absorption spectra and b) exponential decay as observed at the 
absorption maximum of 19c (487 nm) over time. 
 
Figure 2-13: UPLC-MS DAD traces at 292 nm of DAE 19 in H2O at the PSS after irradiation with light 
(λirr = 313 nm) composed of 19o, 19c, and reaction product RPo. 
The DA adducts of 19 with maleimide and N-ethylmaleimide were considered for 
synthesis as both maleimide derivatives have been explored as catalytic TOP2 inhibitors as 
well as TOP2 poison antagonists in the literature.[193,194] Synthesis of maleimide adducts 22c 
and 23c can be carried out via two different routes (Scheme 2-7). The first route starts with 
ester 18 on which the DA reaction with the respective maleimide is subsequently performed to 
give adducts 20o or 21o in yields from 79–83% after chromatographic purification. These can 
then be irradiated preparatively in a photochemical chamber reactor with light of the 
wavelength λirr = 300 nm to yield their respective closed forms 20c and 21c which, in turn, 
can be saponificated quantitatively with NaOH to the corresponding sodium carboxylates 22c 
and 23c. While the latter step is generally quantitative, the preparative irradiation produces a 
decent amount of by-products that are difficult to separate by column chromatography. As 
additionally the intermediate ring-closed forms 20c and 21c are prone to oxidation, the 
received yields (< 38%) were rather poor. Thus, the first route was not identified as the ideal 
path towards the target compounds and only followed terminally in the case of adduct 22c. 
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These considerations led to an alternative second route, which relies on the DA reaction of the 
respective maleimide derivative with the already water-soluble DAE 19 in EtOH to yield 
quantitative conversion to the respective DA adducts 22o and 23o. These are then converted 
to their corresponding ring-closed forms 22c and 23c on demand directly before the actual 
experiment by irradiation with light of the wavelength λirr = 313 nm generated by a 500 W 
medium pressure mercury lamp. This second route simplifies the handling of the compounds 
and also leads to target molecules of higher purity as the side-products produced during 
preparative irradiation in the photochemical reactor can be omitted. 
 
Scheme 2-7: Syntheses of water-soluble closed form maleimide and N-ethylmaleimide adducts 22c and 23c. 
Expediently, the ratio of endo to exo stereoisomers produced in the DA reaction of 19 
with the two different maleimides can be tuned simply by varying the reaction temperature. 
While furan 19 and maleimide were reacted at room temperature for 1 d to yield a mixture 
consisting of 40% of the endo and 60% of the exo isomer for adduct 22o, stirring 19 and N-
ethylmaleimide at 70 °C for 6 h led to almost exclusively (97%) the exo stereoisomer of 23o. 
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While the endo to exo ratio can be fine-tuned regardless of the maleimide derivative 
employed, these two combinations were chosen to gain insight into their different release 
kinetics since the retro DA reaction of the endo stereoisomer is expected to take place at an 
increased rate as compared to the exo isomer (compare Chapter 2.2.3) 
The molar absorptivities, absorption maxima, and composition at the PSS of DAEs 22 
and 23 are summarized in Table 2-6. All irradiation experiments were performed in phosphate 
buffered saline (PBS), successfully verifying that switches 22 and 23 are applicable under in 
vivo conditions. Both derivatives almost quantitatively convert to their respective ring-closed 
forms 22c and 23c at the PSS after irradiation with UV-light. This can be observed in Figure 
2-14a and Figure 2-15a and is indicated through the appearance of the characteristic bands at 
412 nm. When employing light with a higher wavelength than 400 nm, the cycloreversion 
reaction from 22c and 23c to 22o and 23o is induced regenerating the ring-open isomers 
(Figure 2-14b and Figure 2-15b). Although the almost quantitative character of these ring-
opening processes was confirmed by UPLC measurements, the absorption bands at 316 nm 
are not completely regenerated in the ring-open forms. 
Table 2-6: Molar absorptivities, absorption maxima, and composition at the PSS of adducts 22 and 23 in PBS. 
Molar absorptivities should be regarded as preliminary as aggregation phenomena may alter them artificially. 
ε / L mol-1cm-1 λmax / nm PSS313 nm / % 
22o 22c 23o 23c 22o 22c 23o 23c 22 23 
16700 11500 18500 12600 316 412 316 412 97 98 
 
  
Figure 2-14: UV/vis absorption spectra during the course of a) ring-closure of DAE 22o induced by irradiation 
with UV-light (λirr = 313 nm) and b) ring-opening of DAE 22c induced by irradiation with vis-light 
(λirr > 400 nm) in phosphate buffered saline (PBS) (c ~ 7x10-5 M) at 25 °C. 
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Figure 2-15: UV/vis absorption spectra during the course of a) ring-closure of DAE 23o induced by irradiation 
with UV-light (λirr = 313 nm) and b) ring-opening of DAE 23c induced by irradiation with vis-light 
(λirr > 400 nm) in phosphate buffered saline (PBS) (c ~ 10-4 M) at 25 °C. 
We attribute this phenomenon to the formation of aggregates in solutions of the ring-open 
forms that contribute to their molar absorptivities in that area and that are not homogeneously 
restored after the consecutive ring-opening reactions. 
Importantly, a water-soluble furyl-substituted DAE 19o has been designed that not 
only exhibits interesting aggregation behavior in aqueous solution but also performs a 
chemical reaction from its ring-closed form 19c leading to a thermally reversible 
photochromic product. The usability of this system in the context of photoswitchable 
stoichiometric reactions still has to be explored. Moreover, two DA adducts 22 and 23 have 
been synthesized that are highly suitable for the release of maleimide in physiological media, 
as they combine all the necessary properties that are demanded: (i) they exhibit a high 
solubility in water as well as in PBS, (ii) their respective compositions at the PSS in 
physiological solution are outstanding, meaning that the ring-closed forms 22c and 23c can be 
generated basically quantitatively on demand without any further purification, and (iii) the 
ring-closed adducts can be transformed into their ring-open counterparts by irradiation with 
highly bioorthogonal visible light (λirr > 400 nm). 
2.2.3 Photoinduced Release of Maleimide Derivatives 
To prove the conceptual validity of triggering the release of maleimide derivatives from their 
respective adducts 22o and 23o, closed forms 22c and 23c have to be generated as they 
constitute the deactivated and presumably pharmacologically inactive form. This was realized 
in situ by irradiation of a 10-4 M solution of the corresponding ring-open forms 22o and 23o 
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until the photostationary state was reached (dashed lines in Figure 2-16a and Figure 2-16b). 
The ring-closed derivatives were then irradiated with vis-light (λirr > 400 nm) to regenerate 
the corresponding active ring-open forms 22o and 23o (grey solid lines in Figure 2-16a and 
Figure 2-16b) and subsequently heated at 80 °C to release maleimide or N-ethylmaleimide 
over time (black lines in Figure 2-16a and Figure 2-16b). Hence, it was demonstrated that the 
release of maleimide derivatives can be carried out quantitatively in PBS by applying high 
temperatures. 
  
Figure 2-16: UPLC-MS DAD traces at 280 nm of the ring-closed DA adducts at the PSS, the ring-open DA 
adducts after irradiation with vis-light (λirr > 400 nm, 20 min) in PBS, and the successful release of a) maleimide 
after 3 h at 80 °C for 22c and 22o and b) N-ethylmaleimide after 5 h at 80 °C for 23c and 23o. 
However, 80 °C are nowhere near to physiological temperatures and thus the release 
of maleimide from 22o was investigated in detail at temperatures ranging from 40 °C to 80 °C 
(Figure 2-17). As expected, the retro DA reaction becomes increasingly slower with 
decreasing temperatures. Nevertheless, it can be seen that a continuous release of maleimide 
takes place even at 40 °C to an extent of about 50% after 92 h. However, as a mixture of the 
endo and exo stereoisomers of 22o was employed for the retro DA reaction, the information 
content of Figure 2-17 seems rather limited and a detailed kinetic analysis of the release was 
carried out. 
For this purpose, it is necessary to determine which reactions can actually take place in 
a solution of a mixture of an endo and exo DA adduct. From Scheme 2-8 it can be extracted 
that for the complete kinetic description of the reaction system the forward (DA) reactions 
from the starting materials to either endo or exo adducts, represented through their respective 
rate constants fexok  and fendok , as well as the backward (retro DA) reactions, represented 
through their respective rate constants bexok  and bendok , have to be taken into account. Evidently, 
the resulting system of rate equations cannot be solved analytically and hence some 
simplifications are necessary. 
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Figure 2-17: Retro DA reaction of 22o to 19 and maleimide at different temperatures in PBS as visualized by the 
evolution of the adduct’s molar fraction x over time. The compositions of the reaction mixtures were determined 
by integrating the peak areas of the DAD detector at 280 nm after UPLC measurements. 
  
Scheme 2-8: Reversible DA reaction between DAE 19 and maleimide derivatives leading to either endo or exo 
stereoisomers of 22o and 23o respectively. 
Our primary interest lies in the release of maleimide and thus in the rate constants for 
the retro DA reaction bk . The retro DA reaction from adducts 22o and 23o to switch 19 is a 
unimolecular reaction and thus follows first-order kinetics (Scheme 2-8). The differential rate 
equation – exemplarily expressed through the concentration of the exo adduct – accordingly 
yields the expression 
 f bexo exo exo mal exo exo
d
d
c c k c c k c
t
= = ⋅ ⋅ − ⋅19  (2.1) 
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where contributions of DA as well as retro DA reactions are taken into account through their 
respective rate constants k and concentrations of the participating species c. As at any given 
point of the reaction malc c=19 , Equation (2.1) can be simplified to 
 f 2 bexo exo exo exoc k c k c= ⋅ − ⋅19 . (2.2) 
However and as stated beforehand, no analytic solution for any of these expressions can be 
found. Conveniently, with decreasing adduct concentrations the bimolecular forward DA 
reaction becomes increasingly insignificant as the term f 2exok c⋅ 19  decreases faster than bexo exok c⋅ . 
Consequently, Equation (2.2) can be approximated to 
 bexo exo exoc k c= − ⋅  (2.3) 
in diluted solutions and integrated to yield the expression 
 
b
exo
exo 0
k tc c e− ⋅= ⋅  (2.4) 
with 0c  being the exo adduct’s concentration at 0t = . Finally the rate constant can be 
determined by logarithmic conversion to 
 ( ) ( )bexo exo 0ln lnc k t c= − ⋅ +  (2.5) 
as this expression represents a linear relationship and thus k can be extracted from the slope 
by simple linear regression. Certainly, equivalent expressions can be formulated for all 
equations with respect to the endo stereoisomer employing endoc . 
For the determination of the rate constants of the retro DA reaction the individual 
evolution of the endo and exo adducts of 22o (60% exo, 40% endo) and 23o (97% exo, 3% 
endo) in 10-4 M solutions in PBS was followed over time by integrating the DAD signal of the 
corresponding UPLC traces at λ = 280 nm where the DA adducts as well as 19o exhibit 
approximately the same molar absorptivities (Figure 2-18). A number of expected features can 
be extracted from this set of figures: i) The release of maleimide is faster at 40 °C than it is at 
37 °C, and ii) the release of maleimide from the endo stereoisomer is faster than from the 
corresponding exo stereoisomer. However, it is also easily recognized that the evolution of the 
individual concentrations does not follow the expected exponential decay. Instead, for the 
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retro DA reaction of 22o to 19 even an intermediate increase in the amount of exo 
stereoisomer is observed completely contradicting the simplifications applied to the rate 
equations earlier. Thus, the forward DA reaction cannot be neglected despite supposedly 
being multiple orders of magnitude more slowly. 
 
Figure 2-18: Retro DA reaction at 37 °C and 40 °C in PBS as visualized by the evolution of the endo and exo 
adduct’s molar fraction x over time as determined by UPLC measurements of a) 22o to 19 and maleimide and b) 
23o to 19 and N-ethylmaleimide. Ratios recorded at t = 0 h can slightly deviate from the ratios determined 
directly after synthesis as retro DA reaction did already set in. 
As direct interconversion of the stereoisomers is not possible without performing the 
forward or backward DA reaction,[158] it is reasonable to assume that the predicted reaction 
pathway must be different from the pathway observed. As the forward DA reaction follows 
bimolecular kinetics, it is apparent that the concentrations of 19 and the respective maleimide 
derivative are the critical variables that have to be considered in detail. Hence, it may be 
possible that the effective concentration of the reactants deviates from the concentration of 
10-4 M that would be expected in homogeneous solution. One way to rationalize the observed 
effects leading to the intermediate formation of exo-22o is to assume aggregation in aqueous 
solution causing increased local concentrations. An additional step that describes the 
association to (via ak ) as well as the dissociation from the aggregate (via dk ) could describe 
how after triggering the retro DA reaction the maleimide derivative is not covalently bound in 
the adduct anymore but trapped inside an aggregate increasing its effective concentration in 
the vicinity of unreacted 19o (Scheme 2-9). Eventually, the forward DA reaction becomes 
relevant and not negligible when the dissociation from the adduct to homogeneous solution is 
slow enough, i.e. d fk k< .  
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Scheme 2-9: Reversible DA reaction between DAE 19 and maleimide derivatives via association and 
dissociation to aggregates leading to either endo or exo stereoisomers of 22 and 23 respectively. 
To gather hints whether the phenomenon is indeed related to aggregation, the release 
of maleimide from 22o (60% exo, 40% endo) in a deaggregating solvent mixture 
(H2O:THF:MeCN = 2:1:1) was followed at 40 °C by UPLC measurements (Figure 2-19). As 
can be seen in Figure 2-19a and as opposed to the measurements in PBS, the amount of 
exo-22o is not increasing in the deaggregating solvent mixture but conversely follows the 
initially expected exponential rate law. Moreover, Figure 2-19b reveals a linear relationship 
between the natural logarithm of the concentrations of exo-22o or endo-22o against the 
reaction time thus confirming the simplifications applied to yield Equation (2.5) and its 
pseudo first-order kinetics. 
Inconveniently, this finding renders the simplifications applied to analytically solve the 
rate equations invalid when applied to the retro DA reaction in aggregation-inducing solvents 
such as PBS. Moreover, a thorough determination of the actual rate constants for the retro DA 
reaction in PBS would yield no noteworthy insight into the release dynamics as the back 
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reaction might not be the rate-determining step. Thus, it becomes necessary to compare the 
released amounts of the respective maleimide derivative directly. 
  
Figure 2-19: Retro DA reaction of 22o (60% exo, 40% endo, 5×10-5 M) to 19 and maleimide at 40 °C in 
deaggregating solvent mixture (H2O:THF:MeCN = 2:1:1) over time as visualized by the evolution of the endo 
and exo adduct’s a) molar fraction x and b) natural logarithm of their concentration ln(c). 
From the data presented in Figure 2-18, the overall concentration of released 
maleimide MIc  – or N-ethylmaleimide NEMc , respectively – can be calculated at any point of 
the reaction according to 
 endo exo 0
100
100
x xc c− −= ⋅  (2.6) 
and the graphs resulting thereof are presented in Figure 2-20. Since bendok  is expected to be at 
least one order of magnitude higher than bexok , the release of maleimide from 22o (consisting 
of 40% endo isomer) is with 46 μMd-1 at 37 °C and 59 μMd-1 at 40 °C unsurprisingly much 
higher than the release of N-ethylmaleimide from 23o (consisting of 3% endo isomer) with 
5 μMd-1 at 37 °C and 6 μMd-1 at 40 °C. These daily concentrations are estimated from the 
release that was monitored over 12 h and most importantly lie in the range of therapeutic 
applicability suitable for in vivo applications.[194] Furthermore, these results show the 
possibility to conveniently fine-tune the amount of released maleimide derivative over time 
by synthesizing DA adducts with varying endo to exo stereoisomer compositions: While a 
higher endo fraction ensures a larger initial release of maleimide, a higher exo fraction leads 
to a slower release creating a ‘depot effect’. Figure 2-20a and Figure 2-20b also show that the 
release from the deactivated ring-closed forms is negligible and can be disregarded. Another 
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feature potentially useful for in vivo application is the increased release rate at 40 °C as 
compared to 37 °C. As tumor tissue tends to exhibit higher metabolic activity than unaffected 
tissue, the release of maleimide derivatives can be particularly stimulated in those areas. 
  
Figure 2-20: Retro DA reactions at 37 °C and 40 °C, respectively, in PBS (c = 1×10-4 M) as visualized by the 
evolution of the concentration c of a) maleimide released from 22o and b) N-ethylmaleimide released from 23o 
over time compared to the release from the respective closed form adducts 22c and 23c. 
Moreover, the reversibility of the switching process in DAEs in combination with the 
slow thermal release allows for the ‘on’ and ‘off’ switching of the maleimide release in situ 
(Figure 2-21). 
 
Figure 2-21: Switching the release of maleimide in situ ‘off’ from 22o to 22c (λ = 313 nm for 9 min) and ‘on’ 
again from 22c to 22o (λ > 400 nm for 20 min) at 40 °C in PBS (c = 1×10-4 M) as visualized by the evolution of 
the concentration of maleimide cMI over time.  
Besides the activation of the retro DA reaction by ring-opening 22c to 22o with vis-light, the 
release of maleimide could subsequently be inhibited to a wide extent by ring-closing 
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unreacted 22o back to 22c by UV-light in situ rendering this system potentially useful in the 
context of photopharmacology where the prodrug could be switched ‘off’ after the desired 
effect on the organism was observed. The system then remains inactive for the chosen time 
and can subsequently be reactivated on demand allowing for the release of maleimide again. 
In conclusion, maleimide and N-ethylmaleimide could be successfully released from 
their corresponding DA adducts 22o and 23o under physiological conditions (i.e. at body 
temperature and in aqueous buffer). The active ring-open forms could be generated in situ by 
irradiation with highly bioorthogonal vis-light from their respective ring-closed forms 22c and 
23c, the latter of which were shown not to exhibit any significant release behavior. Not only 
lies the amount of released maleimide derivative in the pharmacologically active μM range, it 
could also be stimulated conveniently by higher temperatures (as in tissue with higher 
metabolic activity) or the initial ratio of endo to exo stereoisomer. While a high endo fraction 
ensures immediate release, a high exo fraction is useful when a depot, releasing small 
amounts of maleimide over days, is desired. Additionally, the photoreversible character of the 
DAEs could be exploited to switch the adduct’s release activity ‘off’ and ‘on’ again enabling 
in situ control over when the maleimide is being released. 
2.2.4 Aggregation Behavior of Furyl DAE 19o 
In Chapter 2.2.2, Figure 2-11 we deduced from the scattering observed when performing 
UV/vis spectroscopy in PBS that furyl-substituted DAE 19o might be prone to an aggregation 
process dependent on the nature of the solvent employed. The formation of aggregates is 
highly dependent on a variety of external effects, i.a. concentration, pH, or ionic strength. 
Likewise, the molecular shape and relative orientation of substituents, in particular polar 
groups, govern the type of aggregates formed.  
Though DAE 19o exhibits no characteristically long, nonpolar chain and is thus 
unlikely to form typical micelles or vesicles in water, the concentration dependence of 
aggregation was investigated using techniques usually employed to determine critical micelle 
concentrations (CMCs).[251] For this purpose a 3.4×10-4 M solution of 1-(2-pyridylazo)-2-
naphthol (PAN) in pentane was added to differently concentrated dispersions of 19o in water. 
PAN as probe molecule is insoluble in aqueous solvents and indicates its inclusion into 
aggregates when a signal in the visible range of the spectrum can be measured. For that 
purpose, a UV/vis spectrum has to be recorded before and after the addition of PAN as 
illustrated in Figure 2-22a. The difference in absorbance ΔA at the absorption maximum 
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λ = 476 nm is then plotted against the concentration of the surfactant DAE 19o (Figure 
2-22b). The inclusion of PAN was first detected at a concentration of 19o of 2×10-3 M, hinting 
towards the existence of a critical aggregation concentration (CAC) below which no 
aggregation takes place. 
  
Figure 2-22: Investigation of concentration dependence of the aggregation behavior of DAE 19o in H2O by 
UV/vis spectroscopy employing PAN as probe molecule. a) Exemplary UV/vis spectra of PAN in isopentane 
(c = 1×10-5 M), 19o in water (c = 5.3×10-3 M), and 19o in water (c = 5.3×10-3 M) with PAN evaporated from 
200 µL of a solution in isopentane (c = 3.4×10-4 M) for illustration. b) Difference in absorbance ΔA at 
λ = 476 nm plotted against the concentration of 19o. 
To verify that assumption dynamic light scattering (DLS) was performed on solutions 
with three different concentrations lying i) below, ii) in the range of, and iii) above the 
assumed CAC (Figure 2-23). 
 
Figure 2-23: Investigation of concentration dependence of the aggregation behavior of DAE 19o in H2O by DLS 
measurements. 
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However, for all samples a similar signal was recorded indicating the existence of aggregates 
independent of concentration. An estimation of the aggregate size from these measurements 
appears not to be practicable as the shape of the aggregates is unknown. 
Eventually, the results obtained from DLS measurements seem to contradict the 
finding that a CAC of 2×10-3 M exists. This discrepancy is most likely caused by the 
inapplicability of the spectro-photometric method (solvatochromism of the PAN probe) in this 
case. However, a definitive statement over the nature of the formed aggregates would require 
more elaborate techniques, such as cryo-electron microscopy, to directly observe the formed 
structures. In addition to the intriguing results concerning water-soluble switch 19 in the 
context of photoswitchable stoichiometric reactions tangentially covered in Chapter 2.2.2, the 
observed aggregation phenomena leave a lot of room for exploration and interpretation and 
could prospectively prove useful in the field of photoswitchable microenvironments and 
nanoreactors.  
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2.3 Furyl DAEs for the Reversible Covalent Functionalization of Carbon Nanotubes 
2.3.1 Conceptual Outline 
In Chapter 1.7 the functionalization of CNTs and furans via the DA reaction was introduced. 
A number of features were highlighted that are advantageous for this modification of sp2-
carbon allotropes, such as the non-covalent approach’s reversibility and ability to regenerate 
an undisturbed π-lattice as well as the covalent approach’s characteristically strong bonds. 
Employing light as a trigger to regulate this reversibility could offer a new and unprecedented 
level of control, especially over when and where the reversibility is switched ‘on’ or ‘off’. 
Conceptually, the DA reaction of a furyl-substituted DAE with a CNT (or carbonaceous sp2-
lattice in general) is closely related to the idea of controlling covalent connection and 
disconnection by light that was highlighted in Chapter 2.1.[95] Scheme 2-10 summarizes the 
different stages that could potentially occur. 
 
Scheme 2-10: General scheme of a DA reaction between a furyl-substituted DAE and generic, dienophilic sp2-
carbon lattice, as part of a graphene sheet. 
As already established earlier, the furyl-substituted DAE could participate in a thermal 
DA equilibrium between its unreacted form and the adduct with the respective carbonaceous 
material. Both forms incorporating a DAE moiety should retain their photochromic properties 
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and thus be convertible reversibly to forms that switch ‘off’ the possibility to participate in the 
thermal DA equilibrium.  
Besides its potential to photochemically modulate the electronic properties of the π-
electron system of a CNT depending on the functionalization density, the presented system 
could furthermore be used to reversibly attach solubility promoting groups to the CNT. By 
connecting furyl DAEs bearing specifically designed solubilizing groups on their aryl 
moieties via the DA reaction to CNTs, a photoinduced alteration of the CNTs’ solubility could 
be achieved. This modification would prove particularly useful in photolithography 
applications (Figure 2-24). A film of functionalized CNTs casted on a surface could be 
irradiated with UV-light through a mask to only ring-close the DAE-CNT adducts where the 
irradiation occurred. Afterwards, the substrate could be heated inducing the retro DA reaction 
only on the compartments on the surface that have not been irradiated. Subsequent washing 
would only remove the ‘solubility-locked’ CNTs leaving an inverse pattern of pristine CNTs 
on the substrate. 
 
Figure 2-24: Conceptual depiction of a photolithographic process involving CNTs reversibly functionalized with 
furyl-substituted DAEs. a) CNTs functionalized with solubility-promoting DAEs, b) irradiation through a mask, 
c) selectively ring-closed and thus ‘solubility-locked’ fraction of the DAEs, d) heating of the substrate induces 
retro DA on non-irradiated fraction regenerating pristine CNTs, e) ‘solubility-locked’ fraction is washed away to 
yield negative. 
Employing water-soluble furyl-substituted DAEs as solubility promoters would have 
the advantage to simplify analysis of the functionalized CNTs as water gives only weak 
reflexes in Raman spectroscopy. Hence, DAE 19o introduced in Chapter 2.2 is envisioned as 
ideal candidate for this purpose. Eventually, it is important to remark that there are not many 
examples reported in the literature where DAEs are photoswitched in the vicinity of CNTs. 
Besides the covalent bridging of two tubes with different DAEs via their termini[252–255] and 
the blending of CNTs and DAEs in a transistor,[256] the surface or side-wall functionalization 
of CNTs has, to the best of our knowledge, never been carried out. Thus, it is unclear whether 
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the attached DAE would retain its switching performance after the functionalization event or 
if excitation quenching would occur.[201] 
2.3.2 Functionalization and Characterization of CNTs 
Before the functionalization of CNTs with target molecule 19o can be carried out, test 
reactions trying to reproduce results from the literature and to optimize the reaction conditions 
had to be performed. As reversible covalent functionalization on CNTs is described in the 
literature with furfuryl alcohol (FA), it was one of the two probe molecules selected for the 
test reactions.[209,210] Furthermore, 3-acetyl-2,5-dimethylfuran (ADMF) was predicted to 
sufficiently resemble 19o sterically as well as electronically (Scheme 2-11).  
 
Scheme 2-11: Structural formulas of a) furfuryl alcohol, b) 3-acetyl-2,5-dimethylfuran, and c) DAE 19o. 
Various iterations of test reactions were run until proper reaction conditions were 
found for the DA functionalization of MWCNTs. Stirring a solution of the respective furan at 
50 °C in DMSO over 3 d seemed to give most pronounced results as detected by FTIR 
spectroscopy and thermogravimetric analysis (TGA). Figure 2-25a shows that after the 
functionalization with furfuryl alcohol, an absorption band at ca. 900 cm-1 is visible in the IR 
spectrum as compared to the pristine MWCNTs and can be attributed to the C–O-stretch 
movement.[209] However, other expected absorption bands, such as for the C=C- or C–H-
stretch movements of the resulting adduct could not be detected. TGA measurements reveal 
that the tubes lose approximately 2% more of their mass as compared to the pristine 
MWCNTs until decomposition sets in (Figure 2-25b). However, a degree of functionalization 
of 10% and more, such as observed by Chang and Liu in 2009, could not be reproduced.[209] 
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Figure 2-25: Comparison of the FTIR and TGA measurements of MWCNT before and after the reaction with FA 
for 3 d at 50 °C in DMSO. 
Analogous results were obtained for the reaction of ADMF and MWCNTs in DMSO. 
Figure 2-26a expectedly misses the C–O-stretch absorption band visible in Figure 2-25a as no 
C–O single bond is existing in that adduct. Yet, neither the anticipated C=O-, C=C-, nor the 
C–H-stretch absorptions could be observed in the IR spectra after the DA reaction. The results 
obtained by TGA measurements for this adduct resemble the data produced from the reaction 
with furfuryl alcohol (Figure 2-26b). Approximately 2.5% of weight loss was found when 
compared to the same batch of pristine MWCNTs.  
  
Figure 2-26: Comparison of the FTIR and TGA measurements of MWCNT before and after the reaction with 
ADMF for 3 d at 50 °C in DMSO. 
Even though these results were not unambiguous about whether the DA 
functionalization had actually taken place or not, we were encouraged to submit furyl-
substituted DAE 2o to the same conditions. As can be extracted from Figure 2-27a, again 
none but a broad absorption band at ca. 900 cm-1 could be observed upon performing FTIR 
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spectroscopy on the processed tubes. TGA measurements also resembled the ones carried out 
in the test reactions beforehand with an approximate weight loss of about 2–2.5% as 
compared to the pristine MWCNTs (Figure 2-27b). 
  
Figure 2-27: Comparison of the FTIR and TGA measurements of MWCNT before and after the reaction with 2o 
for 3 d at 50 °C in DMSO. 
The apparent resemblance of all the gathered data despite employing three different 
molecules strongly suggested that another process than the actual DA functionalization had 
taken place. To rule out unwanted side-reactions, the MWCNTs were heated in a blank test at 
50 °C for 3 d in DMSO without any further additives and analyzed with the same methods 
that have been used earlier. Figure 2-28a reveals a strong similarity between the FTIR spectra 
of the pristine and the processed MWCNTs received from the blank test. 
  
Figure 2-28: Comparison of the FTIR and TGA measurements of MWCNT before and after heating at 50 °C for 
3 d in DMSO. 
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However, TGA analysis clearly shows that the MWCNTs are altered by stirring them in 
DMSO as they exhibit the same mass loss of 2–2.5% that was observed after the assumed DA 
functionalization. Unwanted oxidation reactions and/or the introduction of defects as well as 
adsorbed residual solvent could be the reason for that behavior. The latter would also explain 
the absorption band at 900 cm-1 observed in Figure 2-25a and Figure 2-27a as DMSO exhibits 
strong IR absorption in that region.  
To exclude that the DA functionalization was actually taking place yet it could just not 
be detected properly, the substrate was altered to more defined SWCNTs. Importantly, 
SWCNTs exhibit a higher surface to overall mass ratio and thus a functionalization event 
should be detectable more easily. Target switch 19o was subjected to the same reaction 
conditions as used earlier (50 °C, 3 d) while instead of DMSO water was employed as solvent 
to avoid the suspected unspecific oxidation reactions. From Figure 2-29a it can be seen that 
the IR spectra of the pristine SWCNTs and the supposedly DA-functionalized SWCNTs are 
identical as far as possible. From the TGA data, however, a significant change when compared 
to the pristine SWCNTs can be observed. Figure 2-29b clearly shows a mass loss of 
approximately 5% at a temperature around 200 °C. The delay in decomposition as compared 
to the pristine SWCNTs is also peculiar. However, this behavior is attributed to the removal of 
residual transition metal catalyst during the washing steps, as these SWCNTs have been 
synthesized via chemical vapor deposition (CVD) using CoMoCAT catalyst.  
  
Figure 2-29: Comparison of the FTIR and TGA measurements of SWCNT before and after the reaction with 19o 
for 3 d at 50 °C in water. 
In order to gain further insight into whether the DA functionalization with 19o was 
successful on SWCNTs, UV/vis spectroscopy measurements were carried out. For that 
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purpose, the supposedly functionalized SWCNTs were dispersed in DMSO, subjected to 
sonication, and subsequently centrifuged to yield a solution after decantation. The evolution 
of the UV/vis absorption spectra during the course of irradiation with light of the wavelength 
λirr = 313 nm is depicted in Figure 2-30a. It is clearly visible that a new band forms in the 
visible range of the spectrum indicating the ring-closing event of a diarylethene. However, the 
absorption maximum of the ring-closed form lies around 510 nm which is shifted 
bathochromically as compared to the DA adducts synthesized earlier (compare Chapters 2.1 
and 2.2). As the DA adduct’s ring-closed form typically exhibits its absorption maximum at 
around 400 nm, due to the lack of one double bond, it is reasonable to assume that the 
observed species is in fact not a DA adduct but the unreacted switch 19o. This could either 
mean that a co-precipitation of SWCNTs and 19o occurred and the latter could not be 
removed during the washing steps, or that 19o adsorbed to the SWCNTs’ surface. However, it 
can be excluded that a covalent functionalization event occurred, as a bathochromic shift of 
approximately 100 nm for the SWCNT-19o adduct as compared to the DA adducts 
synthesized earlier seems unlikely. 
Remarkably, prolonged irradiation at 313 nm of the solution of 19o and SWCNTs led 
to precipitation of the SWCNTs presumably due to bundling. To exclude that this effect is 
related to the presence of 19o or 19c, irradiation of a solution of pristine SWCNTs in DMSO 
was performed (Figure 2-30b). It is clearly visible that the tubes precipitate during the course 
of the irradiation with UV-light. 
  
Figure 2-30: UV/vis spectra of DMSO solutions of a) the supposed adduct of 19o and SWCNTs during the 
course of the irradiation with light of the wavelength λirr = 313 nm and b) pristine SWCNTs before and after 
irradiation with light of the wavelength λ = 313 nm. 
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A blind experiment in the dark without any irradiation showed that the solution of SWCNTs is 
stable over multiple hours excluding the thermally induced aggregation as explanation for this 
phenomenon. Until now, no satisfactory reasons could be found explaining this behavior of 
the SWCNTs in solution. However, this phenomenon appears to be an unprecedented and 
significant finding justifying further investigations to understand its origins and implications. 
In conclusion, a covalent functionalization of CNTs could neither be achieved with the 
probing molecules furfuryl alcohol and 3-acetyl-2,5-dimethylfuran trying to reproduce the 
results reported in the literature,[209,210] nor with furyl-substituted DAEs 2o and 19o. The 
reasons for these unsuccessful attempts still remain mostly unclear. Recent calculations and 
findings on graphene, however, leave serious doubt over whether a DA functionalization 
event is actually possible on the undisturbed sp2-lattice suggesting defective positions and 
vacancies in the lattice as reactive sites.[257,258] Nevertheless, the overall goal of this chapter 
remains highly attractive and efforts will continue to be undertaken to realize the 
photocontrolled reversible covalent functionalization of sp2-carbon materials. 
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3. Conclusions and Outlook 
3.1 Controlling Covalent Connection and Disconnection by Light 
As described in Chapter 2.1, a novel set of furyl-substituted DAEs was designed and 
synthesized that offers an unprecedented level of control over the DA reaction. A true 
foundation for various purposes was laid by designing the prototypic furyl-substituted 
switches 1o and 2o that could reversibly undergo the DA reaction with maleimide to their 
corresponding DA adducts 3o and 4o. By in situ illumination of a reactant system consisting 
of 2o and maleimide with light of different wavelengths, the outcome of the DA reaction 
could be biased to a considerable extent, i.e. the DA equilibrium could be switched between 
the side of the starting materials and the side of the products. This was achieved through the 
separate spectral addressability of the respective ring-closed derivatives 2c and 4c as their 
absorption maxima are almost fully separated in the visible part of the spectrum (compare 
Figure 2-5b). This manipulation of a chemical equilibrium enabled us to employ this 
prototypic reaction system for a variety of potential applications as it allows for the external, 
non-invasive, and highly orthogonal control over the formation and scission of covalent bonds 
only by light. 
Despite the reaction system’s prototypic character, there remains ample room for 
improvements. As visualized in Figure 2-5a, the amplification as well as the inhibition of the 
DA reaction is non-quantitative at any of the employed temperatures. This is an intrinsic 
feature of a highly reversible reaction system, as increasing the thermodynamic stability of the 
reaction products would render the reaction irreversible and increasing the thermodynamic 
stability of the starting materials would yield no conversion at all. Thus, other molecular 
concepts have to be identified that can overcome some of these limitations. A highly 
intriguing approach could, for example, exploit the photoinduced modulation of aromaticity to 
govern the outcome of a DA reaction. As the generation of an aromatic π-system stabilizes the 
DA adduct of isobenzofuran and N-methylmaleimide, the DA reaction becomes fast, 
quantitative, and only reversible at temperatures far beyond 100 °C for this particular reaction 
(Scheme 3-1).[159] Consequently, it would be highly fascinating to modulate the aromatic 
stabilization energy generated during this process to exert control over the DA equilibrium. 
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Scheme 3-1: DA reaction between isobenzofuran and N-methylmaleimide. 
This idea could be implemented into a photoswitchable DAE in a straightforward 
manner (Scheme 3-2). By attaching the modified isobenzofuryl moiety in such a way, that one 
of the double bonds of the residual heterocycles is incorporated into the π-system of a 
photoswitchable DAE, the aromaticity of the DA adduct could be switched ‘on’ or ‘off’. 
Through irradiation of a reaction system composed of the isobenzofuryl switch and maleimide 
with UV-light, the double bond granting aromatic stabilization in the adduct form could be 
removed enabling the retro DA reaction at far lower temperatures than in the previous state. 
At the same time, the thermodynamic driving force for the formation of the DA adduct from 
the starting materials would be withdrawn and thus the system would be switched into a state 
of high reversibility.  
 
Scheme 3-2: General scheme of a DA reaction between an aromatic furyl-substituted DAE and maleimide. The 
reactivity towards the dienophile could be switched by changing the aromatic stabilization energy through 
irradiation with light. 
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This conceptually improved approach would solve the issue of non-quantitative 
turnover as observed in a reaction system constituted of 2o and maleimide and render the 
isobenzofuryl-substituted switches especially useful for the release of dienophilic molecules. 
In a sense this system can be regarded as orthogonal to the one we reported in Chapter 2.1, 
since the reactants are not ‘locked’ but the reversibility is switched ‘on’ by irradiation with 
UV-light. Moreover, the attachment of a second heterocycle to the furan could grant facile 
tunability of the aromaticity achieved, as different heteroatoms introduce different amounts of 
aromatic stabilization energy (compare Chapter 1.5.1). The synthesis of the building blocks 
required for the assembly of such DAEs is also described in the literature to some extent.[259] 
Another, usually omitted factor that hampers the effectiveness of the photoswitchable 
DA reaction is the strong concentration dependence. Naturally, a bimolecular reaction such as 
the DA reaction requires reactant concentrations on the molar to millimolar scale. However, 
the reactants’ molar absorptivities in these concentration ranges would be far too high and 
thus for avoiding total absorption phenomena, photochemistry operates best at concentrations 
on the micromolar scale. One solution to overcome this limitation is to disregard the presented 
system’s reversible character and to employ it as release device, as demonstrated in 
Chapter 2.2. However, focusing only on release applications would hamstring the overall 
potential of the reported switch 2o and thus other solutions need to be found. 
One implementation to keep the molar absorptivity low while increasing the local 
concentrations of the reactants would be to covalently tether the maleimide via its N-terminus 
to the DAE, such as proposed in Scheme 3-3. The covalent connection of the dienophile to the 
diene would turn the former intermolecular reaction into an intramolecular reaction 
accelerating the DA reaction even at low concentrations. This tethering approach, however, 
will only be relevant in some applications. 
 
Scheme 3-3: Covalently tethering the dienophile to the diene could increase local concentrations while retaining 
a low molar absorptivity of the solution.  
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3.2 Photoinduced Release of Maleimide Derivatives in Physiological Systems 
In Chapter 2.2 we reported on the successful release of a TOP2 inhibiting drug under 
physiological conditions employing visible light. For the first time, a water-soluble furyl-
substituted DAE 19o was synthesized that could undergo the DA reaction with maleimide or 
N-ethylmaleimide to their corresponding adducts 22o and 23o. These adducts were proven to 
exhibit outstanding switching behavior with a high composition at the PSS after irradiation 
with UV-light while fully retaining their solubility in physiological media. The adducts’ 
corresponding ring-closed forms 22c and 23c were shown to efficiently impede the retro DA 
reaction back to the starting materials and readily regenerated their active, ring-open forms 
22o and 23o upon irradiation with highly bioorthogonal vis-light. It was confirmed that 22o 
and 23o release their respective maleimide derivative under physiological temperatures over 
time achieving calculated daily concentrations in the micromolar range that clearly lie in the 
reported therapeutic window of these drugs. Not only could the extent of the ‘depot effect’, 
i.e. delayed release, conveniently be tuned through the adjustment of the endo to exo 
stereoisomer ratio in the syntheses of the DA adducts, it could also be shown that after a 
certain release time residual DA adduct could be reversibly deactivated by irradiation with 
UV-light in situ through ring-closing remaining 22o or 23o. This combination of reversibly 
altering a release system from its inactive to its active state whereupon the drug can be 
released via thermal equilibration is best described as ‘photoswitchable prodrug’. Eventually, 
the presented system proved to be a potent photoswitchable prodrug for maleimide based 
drugs and is ready to be surveyed with various assays to prove its pharmacological effect 
upon TOP2 action.  
Even though the presented release devices fulfill most of the criteria to be considered 
as successful representatives in the context of photopharmacology, there is still plenty of room 
for improvements. An obvious flaw is the comparably slow release of the drug that can last 
over days. While this feature is the prerequisite for the ‘depot effect’ reported earlier, the 
advantageous resolution in space that light can offer is lost because of the comparably faster 
distribution of the drug in the organism. Hence, it would be beneficial to design a device that 
releases the maleimide based drug on a shorter timescale. This could be performed by 
considering the isobenzofuryl-substituted DAEs as proposed earlier in Scheme 3-2. When 
substituted with solubilizing groups applicable in aqueous media, these types of switches 
could perform even better for the release of maleimide derivatives than 22o or 23o. 
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A further consideration can be made when recalling the content of Figure 2-19. There 
it was shown that aggregation phenomena possibly retain the retro DA reaction by increasing 
the local reactant concentrations inside of the aggregates. When releasing maleimide from 22o 
in a deaggregating solvent mixture, these remarkable effects could not be observed. Hence, a 
molecular design preventing the aggregation of the active DA adducts would be highly 
desirable. As the hydrophobicity of maleimide is held responsible for the aggregation 
phenomena, it can be reasoned that the utilization of a more water-soluble maleimide would 
overcome that difficulty. For instance, polyethylene glycol chains could be attached to the 
maleimide’s N-terminus. 
A synthetically more challenging approach to increase the rate for the retro DA 
reaction would be to introduce electron-withdrawing substituents to the furyl moiety (compare 
Chapter 1.5.2), as exemplified in Scheme 3-4. The electron-withdrawing group would render 
the furyl moiety a poor diene and make the overall DA reaction endergonic.[159] Naturally, this 
would have consequences for the synthesis of the adducts and while maleimide is easily 
released from the switch, the forward DA reaction necessary to prepare the photoswitchable 
prodrug would be severely hampered. 
 
Scheme 3-4: The introduction of an electron-withdrawing formyl group would render the forward DA reaction 
endergonic thus facilitating the release of maleimide. 
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3.3 Furyl DAEs for the Reversible Covalent Functionalization of Carbon Nanotubes 
It became clear in Chapter 2.3 that a covalent functionalization of CNTs could not be 
detected. Neither employing the probing molecules furfuryl alcohol and 3-acetyl-2,5-
dimethylfuran nor with furyl-substituted DAEs 2o and 19o a functionalization could be 
observed using common analytical methods. We can only speculate over the reasons for these 
findings since we could not reproduce the protocols reported in the literature. As we reasoned 
in Chapter 2.3.2 that sp2-carbon allotropes of lesser quality, i.e. such that contain a high 
amount of defects, could show higher reactivity towards functionalization than an undisturbed 
sp2-lattice, the transition towards such low-quality CNTs could resolve the issues we 
encountered. Clearly, this cannot be considered as optimal solution since with increasing 
defect density the outstanding properties of sp2-hybridized carbon allotropes vanish. 
A further reason for the failed functionalization could be the energetic reaction 
profiles. Up to date, it is only scarcely investigated how exergonic DA reactions on CNTs 
actually are. In fact, calculations have been performed on graphene that suggest that the DA 
functionalization on the pristine, undisturbed sp2-carbon lattice is in fact endergonic and 
thermodynamically not working at all. To empirically approach that problem, a library of 
furans with different substituents ranging from bulky to small and electron-donating to 
electron-deficient has to be employed as probes in test reactions (compare Chapter 1.5.2). The 
degree of functionalization, and by this the energetic profile of the DA reaction, should 
correlate with steric demand as well as with the electronic properties of the employed furans. 
Such a systematic study would allow for a conclusion whether the furan based reversible 
covalent functionalization on CNTs is working at all. 
In addition to these suggestions, the functionalization procedures can be changed 
towards more elaborate methods, e.g. the micelle swelling technique.[260,261] In collaboration 
with the group of Prof. Stefanie Reich, we are currently working on the incorporation of the 
furyl-substituted DAEs into micelles arranged around individual SWCNTs. This method 
would potentially generate higher local concentrations of the furyl moieties at the SWCNT’s 
surface, thereby facilitating the functionalization event.  
Also, other sp2-carbon structures can be considered for the functionalization, such as 
fullerenes.[262] In cooperation with the group of Prof. Nazario Martín, we are trying to employ 
fullerenes as discrete and more defined entities to investigate the principles behind the 
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reversible covalent functionalization employing furyl-substituted DAE 2o. A possible eve of 
this is a photocontrollable modulation of the electron-accepting character of C60, giving rise to 
a wavelength or intensity photomodulation of optoelectronic devices,[7] such as 
photoresponsible transistors,[263] light-emitting diodes,[264] or photovoltaic cells.[265] 
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4. Experimental Section 
4.1 Materials and Methods 
4.1.1 Analytical Instrumentation 
NMR spectra were recorded on a 500 MHz (125 MHz for 13C, 470 MHz for 19F) Bruker 
AVANCE II 500 spectrometer or on a 300 MHz (75 MHz for 13C) Bruker AVANCE II 300 
spectrometer at 25 °C using residual protonated solvent signals[266] as internal standards (1H: 
δ(CDCl3) = 7.26 ppm, δ(C6D6) = 7.16 ppm, δ(CD2Cl2) = 5.32 ppm, δ(DMSO-d6) = 2.50 ppm; 
13C: δ(CDCl3) = 77.16 ppm, δ(C6D6) = 128.06 ppm, δ(CD2Cl2) = 53.84 ppm, δ(DMSO-d6) = 
39.52 ppm). Ultrahigh-performance liquid chromatography / mass spectrometry (UPLC/MS) 
was performed on a Waters Acquity UPLC equipped with a Waters LCT Premier XE Mass 
detector for high-resolution MS (HR-MS, ESI+-ionization) and with Waters Alliance systems 
(consisting of a Waters Separations Module 2695, a Waters Diode Array Detector 996 and a 
Waters Mass Detector ZQ 2000). Dynamic light scattering (DLS) experiments were carried 
out on a Malvern Instruments Zetasizer Nano ZS. Thermogravimetric analysis was performed 
on a PerkinElmer Pyris 1 TGA equipped with a PerkinElmer Pyris 1 TGA autosampler and a 
PerkinElmer thermal analysis gas station. Fourier-transform infrared spectroscopy was carried 
out either on a Jasco FTIR-6600 or a Bruker Vertex 70v each equipped with a Specac Golden 
Gate single reflection diamond ATR sample holder. TLC was performed on Merck Silica Gel 
60 F254 TLC plates with a fluorescent indicator employing 254 nm UV-lamp for 
visualization.  
4.1.2 Chemicals and Solvents 
Solvents and commercial starting materials were used as supplied. The solvents were dried 
before use, if necessary, employing an Innovative Technologies solvent purification system 
(multi-unit micro series). Silica gel for chromatography (0.035–0.070 mm, 60 Å) was used for 
column chromatography. The petroleum ether (PE) used had a boiling range of 40–60 °C.  
Dulbecco’s phosphate buffered saline was purchased from Sigma-Aldrich and was modified, 
without calcium chloride and magnesium chloride, sterile-filtered, and suitable for cell 
culture. Multi-walled carbon nanotubes (MWCNTs) were purchased from Sigma-Aldrich, had 
>98% carbon basis, the specifications 6–13 nm outer diameter × 2.5–20 µm length, and were 
synthesized by chemical vapor deposition (CVD). Single-walled carbon nanotubes 
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(SWCNTs) were purchased from Sigma-Aldrich, had >90% carbon basis, a purity of >77%, 
the specifications 0.7–1.1 nm outer diameter × 0.3–2.3 µm length, and were synthesized by 
CVD on CoMoCAT.  
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4.2 Synthesis and Characterization data 
1-(3-(2,5-Dimethylfuryl))-2-(3-(5-(p-tolyl))-2-methylthienyl)-cyclopentene 1o. 
 
1-(3-(2,5-Dimethylfuryl))-2-(3-(5-chloro-2-methylthienyl))-cyclopentene 12 (0.50 g, 
1.70 mmol) was dissolved in dry THF (8 mL) under Ar. To this solution was added dropwise 
n-BuLi (0.85 mL, 1.87 mmol, 2.2 M in cyclohexane) and the resulting brownish solution was 
stirred at rt for 30 min. Then, B(OEt)3 (0.69 mL, 2.55 mmol) was added and the mixture was 
stirred for 45 min at rt. Meanwhile p-tolyl bromide (0.44 g, 2.55 mmol) was dissolved in THF 
(8 mL) under Ar. To this solution was added Pd(PPh3)4 (0.20 g, 0.17 mmol) and the resulting 
mixture was stirred at rt for 15 min. Afterwards, aq. Na2CO3 solution (2 M, 15 mL) and 
ethylene glycol (3 drops) were added. This mixture was heated to 65 °C and then the solution 
containing the borate was added directly without any workup. The combined solutions were 
stirred at 65 °C for 1 d. Subsequently, the solution was diluted with water and extracted with 
EtOAc. The combined organic layers were dried over anhydr. MgSO4 and the solvent was 
removed in vacuo. The resulting crude product was purified by column chromatography 
(silica, petroleum ether:CH2Cl2 = 10:1) to yield a colorless oil 1o (61%) that was stored under 
Ar to prevent oxidation. 1H-NMR (500 MHz, CCl4/CD2Cl2): δ(ppm) = 7.41 (s, 2H, CHar), 
7.14 (s, 2H, CHar), 7.01 (s, 1H, CHar), 5.66 (s, 1H, CHar), 2.80 (m, 4H, CH2), 2.40 (s, 3H, 
CH3), 2.22 (s, 3H, CH3), 2.13 (s, 3H, CH3), 2.08 (m, 2H, CH2), 2.02 (s, 3H, CH3). 13C-NMR 
(125 MHz, CCl4/CD2Cl2): δ(ppm) = 150.1, 147.7, 141.4, 138.4, 137.5, 134.4, 133.5, 132.9, 
130.7 126.6, 124.7, 119.4, 107.9, 40.2, 39.0, 24.2, 22.6, 15.8, 14.8, 14.5. HR-MS(ESI+): m/z 
= 348.1555 (calcd. 348.1548 for C23H24OS+). 
 
1-(3-(2,5-Dimethylfuryl))-2-(3-(5-(3,5-(bistrifluoromethyl)phenyl))-2-methylthienyl)-
cyclopentene 2o 
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1-(3-(2,5-Dimethylfuryl))-2-(3-(5-chloro-2-methylthienyl))-cyclopentene 12 (1.5 g, 
5.0 mmol) was dissolved in dry THF (5 mL) under Ar. To this solution was added dropwise n-
BuLi (2.5 mL, 5.5 mmol, 2.2 M in cyclohexane) and the resulting brownish solution was 
stirred at rt for 30 min. Then, B(OBu)3 (2.0 mL, 7.5 mmol) was added and the mixture was 
stirred for 45 min at rt. Meanwhile, 3,5-bis(trifluoromethyl)bromobenzene (1.3 mL, 
7.5 mmol) was dissolved in THF (5 mL) under Ar. To this solution was added Pd(PPh3)4 
(0.6 g, 0.5 mmol) and the resulting mixture was stirred at rt for 15 min. Afterwards, degassed 
aq. Na2CO3 sol. (10 mL, 2 M) and ethylene glycol (3 drops) were added. This mixture was 
heated to 65 °C and then the solution containing the borate was added directly without any 
workup. The combined solutions were stirred at 65 °C for 1 d. Afterwards, the solution was 
diluted with water and extracted with Et2O. The combined organic layers were dried over 
anhyd. MgSO4 and the solvent was removed in vacuo. The resulting crude product was 
purified by column chromatography (silica, petroleum ether:CH2Cl2 = 10:1) to yield the target 
compound 2o as a colorless solid that was recrystallized from MeOH/acetone and was stored 
under Ar to prevent oxidation (82%). 1H-NMR (500 MHz, CDCl3): δ(ppm) = 7.90 (s, 2H, 
CHar), 7.70 (s, 1H, CHar), 7.19 (s, 1H, CHar), 5.64 (s, 1H, CHar), 2.76 (m, 4H, CH2), 2.16 (s, 
3H, CH3), 2.13 (s, 3H, CH3), 2.04 (m, 2H, CH2), 1.98 (s, 3H, CH3). 13C-NMR (125 MHz, 
CDCl3): δ(ppm) = 149.5, 146.8, 138.3, 136.8, 132.9, 131.7, 126.7, 125.0, 120.2 118.1, 106.4, 
38.8, 37.7, 23.0, 14.7, 13.5, 13.3. 19F-NMR (470 MHz, CDCl3): δ(ppm) = -63.3. HR-
MS(ESI+): m/z = 470.1134 (calcd. 470.1139 for C24H20OF6S+). 
 
1-(3-(2,5-Dimethylfuryl))-2-(3-(5-(3,5-(bistrifluoromethyl)phenyl))-2-methylthienyl)-
cyclopentene 2c 
 
1-(3-(2,5-Dimethylfuryl))-2-(3-(5-(3,5-(bistrifluoromethyl)phenyl))-2-methylthienyl)-cyclo-
pentene 2o was dissolved in an NMR tube in C6D6 and irradiated with a 313 nm UV-lamp for 
5 min. 1H-NMR (300 MHz, C6D6): δ(ppm) = 7.80 (s, 2H, CHar), 7.58 (s, 1H, CHar), 6.19 (s, 
1H, CHar), 5.08 (s, 1H, CHar), 2.71 (t, 3J(H,H) = 7.5 Hz, 2H, CH2), 2.61 (t, 3J(H,H) = 7.5 Hz, 
2H, CH2), 2.18 (m, 2H, CH2), 1.93 (s, 3H, CH3), 1.90 (s, 3H, CH3), 1.75 (s, 3H, CH3). 
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1-(3-(2,5-Dimethylfuryl))-2-(3-(5-(p-tolyl))-2-methylthienyl)-cyclopentene-N-
phenylmaleimide exo adduct exo-3o. 
 
N-phenylmaleimide (0.24 g, 0.68 mmol) and 1-(3-(2,5-dimethylfuryl))-2-(3-(5-(p-tolyl))-2-
methylthienyl)-cyclopentene 1o (0.12 g, 0.68 mmol) were dissolved in MeCN (5 mL) under 
Ar and stirred for 3 d at rt. Removal of the solvent an subsequent column chromatography 
(silica, petroleum ether:EtOAc = 10:6) yielded exo-3o as white foam (37%). 1H-NMR 
(500 MHz, CCl4/CD2Cl2): δ(ppm) = 7.42 (m, 5H, CHar), 7.26 (d, 3J(H,H) = 8.4 Hz, 2H, 
CHar), 7.16 (d, 3J(H,H) = 8.4 Hz, 2H, CHar), 6.94 (s, 1H, CHar), 5.48 (s, 1H, CHar), 2.85 (m, 
2H, CH), 2.81 (m, 2H, CH2), 2.63 (m, 2H, CH2), 2.39 (s, 3H, CH3), 2.34 (s, 3H, CH3), 2.01 
(m, 2H, CH2), 1.69 (s, 3H, CH3), 1.63 (s, 3H, CH3). HR-MS(ESI+): m/z = 521.2021 (calcd. 
521.2025 for C33H31NO3S+). 
 
1-(3-(2,5-Dimethylfuryl))-2-(3-(5-(3,5-(bistrifluoromethyl)phenyl))-2-methylthienyl)-
cyclopentene-maleimide exo adduct exo-4o 
 
Maleimide (1.04 g, 10.75 mmol) and 1-(3-(2,5-dimethylfuryl))-2-(3-(5-(3,5-
(bistrifluoromethyl)phenyl))-2-methylthienyl)-cyclopentene 2o (1.01 g, 2.15 mmol) were 
dissolved in toluene (5 mL) and stirred for 1 d at 50 °C. The solvent was removed in vacuo 
and the whole redissolved in NH4OH (25%, 5 mL) and THF (5 ml) and stirred for 2 d at rt. 
After addition of aq. HCl (2 M) and extraction with Et2O, column chromatography (silica, 
petroleum ether:THF = 10:2) yielded the target compound as a colorless oil. Redissolution in 
MeOH and precipitation with H2O yielded exo-4o as a white powder (59%). 1H-NMR 
(300 MHz, C6D6): δ(ppm) = 8.39 (s, 1H, NH), 7.79 (s, 2H, CHar), 7.56 (s, 1H, CHar), 6.82 (s, 
1H, CHar), 5.51 (s, 1H, CHar), 2.45 (m, 2H, CH2), 2.41 (d, 3J(H,H) = 6.2 Hz, 1H, CH), 2.31 (d, 
3J(H,H) = 6.2 Hz, 1H, CH), 2.16 (m, 2H, CH2), 2.05 (s, 3H, CH3), 1.76 (m, 2H, CH2), 1.69 (s, 
3H, CH3), 1.56 (s, 3H, CH3). 13C-NMR (125 MHz, CDCl3): δ(ppm) = 174.4, 174.3, 151.1, 
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137.43, 137.41, 137.3, 137.2, 137.0, 136.8, 133.2, 133.0, 132.7, 126.9, 125.6, 89.6, 87.4, 54.8, 
54.4, 39.1, 36.8, 30.6, 23.5, 16.4, 16.3, 14.9. HR-MS(ESI+): m/z = 568.1389 (calcd. 568.1331 
for C28H24NO3F6S+). 
 
1-(3-(2,5-Dimethylfuryl))-2-(3-(5-(3,5-(bistrifluoromethyl)phenyl))-2-methylthienyl)-
cyclopentene-maleimide exo adduct exo-4c 
 
1-(3-(2,5-Dimethylfuryl))-2-(3-(5-(3,5-(bistrifluoromethyl)phenyl))-2-methylthienyl)-cyclo-
pentene-maleimide exo adduct exo-4o was dissolved in an NMR tube in C6D6 and irradiated 
with a 313 nm UV-lamp for 5 min. 1H-NMR (300 MHz, C6D6): δ(ppm) = 7.86 (s, 2H, CHar), 
7.62 (s, 1H, CHar), 7.50 (s, 1H, NH), 6.28 (s, 1H, CHar), 2.82 (t, 4J(H,H) = 2.4 Hz, 1H, CH), 
2.43 (m, 2H, CH2), 2.36 (d, 3J(H,H) = 6.4 Hz, 1H, CH), 2.25 (d, 3J(H,H) = 6.4 Hz, 1H, CH), 
2.10 (m, 2H, CH2), 1.83 (s, 3H, CH3), 1.76 (s, 3H, CH3), 1.75 (m, 2H, CH2), 1.30 (s, 3H, 
CH3). 
 
2-Chloro-5-methylthiophene 5 
 
2-Methylthiophene (50 mL, 520 mmol) and N-chlorosuccinimide (76 g, 80 mmol) were 
dissolved in acetic acid (200 mL) and benzene (200 mL) and refluxed for 1.5 h. After cooling 
to rt, the solution was washed with aq. NaOH solution (3 M, 4 × 150 mL) and the solvent was 
removed in vacuo. Fractional distillation yielded a colorless liquid 5 (47%). 1H-NMR 
(500 MHz, CDCl3): δ(ppm) = 6.60 (d, 3J(H,H) = 3.6 Hz, 1 H, CHar), 6.43 (dq, 3J(H,H) = 
3.6 Hz, 4J(H,H) = 1.2 Hz, 1 H, CHar), 2.32 (d, 4J(H,H) = 1.1 Hz, 3 H, CH3). 13C-NMR 
(125 MHz, CDCl3): δ(ppm) = 138.5, 126.5, 125.8, 124.4, 15.5. 
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5-Keto-5-(3-(5-chloro-2-methylthienyl))-ethylpentanoate 6 
 
Glutaric acid monoethyl ester chloride (3.29 mL, 25 mmol) and 2-chloro-5-methylthiophene 5 
(3.29 g, 25 mmol) were dissolved in CH2Cl2 (25 mL) in a Schlenk flask under Ar and cooled 
to 0 °C with an ice bath. To this solution was added pestled AlCl3 portionwise and the whole 
was stirred for 1.5 h at rt. Afterwards, the mixture was poured into ice water and extracted 
with CH2Cl2. The solvent was removed in vacuo and purification by column chromatography 
(silica, PE:EtOAc = 10:1) yielded the target compound 6 as a yellow liquid (64%). 1H-NMR 
(500 MHz, CDCl3): δ(ppm) = 7.17 (s, 1H, CHar), 4.13 (q, 3J(H,H) = 7.2 Hz, 2H, CH2), 2.82 
(t, 3J(H,H) = 7.2 Hz, 2H, CH2), 2.65 (s, 3H, CH3), 2.39 (t, 3J(H,H) = 7.4 Hz, 2H, CH2), 1.25 
(t, 3J(H,H) = 7.2 Hz, 3H, CH3), 2.39 (t, 3J(H,H) = 7.4 Hz, 2H, CH2). 13C-NMR (125 MHz, 
CDCl3): δ(ppm) = 194.8, 173.3, 147.9, 135.0, 126.9, 125.4, 60.5, 40.7, 33.4, 19.3, 16.2, 14.4. 
HR-MS(ESI+): m/z = 275.0490 (calcd. 275.0509 for C12H16O3SCl+). 
 
5-Keto-5-(3-(5-chloro-2-methylthienyl))-pentanoic acid 7 
 
5-Keto-5-(3-(5-chloro-2-methylthienyl))-ethylpentanoate 6 (4.40 g, 16 mmol), EtOH (40 mL) 
and KOH (2.69 g, 48 mmol) were combined in a round bottom flask and the solution was 
refluxed for 4 h. The mixture was then diluted with water and brine and the basic aq. layer 
was extracted one time with Et2O to remove unreacted ester. Afterwards the aq. layer was 
acidified with conc. HCl until the pH was acidic. The acidified aq. layer was then extracted 
with Et2O, the organic layer dried over anhydrous MgSO4 and the solvent removed in vacuo 
to yield the pure target compound 7 as brown oil (97%). 1H-NMR (500 MHz, CDCl3): 
δ(ppm) = 10.65 (br, 1H, COOH), 7.18 (s, 1H, CHar), 2.87 (t, 3J(H,H) = 7.1 Hz, 2H, CH2), 2.67 
(s, 3H, CH3), 2.49 (t, 3J(H,H) = 7.1 Hz, 2H, CH2), 2.03 (m, 2H, CH2). 13C-NMR (125 MHz, 
CDCl3): δ(ppm) = 194.5, 179.4, 147.9, 134.7, 126.7, 125.4, 40.3, 43.9, 18.7, 16.0. HR-
MS(ESI+): m/z = 247.0182 (calcd. 247.0196 for C10H12O3SCl+). 
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5-Keto-5-(3-(5-chloro-2-methylthienyl))-pentanoic acid chloride 8 
 
To a solution of 5-Keto-5-(3-(5-chloro-2-methylthienyl))-pentanoic acid 7 (3.53 g, 
14.3 mmol) in CH2Cl2 (40 mL) in a Schlenk flask under Ar was added oxalyl chloride 
(3.12 mL, 35.8 mmol). The solution was stirred at rt for 3 h. The solvent and remaining 
reactant were removed in vacuo and the received crude target compound 8 was used as is. 
 
5-Chloro-3-(3-chloropropionyl)-2-methylthiophene 9 
 
5-Chloro-2-methylthiophene 5 (8.3 g, 62.5 mmol) and 3-chloropropionyl chloride (6.0 mL, 
62.5 mmol) were dissolved in CH2Cl2 (freshly distilled, 125 mL) and cooled with an ice bath. 
AlCl3 (10.0 g, 75.0 mmol) was pestled and added carefully and portionwise. The solution was 
then stirred for 1.5 h at 0 °C. Afterwards, the reaction mixture was poured into ice water, 
acidified with HCl (2 M), extracted with CH2Cl2 and the combined organic layers were dried 
over anhydrous MgSO4. The whole was filtered through a pad of silica, the solvent removed 
in vacuo and the target compound 9 received including ca. 10% regioisomer (97%) which was 
removed in later steps. HR-MS (ESI+): m/z = 222.9686 (calcd. 222.9715 for C8H9OSCl2+). 
 
3-Acryloyl-5-chloro-2-methylthiophene 10 
 
5-Chloro-3-(3-chloropropionyl)-2-methylthiophene 9 (13.4 g, 60.0 mmol) was dissolved in 
CH2Cl2 (125 mL) and cooled with an ice bath. To this solution was added 1,8-
diazabicycloundec-7-ene, DBU, (9.0 mL, 60.0 mmol) and the whole was stirred for 1 h at rt. 
Afterwards, dil. aq. NH4Cl solution was added, the reaction mixture extracted with CH2Cl2, 
the combined organic layers dried over anhydrous MgSO4 and the solvent removed in vacuo. 
Column chromatography (silica, petroleum ether:EtOAc = 20:1) yielded the target 
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compound 10 as a colorless oil (46%) that was used immediately in the next reaction. 1H-
NMR (300 MHz, CDCl3): δ(ppm) = 7.12 (s, 1 H, CHar), 6.83 (d×d, 3J(H,H) = 10.4 Hz, 
3J(H,H) = 17.1 Hz, 1 H, CH), 6.34 (d×d, 3J(H,H) = 17.1 Hz, 2J(H,H) = 1.6 Hz 1 H, CH2), 5.83 
(d×d, 3J(H,H) = 10.4 Hz, 2J(H,H) = 1.6 Hz 1 H, CH2), 2.64 (s, 3 H, CH3). 13C-NMR (75 
MHz, CDCl3): δ(ppm) = 185.8, 148.2, 135.3, 134.5, 129.8, 127.0, 125.6, 15.9. HR-MS 
(ESI+): m/z = 187.0057 (calcd. 186.9984 for C8H8OSCl+). 
 
1-(3-(2,5-Dimethylfuryl))-5-(3-(5-chloro-2-methylthienyl))-1,5-pentadione 11 
 
Via Michael addition: Diisopropylamine (9.3 mL, 66.0 mmol) was dissolved in dry THF 
(50 mL) under Ar and cooled to -78 °C. To this solution was added n-BuLi (27.3 mL, 
60.0 mmol, 2.2 M in cyclohexane) dropwise, the whole was allowed to warm to rt and finally 
stirred for further 45 min at rt. The solution was then cooled to -35 °C, 3-acetyl-1,5-
dimethylfuran (6.5 mL, 60.0 mmol) was added whereupon the mixture turned yellow. The 
whole was then stirred for 15 min at -35 °C, subsequently allowed to warm to rt and stirred 
for 10 min. Afterwards, 3-acryloyl-5-chloro-2-methylthiophene 10 (11.2 g, 60 mmol) 
dissolved in dry THF (10 mL) was added at -30 °C, the solution stirred at that temperature for 
15 min, and then allowed to warm to rt and stir for another 1 h. The mixture was then 
quenched with sat. aq. NH4Cl solution and extracted with Et2O. The combined organic layers 
were dried over anhydrous MgSO4 and the solvent and remaining starting material removed in 
vacuo at 70 °C. Column chromatography (silica, petroleum ether:EtOAc = 10:1) yielded the 
target compound as a slightly yellow oil 11 that crystallized (31%). Via Friedel-Crafts 
acylation: 5-Keto-5-(3-(5-chloro-2-methylthienyl))-pentanoyl chloride 8 (3.79 g, 14.3 mmol) 
and 2,5-dimethylfuran (1.52 mL, 14.3 mmol) were dissolved in CH2Cl2 (25 mL) in an ice 
cooled Schlenk flask under Ar. To this solution was added SnCl4 (2.0 mL, 17.2 mmol) and the 
whole was stirred for 2 h at 0 °C. Afterwards, the mixture was poured onto ice water and 
extracted with CH2Cl2. The combined organic layers were dried over anhydrous MgSO4, the 
solvent was removed in vacuo and the obtained crude product was purified by column 
chromatography (silica, PE:EtOAc = 10:1) to yield a yellowish solid 11 (20%). 1H-NMR 
(500 MHz, CDCl3): δ(ppm) = 7.18 (s, 1H, CHar), 6.20 (s, 1H, CHar), 2.84 (t, 3J(H,H) = 
7.0 Hz, 2H, CH2), 2.76 (t, 3J(H,H) = 7.0 Hz, 2H, CH2), 2.65 (s, 3H, CH3), 2.53 (s, 3H, CH3), 
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2.24 (s, 3H, CH3), 2.04 (quin, 3J(H,H) = 7.0 Hz, 2H, CH2). HR-MS(ESI+): m/z = 325.0648 
(calcd. 325.0665 for C16H18O3SCl+). 
 
1-(3-(2,5-Dimethylfuryl))-2-(3-(5-chloro-2-methylthienyl))-cyclopentene 12 
 
TiCl4 (5.3 mL, 48.0 mmol) was added very cautiously dropwise to ice cooled dry THF 
(150 mL) under Ar whereupon the solution turned yellow. To this mixture was added Zn dust 
(6.3 g, 96 mmol) and the slurry was then stirred for 45 min at 65 °C. Afterwards, the solution 
was cooled with an ice bath, pyridine (1.9 mL, 24.0 mmol) was added, the solution was stirred 
for 10 min at 0 °C and subsequently 1-(3-(2,5-dimethylfuryl))-5-(3-(5-chloro-2-
methylthienyl))-1,5-pentadione 11 (5.2 g, 16 mmol) was added. The mixture was then 
reheated to 65 °C for 2 h, successively cooled to rt, and quenched with sat. aq. K2CO3 
solution. The mixture was then acidified with aq. HCl (2 M), extracted with Et2O, the 
combined organic layers washed with brine, dried over anhydrous MgSO4, and the solvent 
was removed in vacuo. The resulting crude product was purified by column chromatography 
(silica, petroleum ether:CH2Cl2 = 20:1) to yield a colorless oil 12 (59%) that crystallized and 
was stored under Ar to prevent oxidation. 1H-NMR (500 MHz, CDCl3): δ(ppm) = 6.59 (s, 
1H, CHar), 5.56 (s, 1H, CHar), 2.72 (t, 3J(H,H) = 7 Hz, 2H, CH2), 2.66 (t, 3J(H,H) = 7.0 Hz, 
2H, CH2), 2.18 (s, 3H, CH3), 2.00 (m, 2H, CH2), 1.98 (s, 3H, CH3), 1.94 (s, 3H, CH3). 13C-
NMR (125 MHz, CDCl3): δ(ppm) = 148.9, 146.4, 135.5, 132.4, 131.1, 126.8, 125.3, 117.7, 
106.4, 38.5, 37.6, 22.7, 14.3, 13.4, 13.1. HR-MS(ESI+): m/z = 293.0772 (calcd. 293.0767 for 
C16H18OSCl+). 
 
1-(3-(2,5-Dimethylfuryl))-2-(3-(5-p-pyridyl)-2-methylthienyl)-cyclopentene 13 
 
1-(3-(2,5-Dimethylfuryl))-2-(3-(5-chloro-2-methylthienyl))-cyclopentene 12 (2.84 g, 
9.7 mmol) was dissolved in dry THF (10 mL) in a Schlenk tube under Ar. To this solution was 
added dropwise n-BuLi (4.9 mL, 2.2 M) and the resulting brownish solution was stirred at rt 
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for 30 min. Then, B(OBu)3 (3.93 mL, 14.6 mmol) was added and the mixture was stirred for 
45 min at rt Meanwhile, 4-bromopyridine hydrochloride (2.83 g, 14.6 mmol) was dissolved in 
THF (15 mL) in a Schlenk flask under Ar. To this solution was added Pd(PPh3)4 (1.12 g, 
1.0 mmol) and the resulting mixture was stirred at rt for 15 min. Afterwards, degassed aq. 
Na2CO3 solution and ethylene glycol (3 drops) were added. This mixture was heated to 65 °C 
and then the solution containing the borate was added directly without any workup. The 
combined solutions were stirred at 65 °C for 1 d. Afterwards, the solution was diluted with 
water and extracted with Et2O. The combined organic layers were dried over anhyd. MgSO4 
and the solvent was removed in vacuo. The resulting crude product was purified by column 
chromatography (silica, petroleum ether:EtOAc = 2:1) to yield the target compound 13 as a 
colorless oil that was recrystallized from MeOH/water (76%). 1H-NMR (500 MHz, C6D6): 
δ(ppm) = 8.48 (d, 3J(H,H) = 5.9 Hz 2H, CHar), 7.17 (s, 1H, CHar), 7.05 (d, 3J(H,H) = 5.9 Hz 
2H, CHar), 5.76 (s, 1H, CH), 2.68 (m, 4H, CH2), 2.03 (s, 3H, CH3), 1.97 (s, 3H, CH3), 1.95 (s, 
3H, CH3), 1.91 (m, 2H, CH2). 13C-NMR (125 MHz, CD3CN): δ(ppm) = 151.2, 150.1, 147.4, 
141.5, 138.7, 137.9, 137.1, 133.2, 132.3, 127.3, 127.1, 119.7, 107.2, 39.3, 38.3, 23.5, 14.9, 
13.64, 13.61. HR-MS(ESI+): m/z = 336.1356 (calcd. 336.1422 for C21H22NOS+). 
 
1-(3-(2,5-Dimethylfuryl))-2-(3-(5-p-methylpyridinium)-2-methylthienyl)-cyclopentene 
chloride 14 
 
1-(3-(2,5-Dimethylfuryl))-2-(3-(5-p-pyridyl)-2-methylthienyl)-cyclopentene 13 (0.80 g, 
2.40 mmol) was dissolved in MeCN (50 mL) under Ar and MeI (0.38 mL, 6.0 mmol) was 
added. The solution was stirred at 70 °C for 4 h. Then, the solvent was evaporated in vacuo 
and CH2Cl2 was added. Subsequently, the solution was washed with brine, dried over anhyd. 
MgSO4, and the solvent removed in vacuo to yield 14 as orange solid (89%). 1H-NMR 
(500 MHz, CD3CN): δ(ppm) = 8.48 (d, 3J(H,H) = 6.8 Hz 2H, CHar), 7.98 (d, 3J(H,H) = 
6.8 Hz 2H, CHar), 7.81 (s, 1H, CHar), 5.68 (s, 1H, CHar), 4.18 (s, 3H, CH3), 2.76 (m, 4H, 
CH2), 2.16 (s, 3H, CH3), 2.11 (s, 3H, CH3), 2.04 (m, 2H, CH2), 1.91 (s, 3H, CH3). 13C-NMR 
(125 MHz, CD3CN): δ(ppm) = 162.0, 151.0, 150.1, 147.9, 146.3, 141.5, 135.2, 134.7, 134.1, 
132.2, 122.9, 119.2, 107.7, 48.4, 39.5, 38.7, 23.9, 15.6, 13.7, 13.6. HR-MS(ESI+): m/z = 
350.0214 (calcd. 350.1579 for C22H24NOS+). 
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1-(3-(2,5-Dimethylfuryl))-2-(3-(5-p-methylpyridinium)-2-methylthienyl)-cyclopentene 
hexafluorophosphate 15 
 
1-(3-(2,5-Dimethylfuryl))-2-(3-(5-p-methylpyridinium)-2-methylthienyl)-cyclopentene 
chloride 14 (0.71 g, 1.85 mmol) was dissolved in MeCN (50 mL) whereupon NaPF6 (2.52 g, 
15 mmol) and H2O (1 mL) were added. The solution was stirred at rt for 1 h and subsequently 
the solvent was evaporated in vacuo. The precipitate was washed extensively with H2O and 
dried in vacuo to yield the target compound 15 as red solid (44%). 1H-NMR (500 MHz, 
C6D6): δ(ppm) = 7.88 (d, 3J(H,H) = 6.8 Hz 2H, CHar), 7.37 (s, 1H, CHar), 7.14 (d, 3J(H,H) = 
6.8 Hz 2H, CHar), 5.66 (s, 1H, CHar), 3.95 (s, 3H, CH3), 2.69 (m, 4H, CH2), 1.99 (s, 3H, CH3), 
1.95 (m, 2H, CH2), 1.94 (s, 3H, CH3), 1.91 (s, 3H, CH3). 13C-NMR (125 MHz, C6D6): 
δ(ppm) = 150.3, 148.4, 147.4, 144.8, 144.4, 140.6, 134.4, 133.6, 133.1, 131.5, 121.8, 118.7, 
107.1, 47.5, 39.2, 38.4, 23.5, 15.2, 13.63, 13.56. 19F-NMR (470 MHz, C6D6): δ(ppm) = -
70.2, -71.7. HR-MS(ESI+): m/z = 350.1513 (calcd. 350.1579 for C22H24NOS+). 
 
1-(3-(2,5-Dimethylfuryl))-2-(3-(5-(p-benzoic acid 1,3-bis(dimethylamino))-2-propanoate)-
2-methylthienyl)-cyclopentene hydrochloride 16 
 
1-(3-(2,5-Dimethylfuryl))-2-(3-(5-chloro-2-methylthienyl))-cyclopentene 12 (0.69 g, 
2.35 mmol) was dissolved in dry THF (5 mL) in a  Schlenk tube under Ar. To this solution 
was added dropwise n-BuLi (1.2 mL, 2.2 M) and the resulting brownish solution was stirred at 
rt for 30 min. Then, B(OBu)3 (0.95 mL, 3.5 mmol) was added and the mixture was stirred for 
45 min at rt. Meanwhile, 17 (1.16 g, 3.5 mmol) was dissolved in THF (5 mL) in a Schlenk 
flask under Ar. To this solution was added Pd(PPh3)4 (0.14 g, 0.1 mmol) and the resulting 
mixture was stirred at rt for 15 min. Afterwards, degassed aq. Na2CO3 solution (10 mL, 2 M) 
and ethylene glycol (3 drops) were added. This mixture was heated to 65 °C and then the 
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solution containing the borate was added directly without any workup. The combined 
solutions were stirred at 65 °C for 1 d. Afterwards, the solution was diluted with water and 
extracted with Et2O. The combined organic layers were washed with brine, dried over anhyd. 
MgSO4, and the solvent was removed in vacuo. The resulting crude product was purified by 
column chromatography (silica, acetone with 1% Et3N) to yield the free base (93%) which 
was converted to the hydrochloride by passing anhyd. HCl (generated from dripping muriatic 
acid into conc. H2SO4) through a solution of the free base in anhyd. Et2O. The received 
compound was recrystallized from MeCN/Et2O to yield the target hydrochloride as off-white 
solid 16 (62%). 1H-NMR (500 MHz, CD3CN): δ(ppm) = 8.06 (d, 3J(H,H) = 8.7 Hz 2H, 
CHar), 7.64 (d, 3J(H,H) = 8.7 Hz 2H, CHar), 7.30 (s, 1H, CHar), 5.95 (m, 1H, CH), 5.67 (s, 1H, 
CHar), 3.90 (m, 2H, CH2), 3.52 (m, 2H, CH2), 2.82 (s, 12H, CH3), 2.72 (m, 4H, CH2), 2.08 (s, 
3H, CH3), 2.05 (s, 3H, CH3), 1.98 (m, 2H, CH2), 1.89 (s, 3H, CH3). 13C-NMR (125 MHz, 
CD3CN): δ(ppm) = 165.8, 150.3, 147.3, 140.2, 139.0, 138.8, 137.2, 133.3, 132.9, 132.7, 
131.7, 128.0, 127.6, 125.6, 119.0, 107.3, 66.0, 58.5, 44.3, 39.1, 38.1, 23.4, 14.5, 13.3, 13.1. 
HR-MS(ESI+): m/z = 507.2584 (calcd. 507.2681 for C30H39N2O3S+). 
 
p-Bromobenzoic acid 1,3-bis(dimethylamino)-2-propanoate 17 
 
To an ice-cooled solution of 1,3-bis(dimethylamino)-2-propanol (3.26 mL, 20 mmol) in 
CH2Cl2 (20 mL) was added 4-bromobenzoyl chloride (5.27 g, 24 mmol) in CH2Cl2 (20 mL) 
dropwise via addition funnel. The resulting mixture was stirred at rt overnight whereupon 
precipitate was formed. Subsequently, the formed hydrochloride was dissolved with sat. aq. 
Na2CO3 sol., the organic layer was washed with brine, and the solvent was removed in vacuo. 
The crude mixture was dissolved in petroleum ether and precipitate was filtered off. The 
filtrate was concentrated in vacuo to yield the target compound as 17 a yellow oil (67%). 1H-
NMR (300 MHz, C6D6): δ(ppm) = 7.84 (m, 1H, CHar), 7.82 (m, 1H, CHar), 7.15 (m, 1H, 
CHar), 7.12 (m, 1H, CHar), 5.58 (m, 1H, CH), 2.47 (m, 4H, CH2), 2.14 (s, 12H, CH3). 13C-
NMR (75 MHz, C6D6): δ(ppm) = 165.6, 154.1, 132.2, 131.8, 130.6, 71.5, 61.9, 46.5. HR-
MS(ESI+): m/z = 329.0737 (calcd. 329.0865 for C14H22N2O2Br+). 
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1-(3-(2,5-Dimethylfuryl))-2-(3-(5-p-ethylbenzoyl)-2-methylthienyl)-cyclopentene 18 
 
To a solution of 1-(3-(2,5-dimethylfuryl))-2-(3-(5-chloro-2-methylthienyl))-cyclopentene 12 
(1.00 g, 3.4 mmol) in dry THF (6 mL) under Ar was added n-BuLi (1.7 mL, 2.2 M). The 
reaction mixture turned dark and was stirred at rt for 30 min. Afterwards, B(OiPr)3 (0.96 g, 
5.1 mmol) was added and the mixture was stirred at rt for 1 h. Meanwhile, p-bromo 
ethylbenzoate (1.17 g, 5.1 mmol) was dissolved in THF (3 mL) and to this solution Pd(PPh3)4 
(0.39 g, 0.34 mmol) was added. The resulting mixture was stirred at rt for 45 min. Then, 
degassed aq. Na2CO3 sol. (6 mL, 2 M) and ethylene glycol (4 drops) were added. The resulting 
solution was heated to 65 °C and the borate was added to this solution via a syringe without 
any workup. The combined solutions were stirred at 65 °C for 1 d. Afterwards, the solution 
was diluted with water and extracted with Et2O. The combined organic layers were washed 
with brine, dried over anhyd. MgSO4, and the solvent was removed in vacuo. The resulting 
crude product was purified by column chromatography (silica, PE:CH2Cl2 = 2:1) to yield the 
target compound 18 as a yellowish oil (67%). 1H-NMR (500 MHz, C6D6): δ(ppm) = 8.13 (d, 
3J(H,H) = 8.5 Hz, 2H, CHar), 7.48 (d, 3J(H,H) = 8.5 Hz, 2H, CHar), 7.17 (s, 1H, CHar), 5.76 (s, 
1H, CHar), 4.15 (q, 3J(H,H) = 7.1 Hz, 2H, CH2), 2.70 (m, 4H, CH2), 2.06 (s, 3H, CH3), 2.00 
(s, 3H, CH3), 1.96 (s, 3H, CH3), 1.91 (m, 2H, CH2), 1.05 (t, 3J(H,H) = 7.1 Hz, 3H, CH3). 13C-
NMR (125 MHz, C6D6): δ(ppm) = 166.0, 149.6, 147.1, 139.3, 139.0, 138.3, 136.0, 132.6, 
132.2, 131.9, 131.4, 130.7, 129.4, 126.1, 125.2, 118.6, 107.0, 60.8, 39.1, 38.0, 23.2, 14.6, 
14.3, 13.4, 13.3. HR-MS(ESI+): m/z = 407.1458 (calcd. 407.1681 for C25H27O3S+). 
 
1-(3-(2,5-Dimethylfuryl))-2-(3-(5-p-sodiumbenzoyl)-2-methylthienyl)-cyclopentene 19 
 
To ester 19 (0.077 g, 0.19 mmol) was added NaOH sol. in EtOH (1.9 mL, 0.1 M). The whole 
was stirred at 65 °C for 3 h and subsequently the solvent was removed in vacuo. The residue 
was suspended in MeCN, filtered off by vacuum filtration, and washed repeatedly with MeCN 
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to yield the target compound 19 as a white solid (75%). 1H-NMR (500 MHz, DMSO-d6): 
δ(ppm) = 7.92 (d, 3J(H,H) = 8.1 Hz, 2H, CHar), 7.47 (d, 3J(H,H) = 8.1 Hz, 2H, CHar), 7.27 (s, 
1H, CHar), 5.73 (s, 1H, CHar), 2.72 (mb, 4H, CH2), 2.10 (s, 3H, CH3), 2.00 (s, 3H, CH3), 1.96 
(m, 2H, CH2), 1.90 (s, 3H, CH3). 13C-NMR (125 MHz, DMSO-d6): δ(ppm) = 169.8, 148.6, 
145.7, 139.0, 138.6, 137.0, 133.9, 133.0, 131.7, 131.0, 129.7, 124.2, 123.5, 117.6, 106.2, 38.1, 
37.0, 21.9, 13.9, 12.9. 12.6. HR-MS(ESI+): m/z = 379.1354 (calcd. 379.1368 for 
C23H23O3S+). 
 
1-(3-(2,5-Dimethylfuryl))-2-(3-(5-p-ethylbenzoyl)-2-methylthienyl)-cyclopentene-
maleimide adduct 20o 
 
Maleimide (0.24 g, 2.50 mmol) and 1-(3-(2,5-dimethylfuryl))-2-(3-(5-p-ethylbenzoyl)-2-
methylthienyl))-cyclopentene 18 (0.20 g, 0.50 mmol) were dissolved in EtOH (2 mL) under 
Ar and stirred for 3 h at 80 °C. Removal of the solvent an subsequent column chromatography 
(silica, petroleum ether:EtOAc = 2:1) yielded 20o as white foam as a mixture of 90% of the 
exo isomer and 10% of the endo isomer (79% overall yield). 1H-NMR (500 MHz, C6D6): 
δ(ppm) = 8.14 (d, 3J(H,H) = 8.7 Hz, 2H, CHar), 7.49 (d, 3J(H,H) = 8.7 Hz, 2H, CHar), 7.48 (sb, 
1H, NH), 7.00 (s, 1H, CHar), 5.85 (s, 1H, endo-CH), 5.51 (s, 1H, exo-CH), 4.41 (q, 3J(H,H) = 
6.9 Hz, 2H, CH2), 2.64 (d, 3J(H,H) = 2.5 Hz, 1H, endo-CH), 2.52 (m, 2H, CH2, endo-CH), 
2.42 (m, 2H, CH2), 2.40 (d, 3J(H,H) = 6.5 Hz, 1H, exo-CH), 2.25 (d, 3J(H,H) = 6.5 Hz, 1H, 
exo-CH), 2.16 (m, 1H, CH2), 2.14 (s, 3H, endo-CH3), 2.09 (s, 3H, exo-CH3), 1.76 (m, 2H, 
CH2), 1.72 (s, 3H, exo-CH3), 1.58 (s, 3H, endo-CH3), 1.52 (s, 3H, exo-CH3), 1.43 (s, 3H, 
endo-CH3), 1.03 (t, 3J(H,H) = 7.1 Hz, 3H, CH3). 13C-NMR (125 MHz, C6D6): δ(ppm) = exo: 
174.7, 170.4, 166.3, 151.0, 140.0, 139.0, 137.4, 137.1, 136.0, 134.4, 132.8, 131.1, 130.0, 
126.2, 125.6, 89.7, 87.4, 61.2, 54.8, 54.4, 39.1, 36.7, 23.6, 16.41, 16.39, 15.1, 14.4. HR-
MS(ESI+): m/z = 504.1792 (calcd. 504.1845 for C29H30NO5S+). 
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1-(3-(2,5-Dimethylfuryl))-2-(3-(5-p-ethylbenzoyl)-2-methylthienyl)-cyclopentene-
maleimide adduct 20c 
 
1-(3-(2,5-Dimethylfuryl))-2-(3-(5-p-ethylbenzoyl)-2-methylthienyl)-cyclopentene-maleimide 
adduct 20o (0.05 g, 0.10 mmol) was dissolved in degassed MeCN (150 mL) and irradiated in 
a Rayonet RPR 100 reactor equipped with 300 nm lamps for 5 min while agitated every 
1 min. Column chromatography (silica, PE:EtOAc = 2:1) yielded the ring-closed form 20c as 
a mixture of the endo and exo adduct (38%). 1H-NMR (500 MHz, C6D6): δ(ppm) = 8.17 (d, 
3J(H,H) = 8.4 Hz 2H, CHar), 7.68 (s, 1H, NH), 7.49 (d, 3J(H,H) = 8.4 Hz 2H, CHar), 6.44 (s, 
1H, CHar), 4.14 (q, 3J(H,H) = 7.1 Hz, 2H, CH2), 2.87 (s, 1H, exo-CH), 2.72 (s, 1H, endo-CH), 
2.44 (d, 3J(H,H) = 5.3 Hz, 2H, exo-CH), 2.43 (m, 2H, CH2, endo-CH), 2.21 (d, 3J(H,H) = 5.3 
Hz, 2H, exo-CH), 2.23 (m, 1H, CH2), 2.11 (m, 3H, CH2, endo-CH), 2.00 (s, 3H, endo-CH3), 
1.92 (s, 3H, exo-CH3), 1.83 (s, 3H, endo-CH3), 1.77 (s, 3H, exo-CH3), 1.59 (m, 2H, CH2), 
1.40 (s, 3H, endo-CH3), 1.34 (s, 3H, exo-CH3), 1.03 (t, 3J(H,H) = 7.1 Hz, 3H, CH3). HR-
MS(ESI+): m/z = 503.1548 (calcd. 503.1766 for C29H29NO5S+). 
 
1-(3-(2,5-Dimethylfuryl))-2-(3-(5-p-ethylbenzoyl)-2-methylthienyl)-cyclopentene-N-
ethylmaleimide adduct 21o 
 
N-ethylmaleimide (0.31 g, 2.50 mmol) and 1-(3-(2,5-dimethylfuryl))-2-(3-(5-p-ethylbenzoyl)-
2-methylthienyl))-cyclopentene 18 (0.20 g, 0.50 mmol) were dissolved in EtOH (2 mL) under 
Ar and stirred for 3 h at 80 °C. Removal of the solvent an subsequent column chromatography 
(silica, PE:THF = 5:1) yielded 21o as yellowish oil as a mixture of 90% of the exo isomer and 
10% of the endo isomer (83% overall yield). 1H-NMR (500 MHz, C6D6): δ(ppm) = 8.14 (d, 
3J(H,H) = 8.7 Hz, 2H, CHar), 7.49 (d, 3J(H,H) = 8.7 Hz, 2H, exo-CHar), 7.44 (d, 3J(H,H) = 8.7 
Hz, 2H, endo-CHar), 7.03 (s, 1H, exo-CHar), 6.99 (s, 1H, endo-CHar), 5.56 (s, 1H, exo-CH), 
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5.46 (m, 1H, endo-CH), 4.14 (q, 3J(H,H) = 7.1 Hz, 2H, CH2), 3.35 (q, 3J(H,H) = 7.1 Hz, 2H, 
exo-CH2), 3.24 (m, 2H, endo-CH2), 2.71 (d, 3J(H,H) = 7.8 Hz, 1H, endo-CH), 2.66 (d, 
3J(H,H) = 7.8 Hz, 1H, endo-CH), 2.56 (m, 1H, CH2), 2.45 (m, 2H, CH2), 2.44 (d, 3J(H,H) = 
6.5 Hz, 1H, exo-CH), 2.30 (d, 3J(H,H) = 6.5 Hz, 1H, exo-CH), 2.20 (m, 1H, CH2), 2.11 (s, 3H, 
CH3), 1.76 (m, 2H, CH2), 1.75 (s, 3H, exo-CH3), 1.66 (s, 3H, endo-CH3), 1.55 (s, 3H, exo-
CH3), 1.46 (s, 3H, endo-CH3), 1.43 (s, 3H, endo-CH3), 1.03 (t, 3J(H,H) = 7.1 Hz, 3H, CH3), 
0.96 (t, 3J(H,H) = 7.1 Hz, 3H, CH3). 13C-NMR (125 MHz, C6D6): δ(ppm) = exo: 174.6, 
174.4, 166.2, 151.1, 140.0, 139.0, 137.5, 137.3, 136.0, 132.9, 130.0, 131.1, 126.2, 125.6, 
108.4, 89.7, 87.4, 67.6, 53.6, 53.2, 39.1, 36.8, 34.0, 29.5, 16.54, 16.50, 15.1, 14.6, 13.4. HR-
MS(ESI+): m/z = 531.2094 (calcd. 531.2097 for C31H33NO5S+). 
 
1-(3-(2,5-Dimethylfuryl))-2-(3-(5-p-sodiumbenzoyl)-2-methylthienyl)-cyclopentene-
maleimide adduct 22o 
 
1-(3-(2,5-Dimethylfuryl))-2-(3-(5-p-sodiumbenzoyl)-2-methylthienyl)-cyclopentene 19 
(0.100 g, 0.25  mmol) and maleimide (0.121 g, 1.25 mmol) were dissolved in EtOH (2.0 mL) 
and stirred at rt for 1 d. Subsequently, the solvent was removed in vacuo, the crude compound 
dispersed in acetone, filtered off and washed with acetone repeatedly to remove residual 
maleimide yielding 22o as a mixture of the endo (40%) and exo adduct (60%) (quant.). 1H-
NMR (500 MHz, D2O): δ(ppm) = 7.80 (m, 2H, CHar), 7.40 (m, 2H, CHar), 6.93 (m, 1H, 
CHar), 5.63 (s, 1H, endo-CHar), 5.55 (s, 1H, exo-CHar) 3.32 (d, 3J(H,H) = 7.1 Hz, 1H, endo-
CH), 3.27 (d, 3J(H,H) = 7.1 Hz, 1H, endo-CH), 2.65 (d, 3J(H,H) = 6.2 Hz, 1H, exo-CH), 2.59 
(d, 3J(H,H) = 6.2 Hz, 1H, exo-CH), 2.35 (m, 4H, CH2), 2.02 (s, 3H, CH3), 1.69 (m, 2H, CH2), 
1.42 (s, 3H, endo-CH3), 1.38 (s, 3H, endo-CH3), 1.33 (s, 3H, exo-CH3), 1.32 (s, 3H, exo-CH3). 
HR-MS(ESI+): m/z = 476.1455 (calcd. 476.1532 for C27H26NO5S+). 
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1-(3-(2,5-Dimethylfuryl))-2-(3-(5-p-sodiumbenzoyl)-2-methylthienyl)-cyclopentene-
maleimide adduct 22c 
 
1-(3-(2,5-Dimethylfuryl))-2-(3-(5-p-ethylbenzoyl)-2-methylthienyl)-cyclopentene-maleimide 
adduct 20c (0.019 g, 0.038 mmol) was dissolved in NaOH in EtOH (0.38 mL, 0.1 M) and 
stirred at 70 °C for 3 h. Evaporation of the solvent yielded the ring-closed form 22c as a 
mixture of the endo and exo adduct (quant.). 1H-NMR (500 MHz, D2O): δ(ppm) = 7.72 (s, 
1H, NH), 7.71 (d, 3J(H,H) = 8.1 Hz, 2H, CHar), 7.60 (d, 3J(H,H) = 8.1 Hz, 2H, CHar), 6.72 (s, 
1H, CHar), 2.82 (s, 1H, CH), 2.76 (m, 1H, CH), 2.71 (m, 1H, CH), 2.38 (m, 2H, CH2), 2.26 
(m, 2H, CH2), 1.67 (m, 2H, CH2), 1.51 (s, 3H, CH3), 1.47 (s, 3H, CH3), 1.00 (s, 3H, CH3). 
HR-MS(ESI+): m/z = 476.1394 (calcd. 476.1532 for C27H26NO5S+). 
 
1-(3-(2,5-Dimethylfuryl))-2-(3-(5-p-sodiumbenzoyl)-2-methylthienyl)-cyclopentene-N-
ethylmaleimide adduct 23o 
 
1-(3-(2,5-Dimethylfuryl))-2-(3-(5-p-sodiumbenzoyl)-2-methylthienyl)-cyclopentene 19 
(0.100 g, 0.25 mmol) and N-ethylmaleimide (0.156 g, 1.25 mmol) were dissolved in EtOH 
(2.0 mL) and stirred at 70 °C for 6 h. Subsequently, the solvent was removed in vacuo, the 
crude compound dispersed in acetone, filtered off and washed with acetone repeatedly to 
remove residual N-ethylmaleimide yielding 23o as mixture of the endo (3%) and the exo 
adduct (97%) (quant.). 1H-NMR (500 MHz, DMSO, D2O): exo adduct: δ(ppm) = 7.76 (d, 
3J(H,H) = 7.5 Hz, 2H, CHar), 7.49 (d, 3J(H,H) = 7.5 Hz, 2H, CHar), 7.17 (s, 1H, CHar), 5.89 (s, 
1H, CHar), 3.27 (q, 3J(H,H) = 6.5 Hz, 2H, CH2), 2.84 (d, 3J(H,H) = 5.6 Hz, 1H, CH), 2.78 (d, 
3J(H,H) = 5.6 Hz, 1H, CH), 2.65 (m, 2H, CH2), 2.43 (m, 2H, CH2), 2.17 (s, 3H, CH3), 1.90 
(m, 2H, CH2), 1.36 (s, 6H, CH3), 0.90 (t, 3J(H,H) = 6.5 Hz, 3H, CH3). HR-MS(ESI+): m/z = 
526.1635 (calcd. 526.1664 for C29H29NO5NaS+). 
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Functionalization Attempts on MWCNTs 
Method A. The functionalization attempts on MWCNTs were carried out in Schlenk tubes 
under Ar according to procedures in the literature.[210] Neat furfuryl alcohol or 3-acetyl-2,5-
dimethylfuran (3 mL) were degassed by repeated sonication and pump cycles whereupon 
MWCNTs (50 mg) were added to the reactant. The dispersions were stirred for 1 d at either 
75 °C or 150 °C. Subsequently the mixtures were cooled to r.t., the tubes collected by vacuum 
filtration, and washed extensively with THF. When TGA and FTIR analysis did not prove any 
visible functionalization the protocol was altered adding a 1 h sonication step before the 
heating.  
Method B. As Method A did not produce any visible functionalization, the protocol was 
changed to the one published by Chang and Liu.[209] Furfuryl alcohol or 3-acetyl-2,5-
dimethylfuran (3 mL) were dissolved in DMSO (15 mL) and degassed by repeated sonication 
and pump cycles. Afterwards, MWCNTs (50 mg) were added to the solution and stirred at 
50 °C or 75 °C for 3 d. Subsequently the mixtures were cooled to r.t., the tubes collected by 
vacuum filtration, and washed extensively with THF. TGA and FTIR analysis showed 
ambiguous results for the runs at 50 °C so Method B was used with switch 2o in a 0.2 M 
solution in DMSO. 
Functionalization attempts on SWCNTs 
Method B optimized earlier with MWCNTs was used for the functionalization of SWCNTs 
using water instead of DMSO and switch 19o (0.1 M).   
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4.3 Procedures and Photochemistry 
4.3.1 General Remarks 
All procedures linked to photochemistry were performed using spectrophotometric grade 
solvents. UV/vis absorption spectroscopy was performed on a Varian Cary 60 UV/vis 
spectrophotometer equipped with a Peltier thermostated cell holder at 25 ± 0.05 °C if not 
indicated otherwise. Analytical irradiation was performed employing an Oriel 500 W mercury 
arc lamp model 68810 in an Oriel universal arc lamp housing model 66055 equipped with an 
Oriel ¼ m grating monochromator model 77200, an Oriel timed shutter and water filter either 
at 313 nm or 334 nm for ring-closure or at 436 nm or 546 nm for ring-opening reactions or on 
an Oriel 1000 W xenon arc lamp model 66924 using an Oriel timed shutter, water filter, and 
various cut-off filters. The lamp output beam was wired into the spectrophotometer 
orthogonal to the beamline of the respective spectrophotometer employing fiber-optics to 
enable simultaneous irradiation and probing.  
Quantum yields were determined using the initial slope method according to 
Equation (1.9) presented in Chapter 1.3.3. Due to the intrinsic error in the mathematical 
approximation (linear fitting of the initial slope) employed and the varying time intervals for 
cyclization and cycloreversion reactions (longer in the case of cycloreversion), the quantum 
yields obtained by this method exhibit an estimated relative uncertainty in measurement of 
10% of the obtained value for photocyclization and for cycloreversion reactions. Quantum 
yields were determined by comparing the initial reaction yields for the cyclization and the 
cycloreversion of the diarylethenes with the isomerization of commercial azobenzene in 
methanol[106] and commercial furyl fulgide Aberchrome 670 in toluene,[267] respectively. 
4.3.2 In situ Diels-Alder Studies 
In situ Diels-Alder studies were carried out in a quartz cuvette employing DAE 2o (10-5 M) 
and maleimide (10-2 M) in spectroscopy grade toluene. The solutions were kept at 
temperatures from 25 °C to 60 °C employing a Varian Cary 60 UV/vis spectrophotometer 
equipped with a Peltier thermostated cell holder for a given time. Simultaneous irradiation 
was performed by employing Roithner LEDs (UVTOP335-BL-TO18, LED375-06, LED395-
02V, LED405-06V, and LED535-01) driven by a GW Instek GPD-3303S linear DC power 
supply. After the given time, the composition of the solutions was analyzed by UPLC/MS. 
The retention times of the involved species were determined independently. The diode array 
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detector signal at 270 nm was chosen for relative integration of the signals as the molar 
absorptivities of the relevant species 2o, 2c, 4o, and 4c are almost similar at this wavelength 
(compare Figure 2-5a).  
Thermal reaction of 2o and maleimide without irradiation was carried out for 1 d. 
Amplification of the Diels-Alder reaction was performed by thermal reaction for 6 h while 
irradiating with 335 nm and 535 nm light. UVTOP335-BL-TO18 at 1 mA and 6.2 V and 
LED535-01 at 20 mA and 4.0 V were employed. Inhibition of the Diels-Alder reaction was 
performed by thermal reaction for 1 d while irradiating with 375 nm light. An LED375-06 at 
20 mA and 4.3 V during the first hour and 1 mA and 4.3 V for the remaining 23 h was 
employed.  
4.3.3 Photoinduced Release of Maleimide Derivatives 
The photoinduced releases of maleimide from 22c and the release of N-ethylmaleimide from 
23c were carried out in situ in a quartz cuvette using phosphate buffered saline as solvent. 
10-4 M solutions were employed and tempered using a Varian Cary 60 or Cary 50 UV/vis 
spectrophotometer equipped with a Peltier thermostated cell holder for a given time. 
Generation of the ring-closed isomers was carried out in situ by irradiation of the respective 
DAEs 22o or 23o employing the Oriel 500 W mercury arc lamp until the quasi quantitative 
PSS was reached. The compositions of the solutions at a certain time were determined by 
UPLC/MS measurements through integration of the DAD signals at 280 nm where the molar 
absorptivity of all participating species was approximately identical. For preparation of the 
UPLC samples, an aliquot of 100 µL was pipetted out of the cuvette and diluted with 50 µL 
MeCN and 50 µL THF to avoid the formation of aggregates that could stick on the column. 
The retention times of the involved species were determined independently on the isolated 
compounds. 
The in situ step experiment for the release of maleimide from 22c was carried out by 
initial irradiation of 22o to the PSS consisting almost exclusively of 22c employing the Oriel 
500 W mercury arc lamp and the grating monochromator. Ring-opening to 22o was then 
performed on the Oriel 1000 W xenon arc lamp using cut-off filters with transmission only at 
wavelengths greater than 400 nm. The following release process was observed by UPLC/MS 
measurements as specified earlier. After 5 h, ring-closing for deactivation was then initiated 
by irradiation of the mixture until 22 reached its PSS employing the Oriel 500 W mercury arc 
lamp and the grating monochromator. Tempering for 15 h was then again observed by 
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UPLC/MS until the 22c was activated, i.e. ring-opened to 22o again by employing the Oriel 
1000 W xenon arc lamp using cut-off filters and followed by subsequent tempering. 
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DAD  — diode array detector 
DAE  — diarylethene 
DBU  — 1,8-diazabicycloundec-7-ene 
DCC  — dynamic covalent chemistry 
DLS  — dynamic light scattering 
DMSO — dimethyl sulfoxide 
DNA  — deoxyribonucleic acid 
ESI  — electrospray ionization 
FA  — furfuryl alcohol 
FTIR  — Fourier transform infrared 
125 
GABA  — γ-aminobutyric acid 
hCAI  — human carbonic anhydrase 1 
HOMO — highest occupied molecular orbital 
LED  — light emitting diode 
LUMO — lowest unoccupied molecular orbital 
MeCN  — acetonitrile 
MI  — maleimide 
MINT  — mechanically interlocked nanotubes 
MS  — mass spectrometry 
MWCNT — multi-walled carbon nanotube 
NEM  — N-ethylmaleimide 
NMR  — nuclear magnetic resonance 
PAN  — 1-(2-pyridylazo)-2-naphthol 
PBS  — phosphate buffered saline 
PDT  — photodynamic therapy 
PE  — petroleum ether 
PSS  — photostationary state 
rt  — room temperature 
SWCNT — single-walled carbon nanotube 
TGA  — thermogravimetric analysis 
THF  — tetrahydrofuran 
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TLC  — thin layer chromatography 
TOP2  — DNA topoisomerase II 
TRPV1 — transient receptor potential cation channel subfamily V member 1 
UPLC  — ultra-high performance liquid chromatography 
UV  — ultraviolet 
vis  — visible 
XPhos  — 2-dicyclohexylphosphino-2‘,4‘,6‘-triisopropylbiphenyl 
